
<html lang="en"     class="pb-page"  data-request-id="16fb4ed5-6571-4b94-bda3-ce23fe67171d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2014.57.issue-5;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm4016203;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Hepatitis C Virus NS5A Replication Complex Inhibitors. Part 6: Discovery of a Novel and Highly Potent Biarylimidazole Chemotype with Inhibitory Activity Toward Genotypes 1a and 1b Replicons" /></meta><meta name="dc.Creator" content="Makonen  Belema" /></meta><meta name="dc.Creator" content="Van N.  Nguyen" /></meta><meta name="dc.Creator" content="Jeffrey L.  Romine" /></meta><meta name="dc.Creator" content="Denis R.  St. Laurent" /></meta><meta name="dc.Creator" content="Omar D.  Lopez" /></meta><meta name="dc.Creator" content="Jason T.  Goodrich" /></meta><meta name="dc.Creator" content="Peter T.  Nower" /></meta><meta name="dc.Creator" content="Donald R.  O’Boyle, II" /></meta><meta name="dc.Creator" content="Julie A.  Lemm" /></meta><meta name="dc.Creator" content="Robert A.  Fridell" /></meta><meta name="dc.Creator" content="Min  Gao" /></meta><meta name="dc.Creator" content="Hua  Fang" /></meta><meta name="dc.Creator" content="Rudolph G.  Krause" /></meta><meta name="dc.Creator" content="Ying-Kai  Wang" /></meta><meta name="dc.Creator" content="A. Jayne  Oliver" /></meta><meta name="dc.Creator" content="Andrew C.  Good" /></meta><meta name="dc.Creator" content="Jay O.  Knipe" /></meta><meta name="dc.Creator" content="Nicholas A.  Meanwell" /></meta><meta name="dc.Creator" content="Lawrence B.  Snyder" /></meta><meta name="dc.Description" content="A medicinal chemistry campaign that was conducted to address a potential genotoxic liability associated with an aniline-derived scaffold in a series of HCV NS5A inhibitors with dual GT-1a/-1b inhib..." /></meta><meta name="Description" content="A medicinal chemistry campaign that was conducted to address a potential genotoxic liability associated with an aniline-derived scaffold in a series of HCV NS5A inhibitors with dual GT-1a/-1b inhib..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 17, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm4016203" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm4016203" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm4016203" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm4016203" /></link>
        
    
    

<title>Hepatitis C Virus NS5A Replication Complex Inhibitors. Part 6: Discovery of a Novel and Highly Potent Biarylimidazole Chemotype with Inhibitory Activity Toward Genotypes 1a and 1b Replicons | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm4016203" /></meta><meta property="og:title" content="Hepatitis C Virus NS5A Replication Complex Inhibitors. Part 6: Discovery of a Novel and Highly Potent Biarylimidazole Chemotype with Inhibitory Activity Toward Genotypes 1a and 1b Replicons" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0015.jpeg" /></meta><meta property="og:description" content="A medicinal chemistry campaign that was conducted to address a potential genotoxic liability associated with an aniline-derived scaffold in a series of HCV NS5A inhibitors with dual GT-1a/-1b inhibitory activity is described. Anilides 3b and 3c were used as vehicles to explore structural modifications that retained antiviral potency while removing the potential for metabolism-based unmasking of the embedded aniline. This effort resulted in the discovery of a highly potent biarylimidazole chemotype that established a potency benchmark in replicon assays, particularly toward HCV GT-1a, a strain with significant clinical importance. Securing potent GT-1a activity in a chemotype class lacking overt structural liabilities was a critical milestone in the effort to realize the full clinical potential of targeting the HCV NS5A protein." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm4016203"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm4016203">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm4016203&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm4016203&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm4016203&amp;href=/doi/10.1021/jm4016203" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 1995-2012</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm301796k" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm401836p" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Hepatitis C Virus NS5A Replication Complex Inhibitors. Part 6: Discovery of a Novel and Highly Potent Biarylimidazole Chemotype with Inhibitory Activity Toward Genotypes 1a and 1b Replicons</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Makonen++Belema">Makonen Belema</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Van+N.++Nguyen">Van N. Nguyen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey+L.++Romine">Jeffrey L. Romine</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Denis+R.++St.+Laurent">Denis R. St. Laurent</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Omar+D.++Lopez">Omar D. Lopez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jason+T.++Goodrich">Jason T. Goodrich</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+T.++Nower">Peter T. Nower</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donald+R.++O%E2%80%99Boyle%2C++II">Donald R. O’Boyle, II</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Julie+A.++Lemm">Julie A. Lemm</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+A.++Fridell">Robert A. Fridell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Min++Gao">Min Gao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hua++Fang">Hua Fang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rudolph+G.++Krause">Rudolph G. Krause</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ying-Kai++Wang">Ying-Kai Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=A.+Jayne++Oliver">A. Jayne Oliver</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+C.++Good">Andrew C. Good</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jay+O.++Knipe">Jay O. Knipe</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicholas+A.++Meanwell">Nicholas A. Meanwell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lawrence+B.++Snyder">Lawrence B. Snyder</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Departments of Discovery Chemistry, <sup>‡</sup>Virology, <sup>§</sup>Lead Discovery and Optimization, <sup>∥</sup>Computer-Assisted Drug Design, and <sup>⊥</sup>Metabolism and Pharmacokinetics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div><div class="corresp-info"><strong>*</strong>Tel: 1-203-677-6928; E-mail: <a href="/cdn-cgi/l/email-protection#8ee3efe5e1e0ebe0a0ecebe2ebe3efceece3fda0ede1e3"><span class="__cf_email__" data-cfemail="402d212b2f2e252e6e22252c252d2100222d336e232f2d">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm4016203&amp;href=/doi/10.1021%2Fjm4016203" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 1995–2012</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 17, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 October 2013</li><li><span class="item_label"><b>Published</b> online</span>17 January 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 March 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm4016203" title="DOI URL">https://doi.org/10.1021/jm4016203</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1995%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMakonen%2BBelema%252C%2BVan%2BN.%2BNguyen%252C%2BJeffrey%2BL.%2BRomine%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D5%26contentID%3Djm4016203%26title%3DHepatitis%2BC%2BVirus%2BNS5A%2BReplication%2BComplex%2BInhibitors.%2BPart%2B6%253A%2BDiscovery%2Bof%2Ba%2BNovel%2Band%2BHighly%2BPotent%2BBiarylimidazole%2BChemotype%2Bwith%2BInhibitory%2BActivity%2BToward%2BGenotypes%2B1a%2Band%2B1b%2BReplicons%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2012%26publicationDate%3DMarch%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm4016203"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1414</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">17</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm4016203" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Hepatitis C Virus NS5A Replication Complex Inhibitors. Part 6: Discovery of a Novel and Highly Potent Biarylimidazole Chemotype with Inhibitory Activity Toward Genotypes 1a and 1b Replicons&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Makonen&quot;,&quot;last_name&quot;:&quot;Belema&quot;},{&quot;first_name&quot;:&quot;Van&quot;,&quot;last_name&quot;:&quot;N. Nguyen&quot;},{&quot;first_name&quot;:&quot;Jeffrey&quot;,&quot;last_name&quot;:&quot;L. Romine&quot;},{&quot;first_name&quot;:&quot;Denis&quot;,&quot;last_name&quot;:&quot;R. St. Laurent&quot;},{&quot;first_name&quot;:&quot;Omar&quot;,&quot;last_name&quot;:&quot;D. Lopez&quot;},{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;T. Goodrich&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;T. Nower&quot;},{&quot;first_name&quot;:&quot;Donald&quot;,&quot;last_name&quot;:&quot;R. O’Boyle&quot;},{&quot;first_name&quot;:&quot;Julie&quot;,&quot;last_name&quot;:&quot;A. Lemm&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;A. Fridell&quot;},{&quot;first_name&quot;:&quot;Min&quot;,&quot;last_name&quot;:&quot;Gao&quot;},{&quot;first_name&quot;:&quot;Hua&quot;,&quot;last_name&quot;:&quot;Fang&quot;},{&quot;first_name&quot;:&quot;Rudolph&quot;,&quot;last_name&quot;:&quot;G. Krause&quot;},{&quot;first_name&quot;:&quot;Ying-Kai&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;A.&quot;,&quot;last_name&quot;:&quot;Jayne Oliver&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;C. Good&quot;},{&quot;first_name&quot;:&quot;Jay&quot;,&quot;last_name&quot;:&quot;O. Knipe&quot;},{&quot;first_name&quot;:&quot;Nicholas&quot;,&quot;last_name&quot;:&quot;A. Meanwell&quot;},{&quot;first_name&quot;:&quot;Lawrence&quot;,&quot;last_name&quot;:&quot;B. Snyder&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;1995-2012&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm4016203&quot;},&quot;abstract&quot;:&quot;A medicinal chemistry campaign that was conducted to address a potential genotoxic liability associated with an aniline-derived scaffold in a series of HCV NS5A inhibitors with dual GT-1a/-1b inhibitory activity is described. Anilides 3b and 3c were used as vehicles to explore structural modifications that retained antiviral potency while removing the potential for metabolism-based unmasking of the embedded aniline. This effort resulted in the discovery of a highly potent biarylimidazole chemotype that established a potency benchmark in replicon assays, particularly toward HCV GT-1a, a strain with significant clinical importance. Securing potent GT-1a activity in a chemotype class lacking overt structural liabilities was a critical milestone in the effort to realize the full clinical potential of targeting the HCV NS5A protein.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4016203&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4016203" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4016203&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4016203" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4016203&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4016203" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm4016203&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4016203&amp;href=/doi/10.1021/jm4016203" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm4016203" /></input><a href="/doi/pdf/10.1021/jm4016203" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (931 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm4016203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm4016203%26sid%3Dliteratum%253Aachs%26pmid%3D24437689%26genre%3Darticle%26aulast%3DBelema%26date%3D2014%26atitle%3DHepatitis%2BC%2BVirus%2BNS5A%2BReplication%2BComplex%2BInhibitors.%2BPart%2B6%253A%2BDiscovery%2Bof%2Ba%2BNovel%2Band%2BHighly%2BPotent%2BBiarylimidazole%2BChemotype%2Bwith%2BInhibitory%2BActivity%2BToward%2BGenotypes%2B1a%2Band%2B1b%2BReplicons%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D5%26spage%3D1995%26epage%3D2012%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291687" title="Reagents">Reagents</a>,</li><li><a href="/action/doSearch?ConceptID=292149" title="Testing and assessment">Testing and assessment</a>,</li><li><a href="/action/doSearch?ConceptID=291831" title="Chemical specificity">Chemical specificity</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291864" title="Fluorescence resonance energy transfer">Fluorescence resonance energy transfer</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jmcmar.2014.57.issue-5/production/jmcmar.2014.57.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/medium/jm-2013-016203_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4016203&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A medicinal chemistry campaign that was conducted to address a potential genotoxic liability associated with an aniline-derived scaffold in a series of HCV NS5A inhibitors with dual GT-1a/-1b inhibitory activity is described. Anilides <b>3b</b> and <b>3c</b> were used as vehicles to explore structural modifications that retained antiviral potency while removing the potential for metabolism-based unmasking of the embedded aniline. This effort resulted in the discovery of a highly potent biarylimidazole chemotype that established a potency benchmark in replicon assays, particularly toward HCV GT-1a, a strain with significant clinical importance. Securing potent GT-1a activity in a chemotype class lacking overt structural liabilities was a critical milestone in the effort to realize the full clinical potential of targeting the HCV NS5A protein.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/57/5"><issue-title>HCV Therapies</issue-title></a> special issue.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23230" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23230" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The hepatitis C virus (HCV) field is expected to experience a significant change in treatment paradigm over the next few years as a consequence of drug-discovery efforts sustained across both the pharmaceutical industry and academia during the past 2 decades.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> A major focus of this endeavor has been the functional disruption of the virus’ key nonstructural proteins, most notably, NS3/4A, NS5A, and NS5B, with direct-acting antiviral agents (DAAs). Various DAA combinations have reached late-stage clinical development and are exhibiting superior efficacy and tolerability compared to the current interferon-based regimens.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">Previously, we have disclosed the clinical validation of the NS5A protein as an antiviral target with daclatasvir (<b>1</b>)<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/medium/jm-2013-016203_0016.gif" alt="" id="GRAPHIC-d1576e338-autogenerated" /></img> as well as various facets of the initial structure–activity relationship (SAR) investigations that, among others, uncovered a class of glycinamide cap derivatives that enhanced the genotype-1a (GT-1a) inhibitory potency of an early NS5A lead series (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, <b>3b</b> and <b>3c</b>).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Although the improved potency was encouraging, the significant disparity observed between GT-1a and GT-1b inhibition suggested that an additional gain in potency toward GT-1a was possible. In addition, although the stilbene core and its alkyne variant were useful scaffolds for exploring the SARs at the periphery of the molecule, there was some concern about the embedded aniline moiety because it may pose a risk for genotoxicity in the event that it is released in vivo by hydrolytic enzymes and becomes activated by further metabolism in the liver.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> For example, it was observed that although anilide <b>2a</b> was nonmutagenic in an Ames assay, both with and without rat liver S9 homogenate, aniline <b>2b</b> was mutagenic when assayed in the presence of rat liver S9 homogenate. Although the susceptibility of the anilide bond to hydrolysis, in vivo or otherwise, was not examined, we opted to explore structural replacements to eliminate the potential liability.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> A compound with a phenylacetamide cap that lacked GT-1a inhibitory activity and two analogues with glycinamide caps, representing previously disclosed basic and nonbasic series exhibiting enhanced GT-1a inhibitory activities, were chosen for this exercise (see the caps of structure <b>3</b>).<a onclick="showRef(event, 'cit3b'); return false;" href="javascript:void(0);" class="ref cit3b">(3b)</a> Herein, we describe the campaign that achieved these objectives through the discovery of a novel and potent biarylimidazole chemotype, the parental series of <b>1</b>, by capitalizing on a number of key SAR findings including an interesting interplay between GT-1a inhibitory potency and core topology.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/medium/jm-2013-016203_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selected analogues of anilide series.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4016203&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry, Results, and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67645" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67645" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Single-crystal X-ray analyses of relevant proline–anilide structural fragments indicated that the amide bond of anilides is coplanar with the phenyl ring and thus, as part of an initial examination of replacements that would act as bioisosteres, the amide moiety was integrated onto the phenyl group, as exemplified by benzimidazole <b>9</b> or regioisomeric benzoxazoles <b>15</b> and <b>16</b>.<a onclick="showRef(event, 'cit3b ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref cit3b ref7 ref8 ref9">(3b, 7-9)</a> It was reasoned that the benzimidazole group in <b>9</b> would retain both the H-bond accepting and H-bond donating properties of the anilide moiety in <b>3</b>, with its tautomers providing alternate modes of H-bond interactions with the NS5A protein, whereas benzoxazole variants <b>15</b> and <b>16</b> would be able to participate as only H-bond acceptors, likely through nitrogen, with defined but differing trajectories.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">The synthetic route to assemble the benzimidazole chemotype is outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Diaminobenzene <b>4</b> was coupled with <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline to afford anilide <b>5</b>, which was cyclized to benzimidazole <b>6</b> by heating in acetic acid. Coupling benzimidazole <b>6</b> with 1,2-bis(trimethylstannyl)ethyne followed by acid-mediated Boc deprotection afforded penultimate precursor <b>8</b>. Final products were prepared from <b>8</b> and the appropriate carboxylic acid cap precursors under standard HATU/DIEA-coupling conditions and purified by reverse-phase preparative HPLC.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/medium/jm-2013-016203_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Analogues with Benzimidazole and Benzoxazole Scaffolds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4016203&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline, HOBT, EDCI, CH<sub>2</sub>Cl<sub>2</sub>; (b.1) AcOH, 65 °C; (b.2) DIAD, Ph<sub>3</sub>P, THF; (c) Me<sub>3</sub>Sn≡SnMe<sub>3</sub>, Pd(Ph<sub>3</sub>P)<sub>4</sub>, DMF, 80 °C; (d.1) HCl/dioxane/MeOH; (d.2) 20% TFA/CH<sub>2</sub>Cl<sub>2</sub>; (e) RCO<sub>2</sub>H, HATU, DIEA, DMF.</p></p></figure><div class="NLM_p">The compounds were screened for their inhibitory activities in GT-1a and GT-1b replicons and cellular toxicity in a GT-1b replicon. In addition, specificity for HCV was assessed using a BVDV replicon that shared the same cellular background, Huh-7 cells, as that of the activity screens. A subset of the analogues were also assayed in a GT-1b LV/YH double-resistant mutant replicon to corroborate target specificity.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">Replicon evaluation of <b>9a</b>–<b>c</b> indicated that although the benzimidazole class still maintained subnanomolar levels of GT-1b inhibitory potency for the glycinamide cap analogues there was a loss in GT-1a inhibitory activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). For example, <b>9b</b> and <b>9c</b> were 26- and 4.2-fold weaker than their anilide counterparts toward the GT-1a replicon, respectively. Although the maintenance of a potent inhibitory activity toward the GT-1b replicon with the benzimidazole chemotype was encouraging, the loss in GT-1a inhibitory potency foreshadowed the challenge encountered subsequently in maintaining and/or enhancing GT-1a coverage while optimizing other parameters.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Activity and Specificity of Anilides <b>3</b>, Benzimidazoles <b>9</b>, and Benzoxazoles <b>15</b> and <b>16</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/medium/jm-2013-016203_0010.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">HCV replicon inhibitory activity</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">GT-1a EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">GT-1b EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">GT-1b CC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">BVDV EC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>400</td><td class="colsep0 rowsep0" align="left">5.6</td><td class="colsep0 rowsep0" align="left">>10<sup>4</sup></td><td class="colsep0 rowsep0" align="left">>10<sup>4</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3b</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">NMe<sub>2</sub></td><td class="colsep0 rowsep0" align="left"><4.6, 13</td><td class="colsep0 rowsep0" align="left"><4.6</td><td class="colsep0 rowsep0" align="left">5390</td><td class="colsep0 rowsep0" align="left">1900</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3c</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">NHCO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="left">0.013</td><td class="colsep0 rowsep0" align="left">>10<sup>4</sup></td><td class="colsep0 rowsep0" align="left">>10<sup>4</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left"><4.6</td><td class="colsep0 rowsep0" align="left">>10<sup>4</sup></td><td class="colsep0 rowsep0" align="left">>10<sup>4</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9b</b></td><td class="colsep0 rowsep0" align="left">NMe<sub>2</sub></td><td class="colsep0 rowsep0" align="left">232</td><td class="colsep0 rowsep0" align="left">0.075</td><td class="colsep0 rowsep0" align="left">6390</td><td class="colsep0 rowsep0" align="left">3420</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9c</b><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">NHCO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="left">108</td><td class="colsep0 rowsep0" align="left">0.055</td><td class="colsep0 rowsep0" align="left">>10<sup>4</sup></td><td class="colsep0 rowsep0" align="left">>10<sup>4</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>10<sup>3</sup></td><td class="colsep0 rowsep0" align="left">>10<sup>3</sup></td><td class="colsep0 rowsep0" align="left">>10<sup>4</sup></td><td class="colsep0 rowsep0" align="left">412</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15b</b></td><td class="colsep0 rowsep0" align="left">NMe<sub>2</sub></td><td class="colsep0 rowsep0" align="left">>10<sup>3</sup></td><td class="colsep0 rowsep0" align="left">>10<sup>3</sup></td><td class="colsep0 rowsep0" align="left">4450</td><td class="colsep0 rowsep0" align="left">1390</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>10<sup>3</sup></td><td class="colsep0 rowsep0" align="left">>10<sup>3</sup></td><td class="colsep0 rowsep0" align="left">>10<sup>4</sup></td><td class="colsep0 rowsep0" align="left">7980</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16b</b><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">NMe<sub>2</sub></td><td class="colsep0 rowsep0" align="left">>10<sup>3</sup></td><td class="colsep0 rowsep0" align="left"><4.6</td><td class="colsep0 rowsep0" align="left">2720</td><td class="colsep0 rowsep0" align="left">390</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Data represent mean values of at least two experiments.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Activity assessment: GT-1a, FRET (<b>3a</b> and <b>9a</b>) or ELISA (remaining set); GT-1b, FRET; and BVDV, luciferase. Cytotoxicity assessment: GT-1b, alamar blue.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Data disclosed previously in ref <a onclick="showRef(event, 'cit3b'); return false;" href="javascript:void(0);" class="ref cit3b">3b</a>.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">EC<sub>50</sub> in GT-1b LV/YH resistant replicon: <b>9c</b> (>3330 nM) and <b>16b</b> (>10<sup>3</sup> nM).</p></div></div></div><div class="NLM_p">Preliminary pharmacokinetic assessments of <b>9b</b> and <b>9c</b> in 4 h rat PK screens (PO: 5 mg/kg, PEG-400 vehicle, <i>n</i> = 2) indicated moderate-to-poor systemic exposure (AUC<sub>4h</sub> < LLQ for <b>9b</b> and AUC<sub>4h</sub> = 466 nM·h for <b>9c</b>). In a follow up 24 h rat PK study (IV/PO: 2/5 mg/kg, PEG-400 vehicle, <i>n</i> = 3), <b>9c</b> had a CL<sub>iv</sub> of 1.1 mL/min/kg, a PO-AUC<sub>24h</sub> of 539 ± 19 nM·h, and an oral bioavailability of <1%. Because <b>9c</b> had low clearance, it was postulated that the poor systemic exposure after oral dosing could be a reflection of poor permeability, with P-glycoprotein efflux likely making an additional contribution based on performance in a Caco-2 bidirectional assay (e.g., <b>9c</b>: B–A/A–B efflux ratio ≥ 7.2).</div><div class="NLM_p">Benzoxazoles <b>15</b> and <b>16</b> were assembled from aminophenols <b>10a</b> and <b>10b</b>, respectively, according to the route illustrated in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Capricious instability was observed during acid-catalyzed Boc deprotection and/or reverse-phase HPLC purification of the final products under acidic medium (MeOH/H<sub>2</sub>O/TFA).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> According to LC/MS analyses, the degradation products, formed as minor components, were consistent with the hydration of one of the benzoxazole moieties, accompanied in some instances by the cleavage of the putative aminobenzoate intermediate to afford aminophenol derivatives. Considering the fact that the primary objective for this exercise was to avoid a potential genotoxic liability by minimizing the formation of anilinic species, this instability issue was of some concern in the context of oral dosing. Nevertheless, final products with targeted purity (≥95%) were obtained through flash chromatography, and we opted to profile their HCV inhibitory activities for a fuller appreciation of the unfolding SAR while being mindful of the need to interpret the pertinent activity data carefully. Surprisingly, compounds <b>15a</b>, <b>15b</b>, and <b>16a</b> were essentially inactive in both GT-1a and GT-1b replicons, whereas <b>16b</b> exhibited potent inhibitory activity toward GT-1b replicon accompanied with a noticeable signal in the BVDV assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Although the stability of the benzoxazole analogues in the replicon medium was not examined closely, the possibility that the compounds may have degraded to variable extents during the course of the assay could not be ruled out.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Consequently, it is possible that the observed potency may not be a true reflection of the nature of the interaction that would have transpired between the targeted dimeric benzoxazoles and the NS5A protein. Evidently, the benzoxazole investigation was neither productive nor truly informative.</div><div class="NLM_p">At this juncture, attention was redirected to the benzimidazole series, and consideration was given to the various factors that could have caused the potency to diminish, particularly toward GT-1a. It was apparent that tying back the amide unit in <b>3</b> onto the phenyl ring to afford benzimidazole <b>9</b> resulted in both a change in the vectorial disposition of the peripheral components and a localized conformational restriction around what appears to be an important H-bond donating/accepting element. To obtain a better understanding on how changes in these parameters may affect the GT-1a activity, two distinct SAR explorations were pursued: one approach focused on examining the ramifications of an anilide-to-benzimidazole conversion within the context of an oxazole-linked scaffold, providing topologies that are distinct from that of the original alkyne series, and the second approach focused on identifying an alternate replacement for the anilide moiety that, among others, was conformationally more flexible than benzimidazole.</div><div class="NLM_p">Anilide-oxazole <b>21</b> was prepared readily from biphenyloxazole <b>17</b> through the adoption of a route communicated previously (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The modular assembly of benzimidazole <b>27</b> from precursors <b>22</b> and <b>24</b> is illustrated in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. A key step of the devised route involved the construction of the oxazole linker through the condensation of aminoketone <b>23</b> and carboxylic acid <b>25</b> followed by dehydration. Replacement of the alkyne linker in <b>3b</b> with an oxazole, as in <b>21</b>, resulted in >60-fold potency loss toward both the GT-1a and GT-1b replicons (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The significant loss in potency, particularly toward GT-1b, was unexpected, and it was not apparent at this stage which of the modified molecular parameters, core vector or linker polarity, was the primary contributing factor. Interestingly, when both anilide moieties of <b>21</b> were replaced with benzimidazoles, as in <b>27</b>, the GT-1b activity improved by >100-fold, whereas the GT-1a activity remained essentially unchanged. Although the oxazole-linked benzimidazole template appeared to provide no advantage over its alkyne counterpart from a GT-1a coverage perspective, an important insight was gleaned from subsequent SAR explorations where the oxazole linker was used to examine the activities of regioisomeric anilide-benzimidazole hybrid templates. The purpose here was to find out how inhibitory potency would be impacted if the topology that an oxazole linker introduces into the core region was offset by changing the substitution pattern of the attachments on the phenyl rings. Activity assessment of hybrid analogues <b>31a</b> and <b>31b</b>, assembled from acid <b>28</b> as described in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>, indicated that whereas the GT-1a potency of <i>para</i>-regioisomer <b>31a</b> was within 3.9-fold of that of <i>bis</i>-benzimidazole <b>27</b>, <i>meta</i>-regioisomer <b>31b</b> exhibited a significantly enhanced GT-1a inhibitory potency.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> It is noteworthy that regioisomers <b>31a</b> and <b>31b</b> had similar GT-1b potencies. The fact that a para-to-meta transposition of the anilide moiety in <b>31a</b>, to afford <b>31b</b>, resulted in ∼70-fold gain in GT-1a potency while having minimal impact on GT-1b activity not only illustrated the differing tolerance of the two NS5A proteins to the modifications examined but also drew attention to a parameter that needed to be examined more closely to optimize the GT-1a activity further. To rule out the possibility that the anilide portion of <b>31b</b> might be responsible for the significant enhancement of the compound’s GT-1a inhibitory potency, <i>bis</i>-anilide <b>38a</b> was prepared (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>), tested, and found to have weaker GT-1a inhibiting properties. It is noteworthy that <i>bis</i>-anilide <b>38b</b>, a regioisomer of <b>38a</b> or <b>21</b>, was very potent toward both GT-1a and GT-1b replicons.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/medium/jm-2013-016203_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Compound <b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4016203&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HNO<sub>3</sub>/H<sub>2</sub>SO<sub>4</sub>; (b) 1 atm H<sub>2</sub>, 20% Pd(OH)<sub>2</sub>/C, MeOH/EtOAc; (c) <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline, EEDQ, CH<sub>2</sub>Cl<sub>2</sub>; (d) HCl/dioxane/MeOH; (e) (<i>R</i>)-PhCH(NMe<sub>2</sub>)CO<sub>2</sub>H, HATU, DIEA, DMF.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/medium/jm-2013-016203_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation Oxazole-Linked <i>bis</i>-Benzimidazole Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4016203&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3 N HCl/H<sub>2</sub>O, 80 °C; (b) SnCl<sub>2</sub>·2H<sub>2</sub>O, MeOH, 70 °C; (c) <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline, HATU, DIEA, DMF; (d) AcOH, 60 °C; (e) NaN<sub>3</sub>, CH<sub>3</sub>CN, 60 °C; (f) SnCl<sub>2</sub>·2H<sub>2</sub>O, MeOH, 60 °C; (g) <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline, <i>i</i>-BuO<sub>2</sub>CCl, <i>N</i>-methylmorpholine, DIEA, THF; (h) NaOH, MeOH; (i) HATU, DIEA, DMF; (j) C<sub>2</sub>Cl<sub>6</sub>, Ph<sub>3</sub>P, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>; (k) HCl/MeOH/dioxane, 0 °C to rt; (l) (<i>R</i>)-PhCH(NMe<sub>2</sub>)CO<sub>2</sub>H, HATU, DIEA, DMF.</p></p></figure><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/medium/jm-2013-016203_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of Oxazole-Linked Benzimidazole-Anilide Hybrid Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4016203&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline, EDCI, CH<sub>2</sub>Cl<sub>2</sub>; (b) <b>23</b>, HATU, DIEA, DMF; (c) C<sub>2</sub>Cl<sub>6</sub>, Ph<sub>3</sub>P, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>; (d) HCl/MeOH/dioxane, 0 °C to rt; (e) (<i>R</i>)-PhCH(NMe<sub>2</sub>)CO<sub>2</sub>H, HATU, DIEA, DMF; (f) (2<i>S</i>)-1-[(2<i>R</i>)-2-(dimethylamino)-2-phenylacetyl]pyrrolidine-2-carboxylic acid, HATU, DIEA, DMF.</p></p></figure><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/medium/jm-2013-016203_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of Regioisomeric Oxazole-Linked Anilides <b>38a</b> and <b>38b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4016203&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HATU, DIEA, DMF; (b) C<sub>2</sub>Cl<sub>6</sub>, Ph<sub>3</sub>P, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>; (c) H<sub>2</sub> (20 psi), 10% Pd/C, MeOH; (d) <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline, HATU, DIEA, DMF; (e) HCl/MeOH/dioxane, 0 °C to rt; (f) (<i>R</i>)-PhCH(NMe<sub>2</sub>)CO<sub>2</sub>H, HATU, DIEA, DMF; (g) EDCI, HOAT, <i>N</i>-methylmorpholine, DMF; (h) Burgess reagent, THF, 100 °C; (i) H<sub>2</sub> (1 atm), 10% Pd/C, EtOH/THF; (j) 20% TFA/CH<sub>2</sub>Cl<sub>2</sub>; (k) <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline, EEDQ, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Activity and Specificity of Oxazole-Linked Analogues<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/medium/jm-2013-016203_0011.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/medium/jm-2013-016203_0012.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Data represent mean values of at least two experiments.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Activity assessment: GT-1a, FRET (<b>21</b>, <b>38a</b>, <b>38b</b>) or ELISA (remaining set); GT-1b, FRET; and BVDV, luciferase. Cytotoxicity assessment: GT-1b, alamar blue.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">EC<sub>50</sub> in GT-1b LV/YH resistant replicon: >10<sup>3</sup> nM.</p></div></div><div></div></div><div class="NLM_p">The fact that hybrid chemotype <b>31b</b> exhibits a GT-1a activity that is significantly better than either of its pseudo-homodimeric counterparts (i.e., <i>bis</i>-benzimidazole <b>27</b> or <i>bis</i>-anilide <b>38a</b>) suggested that it might be feasible to identify a scaffold exhibiting the GT-1a/-1b inhibitory activity of anilides <b>3b/3c</b> but lacking their genotoxic liability through additional isosteric iteration, where the distance between the pharmacophoric elements and their relative topological disposition was varied. It was against this backdrop that deannelation of the benzimidazole moieties of <b>9</b> into phenylimidazoles was pursued, with concomitant removal of the alkyne linker to offset the core lengthening that such structural manipulation would entail. Alternatively, this approach would be equivalent to replacing the amide moieties of original aniline-based lead <b>3</b> with imidazole isosteres and making a compensatory length adjustment to the central scaffold region (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> It was envisioned that such a chemotype would decrease conformational rigidity of the benzimidazole chemotype while providing an opportunity to survey vectorial trajectories that may not have been accessed thus far. This enterprise indeed proved fruitful.</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/medium/jm-2013-016203_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Bioisosteric design strategy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4016203&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The biphenylimidazole chemotype was assembled by the synthetic route illustrated in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>. Heating ketoamide <b>45a</b> with excess NH<sub>4</sub>OAc afforded phenylimidazole <b>46a</b>, contaminated with a minor amount of oxazole <b>46b</b> that was readily removed under standard flash chromatography conditions.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> A Suzuki–Miyaura coupling of bromide <b>46a</b> with its boronate derivative <b>47</b> afforded biphenylimidazole <b>48</b>, which was elaborated to final products <b>50a</b>–<b>d</b> under conditions noted for the chemotypes discussed above. Gratifyingly, glycinamide cap analogues <b>50b</b> and <b>50c</b> exhibited an unprecedented antiviral spectrum in the replicon assays, with GT-1a and GT-1b EC<sub>50</sub> values <50 pM, accompanied by favorable antiviral specificity, as indicated by BVDV EC<sub>50</sub> and GT-1b CC<sub>50</sub> of >1 μM (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Both compounds exhibited weaker potency toward NS5A GT-1b LV/YH resistant replicon, which supports their specificity for the HCV NS5A protein. In line with the cap SAR uncovered with the lead alkyne-linked anilide template, phenylacetamide cap analogue <b>50a</b> exhibited a significant loss in GT-1a inhibitory potency, and the (R) stereoisomer of the dimethylamine cap was much more potent than its (S) counterpart (compare <b>50c</b> vs <b>50d</b>). As part of the preliminary cap-SAR survey of this new chemotype, heterodimeric cap analogues <b>54a</b> and <b>54b</b> were also prepared through the intermediacy of differentially protected precursor <b>51a</b> (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>). The GT-1a EC<sub>50</sub> of <b>54a</b> was similar to that of its homodimeric cap variants <b>50b</b> and <b>50c</b>, which demonstrated that chemical symmetry is not a requirement for effecting potent GT-1a activity. Moreover, in going from homodimer <b>50b</b> to heterodimer <b>54b</b>, the GT-1b potency remained essentially unchanged, whereas the GT-1a potency eroded by ∼530-fold. This finding, coupled with the differential activity exhibited by advanced synthetic precursor <b>52</b> toward GT-1a and -1b replicons, illustrates, yet again, that the GT-1a NS5A protein exhibits a more stringent pharmacophoric requirement for inhibition. Although it is clear that the biphenylimidazole chemotype was optimal for achieving potent GT-1a activity, the poor GT-1a and GT-1b inhibitory activity of the <i>bis</i>-Boc intermediate <b>48</b> coupled with the single-digit nanomolar potency exhibited by anilide <b>3b</b> toward GT-1a revealed, in general, that the cap region plays the more dominant role among the elements of the pharmacophore.</div><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/medium/jm-2013-016203_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Preparation of Biarylimidazole Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4016203&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline, HATU, DIEA, DMF; (b) NH<sub>4</sub>OAc, xylenes, 140 °C; (c) bis(pinacolato)diboron, Pd(Ph<sub>3</sub>P)<sub>4</sub>, KOAc, 1,4-dioxane; (d) <b>46a</b>, Pd(Ph<sub>3</sub>P)<sub>4</sub>, NaHCO<sub>3</sub>, DME, 80 °C; (e) 25% TFA/CH<sub>2</sub>Cl<sub>2</sub>; (f) RCO<sub>2</sub>H, HATU, DIEA, DMF; (g) Pd(Ph<sub>3</sub>P)<sub>4</sub>, NaHCO<sub>3</sub>, DMF, 80 °C; (h) H<sub>2</sub> (60 psi), 10% Pd/C, K<sub>2</sub>CO<sub>3</sub>, MeOH.</p></p></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Activity and Specificity of Biarylimidazoles<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/medium/jm-2013-016203_0013.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/medium/jm-2013-016203_0014.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Data represent mean values of at least two experiments.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Activity assessment: GT-1a, FRET (<b>50a</b>, <b>52</b> and <b>48</b>) or ELISA (remaining set); GT-1b, FRET; and BVDV, luciferase. Cytotoxicity assessment: GT-1b, alamar blue.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">EC<sub>50</sub> in GT-1b LV/YH resistant replicon: <b>50b</b> (166 nM) and <b>50c</b> (233 nM).</p></div></div><div></div></div><div class="NLM_p">Carbamate <b>50b</b> and amine <b>50c</b> were characterized further to gather preliminary information on the chemotype’s broader genotype coverage potential and on its in vitro and in vivo metabolism and pharmacokinetic (MAP) properties. Both compounds exhibited very potent inhibition toward a panel of HCV replicon strains (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), with EC<sub>50</sub> values <60 pM for all except a GT-3a YH resistant strain. Both had very good metabolic stability in human and rat liver microsomes (100% remaining after 10 min of incubation), whereas their PAMPA permeability at pH 7.4 was either poor (7 nm/s for <b>50c</b>) or inconclusive (null for <b>50b</b>). In a 4 h rat PK screen study (IV/PO dose: 2/5 mg/kg, PEG-400 vehicle, <i>n</i> = 2), <b>50b</b> and <b>50c</b> exhibited low estimated clearance after IV dosing (11.1 and 17.4 mL/min/kg, respectively) but essentially no systemic exposure after oral dosing; only one plasma sample obtained at 0.17 h after PO dosing of <b>50c</b> indicated exposure, with a 20 nM concentration recorded. Although the poor PO exposure was disappointing, it can be rationalized when considering the fact that the structural composition of these prototypical molecules lies on the periphery of the chemical space historically deemed drug-like.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> At this stage of the SAR exploration it became apparent that additional iterations of structural refinements were needed to attain targeted PK properties without compromising the gains in replicon inhibitory potency of this promising new chemotype class.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Antiviral Activity of <b>50b</b> and <b>50c</b> toward a Panel of HCV Genotype Strains</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">EC<sub>50</sub> (nM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">HCV replicon strain<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"><b>50b</b></th><th class="colsep0 rowsep0" align="center"><b>50c</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GT-2a (J6)</td><td class="colsep0 rowsep0" align="left">0.023</td><td class="colsep0 rowsep0" align="left">0.032</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GT-3a</td><td class="colsep0 rowsep0" align="left">0.0040</td><td class="colsep0 rowsep0" align="left">0.015</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GT-3a YH</td><td class="colsep0 rowsep0" align="left">4.4</td><td class="colsep0 rowsep0" align="left">3.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GT-4a</td><td class="colsep0 rowsep0" align="left">0.0057</td><td class="colsep0 rowsep0" align="left">0.013</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GT-5a</td><td class="colsep0 rowsep0" align="left">0.014</td><td class="colsep0 rowsep0" align="left">0.032</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Data represent mean values of at least two experiments done with FRET assays.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">All are hybrid replicons in either GT-2a JFH-1 backbone (for GT-2a J6 and GT-5a) or GT-1b Con1 backbone (for GT-3a, GT-3a YH and GT-4a). </p></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62370" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62370" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A novel, highly potent and pan-genotypic biphenylimidazole chemotype was discovered through an optimization campaign that was directed at addressing the potential genotoxic liabilities and nonoptimal virology properties of early program leads containing an anilide moiety. In an initial effort, the anilide was replaced with either benzimidazole or regioisomeric benzoxazoles, which resulted in various levels of inhibitory potency loss toward GT-1a and/or GT-1b replicons. Subsequently, an examination of regioisomeric benzimidazole/anilide hybrid cores with an oxazole central linker revealed the critical importance of core topology in determining GT-1a inhibitory activity, paving the way for consideration of deannelation of the benzimidazole chemotype to enhance GT-1a potency. This strategy succeeded and led to the identification of a biphenylimidazole chemotype that exhibited picomolar inhibitory potency toward a panel of clinically relevant strains. It is intriguing that securing potent GT-1a activity has been consistently problematic both in a previously disclosed cap investigation and the core study discussed here.<a onclick="showRef(event, 'cit3b'); return false;" href="javascript:void(0);" class="ref cit3b">(3b)</a> The evidence gathered to date strongly suggests that potent inhibitory activity toward GT-1a correlates with a dimeric disposition of the pharmacophoric elements located on both the core and the peripheral regions of the inhibitor, whereas this is not necessarily the case for GT-1b.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Compounds <b>50b</b> and <b>50c</b> had poor systemic exposure after oral dosing in rat PK screens, and the subsequent ADME optimization effort that resulted in the discovery of <b>1</b> will be the subject of a forthcoming communication.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16536" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16536" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Unless noted otherwise, all reactions were conducted under nitrogen and, where appropriate, under anhydrous conditions using commercially available substrates and solvents. Products were purified either by flash chromatography on silica gel or Shimadzu reverse-phase preparative HPLC. In cases where the HPLC eluting medium contained TFA additives, the TFA content of the final products was not determined. However, for purposes of yield and EC<sub>50</sub> calculations, it was assumed that the mole equivalent of TFA was the same as the number of basic moieties present in the molecule. Compounds were characterized with a combination of LC/MS, HRMS, and <sup>1</sup>H and <sup>13</sup>C NMR. LC/MS analyses were performed on a Shimadzu LC instrument coupled to a Water Micromass ZQ instrument. All test compounds exhibited ≥95% purity under the LC conditions provided in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> except for <b>27</b> (91%) and <b>31b</b> (90%, see ref <a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">16</a>). HRMS analyses were conducted on a Thermo Scientific Finnegan MAT900 or Fourier Transform Orbitrap spectrometers, calibrated daily. NMR spectra were recorded on a Bruker Ultrashield 400 MHz spectrometer or on a Bruker Advance-III 500 MHz spectrometer, each equipped with a 5 mm TXI cryoprobe. Residual protio-solvent was used as internal standard for chemical-shift assignments. Coupling constants are provided in Hz, with the following spectral pattern designations: s, singlet; d, doublet; t, triplet; q, quartet; dd, doublet of doublets; dt, doublet of triplets; m, multiplet; br, broad; app, apparent. <sup>1</sup>H NMR analyses of most intermediates and final products in DMSO-<i>d</i><sub>6</sub> or CD<sub>3</sub>OD at ambient temperature indicated the presence of rotamers and/or tautomers, and the chemical shift provided is for the dominant rotamer(s) and/or tautomer(s).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. LC Conditions for the Characterization of Final Products</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">LC/MS condition<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">Col<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">GT<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">FR<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">Sol A<a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center">Sol B<a class="ref internalNav" href="#t5fn6" aria-label="f">f</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method A</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">A1</td><td class="colsep0 rowsep0" align="left">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method B</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">A1</td><td class="colsep0 rowsep0" align="left">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method C</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">A2</td><td class="colsep0 rowsep0" align="left">B2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method D</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">A1</td><td class="colsep0 rowsep0" align="left">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method E</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">A1</td><td class="colsep0 rowsep0" align="left">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method F</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">A3</td><td class="colsep0 rowsep0" align="left">B3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method G</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">A1</td><td class="colsep0 rowsep0" align="left">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method H</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">A1</td><td class="colsep0 rowsep0" align="left">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method I</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">A1</td><td class="colsep0 rowsep0" align="left">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method J</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">A1</td><td class="colsep0 rowsep0" align="left">B1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">method K</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">A1</td><td class="colsep0 rowsep0" align="left">B1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Gradient: 0% B to 100% B. Wavelengh (λ): 200 nm.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Col: column, where column 1 = Xbridge Phenyl (2.1 × 50 mm, 2.5 μm), oven temp. 40 °C; column 2 = Phenomenex-Luna C18 (2.0 × 50 mm, 3.0 μm), oven temp. 40 °C; column 3 = XTERRA C18 (4.6 × 50 mm, S5); column 4 = Phenomenex-Luna C18 (3.0 × 50 mm, S10); column 5 = Phenomenex-Luna C18 (4.6 × 50 mm, S10); column 6 = Waters Aquity BEH C18 (2.1 × 50 mm, 1.7 μm), oven temp. 40 °C; and column 7 = XTERRA C18 (3.0 × 50 mm, S7).</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">GT: gradient time (min).</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">FR: flow rate (mL/min).</p></div><div class="footnote" id="t5fn5"><sup>e</sup><p class="last">Sol A: solvent A, where solvent A1 = 0.1% TFA in 10% MeOH/90% H<sub>2</sub>O; solvent A2 = 0.2% H<sub>3</sub>PO<sub>4</sub> in 10% MeOH/90% H<sub>2</sub>O; and solvent A3 = 0.1% TFA in 5% MeOH/95% H<sub>2</sub>O.</p></div><div class="footnote" id="t5fn6"><sup>f</sup><p class="last">Sol B: solvent B, where solvent B1 = 0.1% TFA in 90% MeOH/10% H<sub>2</sub>O; solvent B2 = 0.2% H<sub>3</sub>PO<sub>4</sub> in 90% MeOH/10% H<sub>2</sub>O; and solvent B3 = 0.1% TFA in 95% MeOH/5% H<sub>2</sub>O.</p></div></div></div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 2-Phenyl-1-[(2<i>S</i>)-2-[5-(2-{2-[(2<i>S</i>)-1-(2-phenylacetyl)pyrrolidin-2-yl]-1<i>H</i>-1,3-benzodiazol-5-yl}ethynyl)-1<i>H</i>-1,3-benzodiazol-2-yl]pyrrolidin-1-yl]ethan-1-one (<b>9a</b>)</h3><div class="NLM_p">To a mixture of 4-bromobenzene-1,2-diamine (5.00 g, 26.7 mmol), (<i>S</i>)-1-(<i>tert</i>-butoxy-carbonyl)pyrrolidine-2-carboxylic acid (5.75 g, 26.7 mmol), and HOBT (4.33 g, 32.1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (135 mL) at rt was added EDCI (4.98 g, 26.0 mmol), and the mixture was stirred for 16.5 h. The reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with H<sub>2</sub>O (2×) followed by brine. The organic phase was dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to afford a brownish foam. The foam was treated with glacial acetic acid (100 mL) and heated at 65 °C for 3.5 h. The reaction mixture was removed from the heat, and the volatile component was removed in vacuo. The residue was taken up in EtOAc and washed with a sat. aq. solution of NaHCO<sub>3</sub> (2×) followed by brine, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by flash chromatography (silica gel; EtOAc) to afford benzimidazole <b>6</b> (second elute, tan foam, 3.98 g, 41%) and the <i>bis</i>-acylated side-product <i>tert</i>-butyl (2<i>S</i>)-2-({5-bromo-2-[(2<i>S</i>)-1-[(<i>tert</i>-butoxy)carbonyl]pyrrolidine-2-amido]phenyl}carbamoyl)pyrrolidine-1-carboxylate (brown foam, 1.3 g, 8%). Bromide <b>6</b>: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.53 (br s, 0.32H), 12.47 (br s, 0.27H), 12.44 (br s, 0.23H), 12.37 (br s, 0.18H), 7.75 (d, <i>J</i> = 1.8 Hz, 0.54H), 7.67–7.59 (m, 0.46H), 7.52 (d, <i>J</i> = 8.5 Hz, 0.45H), 7.42 (d, <i>J</i> = 8.5 Hz, 0.55H), 7.34–7.23 (m, 1H), 5.02–4.94 (m, 0.41H), 4.90 (dd, <i>J</i> = 7.8, 3.8 Hz, 0.59H), 3.69–3.50 (m, 1H), 3.50–3.38 (m, 1H), 2.46–2.15 (m, 1H), 2.12–1.77 (m, 3H), 1.41 (s, 3.64H), 1.07 (s, 5.36H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 158.0, 157.6, 157.3, 156.8, 153.1, 152.5, 144.0, 141.6, 141.6, 134.6, 134.5, 132.4, 123.5, 123.2, 120.1, 120.0, 119.4, 119.3, 113.2, 113.0, 112.9, 112.4, 112.3, 112.1, 78.2, 77.7, 54.9, 54.4, 54.4, 46.0, 45.7, 32.5, 31.1, 27.4, 27.0, 23.2, 22.5. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>21</sub>N<sub>3</sub>O<sub>2</sub>Br, 366.08; found, 366.21 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>21</sub>N<sub>3</sub>O<sub>2</sub>Br, 366.0817; found, 366.0800 [M + H]<sup>+</sup>. Side product: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.97–9.05 (m, 2H), 8.22–7.16 (m, 3H), 4.39–4.20 (m, 2H), 3.52–3.36 (m, 4H), 2.34–2.08 (m, 2H), 1.96–1.72 (m, 6H), 1.43 (s, 8H), 1.33 (s, 10H). LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>37</sub>N<sub>4</sub>O<sub>6</sub>BrNa, 603.18; found, 603.24 [M + Na]<sup>+</sup>.</div><div class="NLM_p">To a reaction vessel containing a solution of 1,2-bis(trimethylstannyl)ethyne (1.00 g, 2.84 mmol) and <b>6</b> (2.19 g, 5.97 mmol) in DMF (25 mL) was added Pd(Ph<sub>3</sub>P)<sub>4</sub> (0.329 g, 0.284 mmol). The mixture was thoroughly flushed with N<sub>2</sub> before being sealed and heated at 80 °C for 23 h. After it was allowed to cool to rt, the volatile component was removed in vacuo. The residue was purified by flash chromatography (silica gel; EtOAc) to afford a light yellow foam (811.6 mg). The foam was dissolved in EtOH (6 mL) with heating and allowed to cool to rt to afford <b>7</b> as a light yellow solid (421 mg). The filtrate was heated and allowed to cool again to afford a second crop of <b>7</b> (120 mg), resulting in a combined yield of 32%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.57–12.47 (series of s, 1.18H), 12.47–12.36 (series of s, 0.82H), 7.76 (app d, <i>J</i> = 6.0 Hz, 1H), 7.69–7.62 (m, 1H), 7.58 (dd, <i>J</i> = 8.3, 1.8 Hz, 1H), 7.49 (app d, <i>J</i> = 8.0 Hz, 1H), 7.42–7.27 (m, 2H), 5.06–4.97 (m, 0.81H), 4.97–4.87 (m, 1.19H), 3.70–3.53 (m, 2H), 3.53–3.39 (m, 2H), 2.48–2.17 (m, 2H), 2.16–1.82 (m, 6H), 1.42 (s, 7.26H), 1.08 (s, 10.74H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 158.1, 157.9, 157.4, 157.2, 153.1, 152.5, 142.7, 142.4, 133.5, 133.2, 124.6, 124.0, 120.6, 117.9, 114.9, 114.5, 113.5, 113.2, 111.0, 110.7, 88.4, 88.3, 87.9, 87.8, 78.2, 77.7, 55.0, 54.5, 46.1, 45.8, 32.6, 31.2, 27.4, 27.0, 23.2, 22.5. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>41</sub>N<sub>6</sub>O<sub>4</sub>, 597.32; found, 597.43 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>41</sub>N<sub>6</sub>O<sub>4</sub>, 597.3189; found, 597.3184 [M + H]<sup>+</sup>.</div><div class="NLM_p">To a suspension of <b>7</b> (0.410 g, 0.687 mmol) in 4 N HCl in dioxane (80 mL) was added MeOH (20 mL), and the mixture was stirred at rt for 17 h. The volatile component was removed in vacuo, and the resultant solid was dissolved in MeOH (25 mL) and treated with Et<sub>2</sub>O to cause precipitation. The solid was filtered and dried in vacuo to afford the HCl salt of <b>8</b> as a tan solid (315 mg, 85% assuming 4 equiv of HCl). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.74 (br s, 2H), 9.79 (br s, 2H), 9.68 (br s, 4H), 7.96 (s, 2H), 7.77 (d, <i>J</i> = 8.5 Hz, 2H), 7.59 (dd, <i>J</i> = 8.4, 1.4 Hz, 2H), 5.20–4.94 (m, 2H), 3.63–3.24 (m, 4H), 2.63–2.53 (m partially hidden under DMSO, 2H), 2.47–2.31 (m, 2H), 2.27–2.13 (m, 2H), 2.13–1.99 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 149.9, 135.3, 135.3, 126.5, 117.3, 116.8, 114.7, 88.4, 53.7, 44.6, 29.1, 22.9. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>25</sub>N<sub>6</sub>, 397.21; found, 397.23 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>25</sub>N<sub>6</sub>, 397.2141; found, 397.2126 [M + H]<sup>+</sup>.</div><div class="NLM_p last">To a solution of the HCl salt of <b>8</b> (60.0 mg, 0.111 mmol), 2-phenylacetic acid (0.033 g, 0.24 mmol), and DIEA (0.16 mL, 0.89 mmol) in DMF (2 mL) was added HATU (88.0 mg, 0.232 mmol). The reaction mixture was stirred at rt for 1.5 h. It was then diluted with MeOH (2 mL) and purified by reverse-phase HPLC (MeOH/H<sub>2</sub>O/TFA) to afford the TFA salt of title compound <b>9a</b> as an off-white solid (42 mg, 44%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.95 (s, 1.67H), 7.88–7.81 (m, 0.34H), 7.81–7.72 (m, 1.67H), 7.69–7.58 (m, 1.97H), 7.51 (dd, <i>J</i> = 8.4, 1.4 Hz, 0.33H), 7.38–7.27 (m, 3.54H), 7.27–7.20 (m, 4.97H), 7.20–7.08 (m, 0.90H), 7.08–7.00 (m, 0.61H), 5.52 (dd, <i>J</i> = 8.0, 2.0 Hz, 0.31H), 5.29 (dd, <i>J</i> = 8.4, 3.1 Hz, 1.69H), 3.98–3.87 (m, 1.63H), 3.79 (t, <i>J</i> = 1.0 Hz, 3.72H), 3.72–3.49 (m, 2.35H), 3.38 (d, <i>J</i> = 15.6 Hz, 0.30H), 2.50–2.28 (m, 2.12H), 2.26–2.01 (m, 5.15H), 2.01–1.77 (m, 0.73H). Note: signals for the two exchangeable NH protons were not observed. LC (method A): <i>t</i><sub>R</sub> = 3.38 min. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>40</sub>H<sub>37</sub>N<sub>6</sub>O<sub>2</sub>, 633.30; found, 633.35 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>40</sub>H<sub>37</sub>N<sub>6</sub>O<sub>2</sub>, 633.2978; found, 633.2958 [M + H]<sup>+</sup>.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> (2<i>R</i>)-2-(Dimethylamino)-1-[(2<i>S</i>)-2-[5-(2-{2-[(2<i>S</i>)-1-[(2<i>R</i>)-2-(dimethylamino)-2-phenylacetyl] pyrrolidin-2-yl]-1<i>H</i>-1,3-benzodiazol-5-yl}ethynyl)-1<i>H</i>-1,3-benzodiazol-2-yl]pyrrolidin-1-yl]-2-phenylethan-1-one (<b>9b</b>)</h3><div class="NLM_p last">Title compound <b>9b</b> (TFA salt, light yellow solid) was prepared from <b>8</b> and (<i>R</i>)-2-(dimethylamino)-2-phenylacetic acid·HCl according to the procedure described for <b>9a</b>. For purposes of comparing the activities of different forms in replicon medium, a portion of the sample was free-based with MCX cartridge (MeOH wash, 2.0 N NH<sub>3</sub>/MeOH elution) to afford a light yellow solid. TFA salt: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.25 (br s, 2H), 7.86 (s, 1.69H), 7.69 (s, 0.86H), 7.67 (s, 0.98H), 7.66–7.55 (m, 8.69H), 7.55–7.46 (m, 1.81H), 7.45–7.30 (m, 0.67H), 7.07–6.97 (m, 0.51H), 6.97–6.88 (m, 0.29H), 6.88–6.76 (m, 0.50H), 5.81 (d, <i>J</i> = 8.3 Hz, 0.24H), 5.54 (s, 1.70H), 5.47 (br s, 0.30H), 5.27 (dd, <i>J</i> = 8.4, 2.6 Hz, 1.76H), 4.18–4.02 (m, 1.73H), 3.95–3.81 (m, 0.27H), 3.76–3.63 (m, 0.24H), 3.18–3.07 (m, 1.76H), 3.05–2.69 (m, 6H), 2.46 (br s, 5H), 2.35 (app s, 1H), 2.31–2.20 (m, 1.78H), 2.19–2.01 (m, 3.85H), 2.01–1.77 (m, 2.37H). LC (method J): <i>t</i><sub>R</sub> = 0.99 min. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>44</sub>H<sub>47</sub>N<sub>8</sub>O<sub>2</sub>, 719.38; found, 719.38 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>44</sub>H<sub>47</sub>N<sub>8</sub>O<sub>2</sub>, 719.3822; found, 719.3799 [M + H]<sup>+</sup>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Methyl <i>N</i>-[(1<i>R</i>)-2-[(2<i>S</i>)-2-[5-(2-{2-[(2<i>S</i>)-1-[(2<i>R</i>)-2-[(Methoxycarbonyl)amino]-2-phenylacetyl]pyrrolidin-2-yl]-1<i>H</i>-1,3-benzodiazol-5-yl}ethynyl)-1<i>H</i>-1,3-benzodiazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate (<b>9c</b>)</h3><div class="NLM_p last">Title compound <b>9c</b> (TFA salt, light yellow solid) was prepared from <b>8</b> and (<i>R</i>)-2-((methoxycarbonyl) amino)-2-phenylacetic acid according to the procedure described for <b>9a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.96 (s, 1.59H), 7.94–7.83 (m, 0.54H), 7.78 (app d, <i>J</i> = 8.5 Hz, 1.66H), 7.73 (app d, <i>J</i> = 8.0 Hz, 1.80H), 7.69–7.60 (m, 1.62H), 7.51 (app s, 0.66H), 7.47–7.40 (m, 5.90H), 7.40–7.27 (m, 2.77H), 6.98–6.88 (m, 0.62H), 6.88–6.77 (m, 0.86H), 5.77 (app d, <i>J</i> = 8.0 Hz, 0.29H), 5.57 (d, <i>J</i> = 8.0 Hz, 1.63H), 5.40 (d, <i>J</i> = 7.8 Hz, 0.37H), 5.29 (dd, <i>J</i> = 8.4, 2.1 Hz, 1.71H), 4.07–3.89 (m, 1.80H), 3.88–3.66 (m, 0.46H), 3.65–3.54 (m, 3.40H), 3.51 (s, 3H), 3.30–3.19 (m, 1.34H), 2.46–2.20 (m, 1.85H), 2.20–2.02 (m, 3.84H), 2.01–1.80 (m, 2.31H). Note: signals for the two exchangeable NH protons were not observed. LC (method A): <i>t</i><sub>R</sub> = 3.40 min. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>44</sub>H<sub>43</sub>N<sub>8</sub>O<sub>6</sub>, 779.33; found, 779.45 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>44</sub>H<sub>43</sub>N<sub>8</sub>O<sub>6</sub>, 779.3306; found, 779.3273 [M + H]<sup>+</sup>.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 2-Phenyl-1-[(2<i>S</i>)-2-[5-(2-{2-[(2<i>S</i>)-1-(2-phenylacetyl)pyrrolidin-2-yl]-1,3-benzoxazol-5-yl}ethynyl)-1,3-benzoxazol-2-yl]pyrrolidin-1-yl]ethan-1-one (<b>15a</b>)</h3><div class="NLM_p">To a mixture of 2-amino-4-bromophenol (5.0 g, 27 mmol), (<i>S</i>)-1-(<i>tert</i>-butoxycarbonyl) pyrrolidine-2-carboxylic acid (5.72 g, 26.6 mmol), and HOBT (3.95 g, 29.3 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (130 mL) at rt was added EDCI (5.61 g, 29.3 mmol), and the mixture was stirred for 20 h. It was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with water (2×) and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to afford a tan foam. To a solution of the foam and Ph<sub>3</sub>P (7.67 g, 29.3 mmol) in THF (150 mL) at rt was added DIAD (5.69 mL, 29.3 mmol) dropwise over a few minutes, and the mixture was stirred for 21 h. The volatile component was removed in vacuo, and the residue was triturated with Et<sub>2</sub>O and hexanes (30:1 v/v), and the precipitate was filtered off. The filtrate was concentrated in vacuo, and the residue was purified by flash chromatography (silica gel; 15–25% EtOAc/hexanes) to afford <b>12a</b> as a viscous orange oil containing residual EtOAc in a 1.0:0.17 product/EtOAc mole ratio (7.44 g, ∼75%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.06–7.92 (m, 1H), 7.80–7.66 (m, 1H), 7.56 (dd, <i>J</i> = 8.5, 1.8 Hz, 1H), 5.09–5.01 (m, 0.38H), 4.99 (dd, <i>J</i> = 8.0, 4.5 Hz, 0.62H), 3.64–3.50 (m, 1H), 3.50–3.38 (m, 1H), 2.49–2.24 (m, 1H), 2.18–1.83 (m, 3H), 1.39 (s, 3.36H), 1.10 (s, 5.64H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.2, 167.9, 152.8, 152.0, 148.5, 141.8, 127.1, 127.0, 121.6, 121.5, 115.7, 115.7, 112.0, 111.9, 78.5, 78.1, 54.0, 53.8, 45.8, 45.6, 31.3, 30.3, 27.3, 26.9, 23.2, 22.5. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>19</sub>N<sub>2</sub>O<sub>3</sub>BrNa, 389.05/391.05; found, 389.05/391.05 [M + Na]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>20</sub>N<sub>2</sub>O<sub>3</sub>Br, 367.0652; found, 367.0641 [M + H]<sup>+</sup>.</div><div class="NLM_p">To a solution of <b>12a</b> (1.90 g, 5.17 mmol) and 1,2-bis(trimethylstannyl)ethyne (1.00 g, 2.84 mmol) in DMF (25 mL) was added Pd(Ph<sub>3</sub>P)<sub>4</sub> (0.299 g, 0.259 mmol). The mixture was thoroughly flushed with N<sub>2</sub> before the reaction vessel was sealed and heated at 80 °C for 17.5 h. The volatile component was removed in vacuo, and the residue was purified by flash chromatography (silica gel; 25–100% EtOAc/hexanes) to afford <b>13a</b> as a light yellow solid (1.2 g) contaminated with Ph<sub>3</sub>PO, as determined by LC/MS analysis. The product was recrystallized from EtOAc to afford a crop of <b>13a</b> as a light yellow solid (350 mg), and the filtrate was concentrated and repurified by flash chromatography (silica gel; EtOAc) to afford additional <b>13a</b> (570 mg, 59% combined yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.04–7.91 (m, 2H), 7.89–7.73 (m, 2H), 7.70–7.55 (m, 2H), 5.13–5.03 (m, 0.73H), 5.01 (dd, <i>J</i> = 8.0, 4.8 Hz, 1.27H), 3.64–3.51 (m, 2H), 3.51–3.39 (m, 2H), 2.50–2.26 (m, 2H), 2.23–1.84 (m, 6H), 1.41 (s, 6.27H), 1.11 (s, 11.73H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.9, 167.7, 152.8, 152.1, 149.4, 149.3, 140.3, 128.0, 121.7, 117.9, 110.8, 110.7, 87.7, 78.5, 78.1, 54.1, 45.9, 45.7, 31.3, 30.3, 27.3, 26.9, 23.2, 22.6. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>39</sub>N<sub>4</sub>O<sub>6</sub>, 599.29; found, 599.35 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>39</sub>N<sub>4</sub>O<sub>6</sub>, 599.2870; found, 599.2842 [M + H]<sup>+</sup>.</div><div class="NLM_p">A solution of <b>13a</b> (0.50 g, 0.84 mmol) in 20% TFA/CH<sub>2</sub>Cl<sub>2</sub> (15 mL) was stirred at rt for 4 h. The volatile component was removed in vacuo, and the residue was azeotroped with benzene and then free-based by MCX cartridge (MeOH wash; 2 N NH<sub>3</sub>/MeOH elution). The resultant material was crystallized from MeOH to afford <b>14a</b> as an off-white solid (300 mg, 90%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.98–7.90 (m, 2H), 7.83–7.73 (m, 2H), 7.60 (dd, <i>J</i> = 8.4, 1.6 Hz, 2H), 4.46 (dd, <i>J</i> = 8.0, 5.8 Hz, 2H), 3.11 (app br s, 2H), 2.96 (app t, <i>J</i> = 6.8 Hz, 4H), 2.28–2.03 (m, 4H), 1.97–1.84 (m, 2H), 1.84–1.70 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.7, 149.7, 140.2, 127.9, 121.7, 117.7, 110.6, 87.7, 54.2, 45.8, 29.5, 24.8. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>22</sub>N<sub>4</sub>O<sub>6</sub>Na, 421.16; found, 421.21 [M + Na]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>23</sub>N<sub>4</sub>O<sub>2</sub>, 399.1816; found, 399.1804 [M + H]<sup>+</sup>.</div><div class="NLM_p last">To a mixture of <b>14a</b> (71.7 mg, 0.180 mmol), 2-phenylacetic acid (54.0 mg, 0.396 mmol), and DIEA (0.13 mL, 0.72 mmol) in DMF (2 mL) was added HATU (0.144 g, 0.378 mmol), and the reaction mixture was stirred at rt for 2.3 h. The volatile component was removed in vacuo, and the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> and washed (2×) with a 10:1 mixture of H<sub>2</sub>O and sat. aq. NaHCO<sub>3</sub>. The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by flash chromatography (silica gel; EtOAc) to afford title compound <b>15a</b> as a white foam (63.7 mg, 56%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.01–7.97 (m, 0.38H), 7.97–7.91 (m, 1.45H), 7.83–7.74 (m, 1.98H), 7.68–7.57 (m, 1.98H), 7.38–7.29 (m, 3.38H), 7.29–7.21 (m, 4.89H), 7.21–7.15 (m, 0.78H), 7.15–7.04 (m, 1.16H), 5.62 (dd, <i>J</i> = 8.0, 1.8 Hz, 0.36H), 5.20 (dd, <i>J</i> = 8.3, 3.3 Hz, 1.64H), 3.90–3.79 (m, 1.75H), 3.77 (s, 3.16H), 3.75–3.66 (m, 1.90H), 3.66–3.47 (m, 1.19H), 2.49–2.26 (m, 2.42H), 2.25–1.82 (m, 5.58H). LC (method B): <i>t</i><sub>R</sub> = 4.16 min. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>40</sub>H<sub>35</sub>N<sub>4</sub>O<sub>4</sub>, 635.27; found, 635.30 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>40</sub>H<sub>35</sub>N<sub>4</sub>O<sub>4</sub>, 635.2658; found, 635.2633 [M + H]<sup>+</sup>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (2<i>R</i>)-2-(Dimethylamino)-1-[(2<i>S</i>)-2-[5-(2-{2-[(2<i>S</i>)-1-[(2<i>R</i>)-2-(dimethylamino)-2-phenylacetyl]pyrrolidin-2-yl]-1,3-benzoxazol-5-yl}ethynyl)-1,3-benzoxazol-2-yl]pyrrolidin-1-yl]-2-phenylethan-1-one (<b>15b</b>)</h3><div class="NLM_p last">Title compound <b>15b</b> (light yellow solid) was prepared from <b>14a</b> and (<i>R</i>)-2-(dimethylamino)-2-phenylacetic acid·HCl according to the procedure described for <b>15a</b> with the exception that the flash chromatography used 5% MeOH/CH<sub>2</sub>Cl<sub>2</sub> as eluant. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.97–7.92 (m, 1.66H), 7.83 (app t, <i>J</i> = 1.0 Hz, 0.28H), 7.78 (d, <i>J</i> = 8.3 Hz, 1.73H), 7.63 (dd, <i>J</i> = 8.4, 1.6 Hz, 1.76H), 7.57 (app d, <i>J</i> = 0.8 Hz, 0.52H), 7.49–7.42 (m, 3.56H), 7.41–7.29 (m, 5.26H), 7.05–6.97 (m, 0.50H), 6.97–6.86 (m, 0.73H), 5.83 (dd, <i>J</i> = 8.2, 1.1 Hz, 0.25H), 5.13 (dd, <i>J</i> = 8.3, 3.8 Hz, 1.75H), 4.35 (br s, 0.39H), 4.30 (br s, 1.61H), 4.13–4.00 (m, 2H), 3.68–3.58 (m, 0.49H), 3.57–3.46 (m, 1.51H), 2.38–2.20 (m, 2.86H), 2.17 (br s, 2.18H), 2.15 (br s, 9.52H), 2.13–1.89 (m, 5.44H). LC (method B): <i>t</i><sub>R</sub> = 3.20 min. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>44</sub>H<sub>45</sub>N<sub>6</sub>O<sub>4</sub>, 721.35; found, 721.33 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>44</sub>H<sub>45</sub>N<sub>6</sub>O<sub>4</sub>, 721.3502; found, 721.3477 [M + H]<sup>+</sup>.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 2-Phenyl-1-[(2<i>S</i>)-2-[6-(2-{2-[(2<i>S</i>)-1-(2-phenylacetyl)pyrrolidin-2-yl]-1,3-benzoxazol-6-yl}ethynyl)-1,3-benzoxazol-2-yl]pyrrolidin-1-yl]ethan-1-one (<b>16a</b>)</h3><div class="NLM_p">To a solution of 2-amino-5-bromophenol (1.0 g, 5.3 mmol) and (<i>S</i>)-1-(<i>tert</i>-butoxycarbonyl)pyrrolidine-2-carboxylic acid (1.15 g, 5.32 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (25 mL) was added HOBT (0.791 g, 5.85 mmol) followed by EDCI (1.12 g, 5.85 mmol). The reaction mixture was stirred at rt for 7.5 h. It was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with water (2×) and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to afford a tan foam. The foam was dissolved in THF (30 mL), and Ph<sub>3</sub>P (1.54 g, 5.86 mmol) was added followed by the dropwise addition of DIAD (1.14 mL, 5.85 mmol) over a few minutes. The reaction mixture was stirred at rt for 23.5 h. The volatile component was removed in vacuo, and the residue was dissolved in EtOAc and washed with H<sub>2</sub>O (2×) and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was subjected to flash chromatography (silica gel; 25% EtOAc/hexanes) to afford a brownish-orange viscous oil that solidified upon standing (1.2 g). The solid was recrystallized from hexanes to afford two crops of <b>12b</b> as gray solid (770 mg, 39%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.09 (d, <i>J</i> = 1.5 Hz, 0.65H), 8.06 (app br s, 0.35H), 7.75–7.64 (m, 1H), 7.60–7.50 (m, 1H), 5.03 (dd, <i>J</i> = 8.0, 2.5 Hz, 0.38H), 4.98 (dd, <i>J</i> = 8.2, 4.4 Hz, 0.62H), 3.61–3.49 (m, 1H), 3.49–3.39 (m, 1H), 2.49–2.26 (m, 1H), 2.17–1.86 (m, 3H), 1.39 (s, 3.33H), 1.10 (s, 5.67H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.5, 167.2, 152.8, 152.0, 150.0, 149.8, 139.4, 127.0, 126.9, 120.3, 120.3, 116.3, 116.2, 113.5, 113.4, 78.5, 78.1, 54.0, 53.8, 45.8, 45.6, 31.3, 30.3, 27.3, 26.9, 23.2, 22.5. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>19</sub>N<sub>2</sub>O<sub>3</sub>BrNa, 389.05; found, 389.05 [M + Na]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>20</sub>N<sub>2</sub>O<sub>3</sub>Br, 367.0652; found, 367.0641 [M + H]<sup>+</sup>.</div><div class="NLM_p">To a solution of 1,2-bis(trimethylstannyl)ethyne (0.369 g, 1.048 mmol) and <b>12b</b> (0.77 g, 2.1 mmol) in DMF (8 mL) was added Pd(Ph<sub>3</sub>P)<sub>4</sub> (0.121 g, 0.105 mmol). The reaction vessel was thoroughly flushed with N<sub>2</sub> before being capped and heated at 80 °C for 15.3 h. The reaction mixture was removed from the heat, and the volatile component was removed in vacuo. The residue was purified by flash chromatography (silica gel; EtOAc) to afford a solid, which was recrystallized from EtOAc to obtain two crops of <b>13b</b> as a light yellow solid (367 mg, 58%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.06–7.95 (m, 2H), 7.85–7.74 (m, 2H), 7.67–7.55 (m, 2H), 5.06 (dd, <i>J</i> = 8.2, 2.4 Hz, 0.74H), 5.01 (dd, <i>J</i> = 7.9, 4.6 Hz, 1.26H), 3.63–3.51 (m, 2H), 3.51–3.41 (m, 2H), 2.50–2.29 (m, 2H), 2.19–1.89 (m, 6H), 1.41 (s, 6.51H), 1.11 (s, 11.49H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.3, 168.0, 152.8, 152.1, 149.2, 149.0, 140.6, 127.7, 127.6, 119.2, 119.1, 118.0, 113.1, 113.0, 88.6, 88.5, 78.5, 78.1, 54.1, 53.9, 45.9, 45.7, 31.4, 30.4, 27.4, 27.0, 23.2, 22.6. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>39</sub>N<sub>4</sub>O<sub>6</sub>, 599.29; found, 599.35 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>39</sub>N<sub>4</sub>O<sub>6</sub>: 599.2864; found 599.2839 [M + H]<sup>+</sup>.</div><div class="NLM_p">Boc deprotection of <b>13b</b> (0.335g, 0.560 mmol) according to the procedure described in the preparation of <b>14a</b> afforded impure <b>14b</b> (213 mg), which was used in the next step without further purification. It is noteworthy that the impurities, which are believed to be derived from hydration and/or hydrolytic cleavage of the benzoxazole moiety, were observed after the MCX free-basing step. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.96 (d, <i>J</i> = 0.8 Hz, 2H), 7.76 (d, <i>J</i> = 8.0 Hz, 2H), 7.58 (dd, <i>J</i> = 8.3, 1.5 Hz, 2H), 4.47 (dd, <i>J</i> = 7.8, 5.8 Hz, 2H), 3.36 (br s, 2H), 2.95 (t, <i>J</i> = 6.7 Hz, 4H), 2.27–2.02 (m, 4H), 1.97–1.83 (m, 2H), 1.83–1.71 (m, 2H). LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>23</sub>N<sub>4</sub>O<sub>2</sub>, 399.18; found, 399.23 [M + H]<sup>+</sup>.</div><div class="NLM_p last">To a solution of <b>14b</b> (70.0 mg, 0.176 mmol), 2-phenylacetic acid (53.0 mg, 0.389 mmol), and DIEA (0.12 mL, 0.70 mmol) in DMF (2 mL) was added HATU (0.140 g, 0.369 mmol), and the reaction mixture was stirred at rt for 1.5 h. Most of the solvent was removed in vacuo, and the residue was purified by reverse-phase HPLC (CH<sub>3</sub>CN/H<sub>2</sub>O/NH<sub>4</sub>OAc). The resultant material was dissolved in CH<sub>2</sub>Cl<sub>2</sub> and washed with H<sub>2</sub>O and sat. aq. NaHCO<sub>3</sub>, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to afford title compound <b>16a</b> as an off-white solid (26.6 mg, 24%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.99 (app d, <i>J</i> = 0.8 Hz, 0.37H), 7.98–7.94 (m, 1.45H), 7.84–7.73 (m, 1.98H), 7.65–7.56 (m, 1.96H), 7.38–7.29 (m, 3.36H), 7.29–7.24 (m, 4.60H), 7.24–7.15 (m, 1.14H), 7.15–7.07 (m, 1.14H), 5.63 (dd, <i>J</i> = 8.0, 1.5 Hz, 0.37H), 5.20 (dd, <i>J</i> = 8.3, 3.0 Hz, 1.63H), 3.90–3.79 (m, 1.69H), 3.77 (s, 3.26H), 3.75–3.67 (m, 1.84H), 3.66–3.48 (m, 1.21H), 2.49–2.27 (m, 2.36H), 2.24–1.87 (m, 5.64H). LC (method B): <i>t</i><sub>R</sub> = 4.15 min. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>40</sub>H<sub>35</sub>N<sub>4</sub>O<sub>4</sub>, 635.27; found, 635.35 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>40</sub>H<sub>35</sub>N<sub>4</sub>O<sub>4</sub>: 635.2658; found 635.2634 [M + H]<sup>+</sup>.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (2<i>R</i>)-2-(Dimethylamino)-1-[(2<i>S</i>)-2-[6-(2-{2-[(2<i>S</i>)-1-[(2<i>R</i>)-2-(dimethylamino)-2-phenylacetyl]pyrrolidin-2-yl]-1,3-benzoxazol-6-yl}ethynyl)-1,3-benzoxazol-2-yl]pyrrolidin-1-yl]-2-phenylethan-1-one (<b>16b</b>)</h3><div class="NLM_p last">Title compound <b>16b</b> (light yellow solid) was prepared from <b>14b</b> and (<i>R</i>)-2-(dimethylamino)-2-phenylacetic acid·HCl according to the procedure described for <b>16a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.01–7.95 (m, 1.52H), 7.81–7.73 (m, 1.82H), 7.66–7.53 (m, 2.27H), 7.50–7.43 (m, 3.45H), 7.43–7.25 (m, 5.79H), 7.03–6.96 (m, 0.48H), 6.94–6.86 (m, 0.67H), 5.83 (app d, <i>J</i> = 9.0 Hz, 0.22H), 5.13 (dd, <i>J</i> = 8.2, 3.9 Hz, 1.78H), 4.33 (s, 0.29H), 4.29 (s, 1.71H), 4.13–3.99 (m, 2H), 3.67–3.58 (m, 0.47H), 3.56–3.47 (m, 1.53H), 2.37–2.18 (m, 2.74H), 2.18–2.13 (m, 10.93H), 2.13–1.89 (m, 6.33H). LC (method B): <i>t</i><sub>R</sub> = 3.16 min. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>44</sub>H<sub>45</sub>N<sub>6</sub>O<sub>4</sub>, 721.35; found, 721.39 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>44</sub>H<sub>45</sub>N<sub>6</sub>O<sub>4</sub>: 721.3502; found 721.3476 [M + H]<sup>+</sup>.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (2<i>S</i>)-1-[(2<i>R</i>)-2-(Dimethylamino)-2-phenylacetyl]-<i>N</i>-[4-(2-{4-[(2<i>S</i>)-1-[(2<i>R</i>)-2-(dimethylamino)-2-phenylacetyl]pyrrolidine-2-amido]phenyl}-1,3-oxazol-5-yl)phenyl]pyrrolidine-2-carboxamide (<b>21</b>)</h3><div class="NLM_p">H<sub>2</sub>SO<sub>4</sub> (10 mL) was cooled to 0 °C, and 2,5-diphenyloxazole <b>17</b> (12.0 g, 54.0 mmol) was added in two portions. To the resultant orange suspension was added dropwise a 1:1 solution of concentrated HNO<sub>3</sub>/H<sub>2</sub>SO<sub>4</sub> acids over 10 min. The reaction mixture was stirred for 2.5 h at 0 °C and poured onto chopped ice, and the precipitate was filtered. The solid was washed with H<sub>2</sub>O and Et<sub>2</sub>O and dried in vacuo to afford <b>18</b> as a yellow solid (5.0 g). The cold filtrate was extracted with EtOAc (300 mL), and the extract was treated with hexanes (60 mL) and allowed to stand at rt for 16 h to afford additional <b>18</b> (2.0 g) as a yellow solid. Both samples were contaminated with an impurity believed to be a regioisomeric nitration product. For the major component: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.46–8.38 (m, 6H), 8.32 (s, 1H), 8.22–8.18 (m, 2H). LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>9</sub>N<sub>3</sub>O<sub>5</sub>, 312.05; found, 312.13 [M + H]<sup>+</sup>.</div><div class="NLM_p">A suspension of impure <b>18</b> (9.83 g) in MeOH (100 mL) and EtOAc (100 mL) was subjected to balloon hydrogenation over 20% Pd(OH)<sub>2</sub>/C (1.0 g) for 6 h at rt. The mixture was filtered through Celite and concentrated in vacuo to afford a red solid, which was recrystallized from MeOH to afford two crops of dianiline <b>19</b> as a brick red solid (4.6 g), each contaminated with an impurity believed to be a regioisomer. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.68 (d, <i>J</i> = 8.5 Hz, 2H), 7.42 (d, <i>J</i> = 8.5 Hz, 2H), 7.28 (s, 1H), 6.65 (d, <i>J</i> = 6.6 Hz, 2H), 6.63 (d, <i>J</i> = 6.6 Hz, 2H). Note: the NH<sub>2</sub> signals were too broad to make peak assignments. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>13</sub>N<sub>3</sub>O, 252.11; found, 252.05 [M + H]<sup>+</sup>.</div><div class="NLM_p">EEDQ (6.2 g, 25.07 mmol) was added in one portion to a stirred mixture of the impure dianiline <b>19</b> (3.0 g) and <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline (5.30 g, 24.5 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (120 mL), and the mixture was stirred at rt for 2 h. Additional <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline (2.6 g) and EEDQ (3.1 g) were added, and stirring was continued for an additional 1.5 h at rt. Most of the volatile component was removed in vacuo, and the residue was subjected to flash chromatography (silica gel; 50% EtOAc/hexanes) to afford <b>20</b> (6.2 g) as an orange solid contaminated with an impurity believed to be a regioisomer. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.32–10.13 (3 s, 2H), 8.03 (m, 2H), 7.85–7.72 (m, 6H), 7.68 (m, 1H), 4.32–4.17 (m, 2H), 3.49–3.40 (m, 2H), 3.38–3.33 (m, 2H), 2.27–2.13 (m, 2H), 1.96–1.75 (m, 6H), 1.42 (s, 6.5H), 1.29 (s, 11.5H). LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>44</sub>N<sub>5</sub>O<sub>7</sub>, 646.63; found, 646.51 [M + H]<sup>+</sup>.</div><div class="NLM_p">To a cold (0 °C) solution of <b>20</b> (6.2 g, 9.6 mmol) in MeOH (5 mL) was added 4 N HCl in dioxane (30 mL). The reaction mixture was allowed to warm to 25 °C, where it was stirred for 4 h before it was diluted with Et<sub>2</sub>O (100 mL) and filtered. The solid was washed with excess Et<sub>2</sub>O and dried in vacuo to afford the HCl salt of (2<i>S</i>)-<i>N</i>-[4-(5-{4-[(2<i>S</i>)-pyrrolidine-2-amido]phenyl}-1,3-oxazol-2-yl)phenyl]pyrrolidine-2-carboxamide (4.9 g) as an orange solid contaminated with an impurity believed to be a regioisomer. According to <sup>1</sup>H NMR analysis, the product-to-impurity mole ratio was ∼96:4. The impurity was purged from the sample through recrystallization from MeOH. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.19 (s, 0.85H), 11.13/11.12/11.09 (3 s, 1.15H), 9.88 (m, 2H), 8.74 (m, 2H), 8.10 (d, <i>J</i> = 8.8 Hz, 2H), 7.87–7.78 (m, 7H), ∼4.90 (m, 2H, overlapped with water signal), 3.30 (m, 4H), 2.5–2.36 (m, 2H), 2.10–1.94 (m, 6H). Note: the chemical shifts of the signals at 9.88 and 8.74 ppm vary among different batches, likely because of concentration differences. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>28</sub>N<sub>5</sub>O<sub>3</sub>, 446.22; found, 446.50 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>28</sub>N<sub>5</sub>O<sub>3</sub>, 446.2192; found, 446.2207 [M + H]<sup>+</sup>.</div><div class="NLM_p last">HATU (39 mg, 0.10 mmol) was added in one portion to a solution of the HCl salt of (2<i>S</i>)-<i>N</i>-[4-(5-{4-[(2<i>S</i>)-pyrrolidine-2-amido]phenyl}-1,3-oxazol-2-yl)phenyl]pyrrolidine-2-carboxamide (25 mg, 0.048 mmol), (<i>R</i>)-2-(dimethyl-amino)-2-phenylacetic acid·HCl (23.0 mg, 0.106 mmol), and DIEA (0.050 mL, 0.29 mmol) in DMF (1.5 mL), and the resultant mixture was stirred at rt for 90 min. The reaction mixture was purified by a reverse-phase HPLC (MeOH/H<sub>2</sub>O/TFA) to afford title compound <b>21</b> as a light yellow solid (42 mg, 88% yield assuming <i>bis</i>-TFA salt). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.58 (s, 1H), 10.47 (s, 1H), 10.31 (br s, 2H), 8.07 (d, <i>J</i> = 8.8 Hz, 2H), 7.83–7.74 (m, 7H), 7.62–7.57 (m, 10H), 5.57 (d, <i>J</i> = 2.9, 2H), 4.52–4.47 (m, 2H), 3.98–3.92 (m, 2H), 3.27–3.21 (m, 2H), 2.97 (d, <i>J</i> = 4.3 Hz, 6H), 2.47 (d, <i>J</i> = 4.3 Hz, 6H), 2.25–2.13 (m, 2H), 2.07–1.83 (m, 6H). Note: the <sup>1</sup>H NMR data is for the major rotamer because it was not feasible to capture the chemical shifts for the minor rotamer accurately. LC (method B): <i>t</i><sub>R</sub> = 2.96 min. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>45</sub>H<sub>50</sub>N<sub>7</sub>O<sub>5</sub>, 768.39; found, 768.44. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>45</sub>H<sub>50</sub>N<sub>7</sub>O<sub>5</sub>, 768.3873; found, 768.3889 [M + H]<sup>+</sup>.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (<i>S</i>)-<i>tert</i>-Butyl 2-(6-(2-Aminoacetyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)pyrrolidine-1-carboxylate (<b>23</b>)</h3><div class="NLM_p">A suspension of <i>N</i>-(4-(2-chloroacetyl)-2-nitrophenyl)acetamide (25.7 g, 0.10 mol) in 3 N HCl (250 mL) was heated in a 1 L screw-top pressure vessel at 80 °C for 20 h. After it was allowed to cool to rt, 1-(4-amino-3-nitrophenyl)-2-chloro-ethanone·HCl (23.2 g, 92%) was isolated as a bright yellow solid by vacuum filtration. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.62 (d, <i>J</i> = 2.1 Hz, 1H), 8.09 (br s, 2H), 7.92 (dd, <i>J</i> = 8.9, 2.1 Hz, 1H), 7.08 (d, <i>J</i> = 9.0 Hz, 1H), 5.09 (s, 2H). LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>8</sub>H<sub>7</sub>ClN<sub>2</sub>O<sub>3</sub>, 215.02; found, 215.19 [M + H]<sup>+</sup>.</div><div class="NLM_p">1-(4-Amino-3-nitrophenyl)-2-chloroethanone·HCl (23.2 g, 0.090 mol) was suspended in MeOH (600 mL), and tin(II) chloride dihydrate (65 g, 0.29 mol) was added in one portion. The suspension was heated at 70 °C for 14 h while being vigorously stirred before an additional 20 g of tin(II) chloride dihydrate was added, and the reaction mixture was stirred further at 70 °C for 8 h. After being cooled to rt, most of the solvent was removed in vacuo, and the residue was poured into a beaker containing EtOAc and a sat. aq. NaHCO<sub>3</sub> solution (1.2 L, 1:1 by volume). <b>Caution:</b><i>significant CO<sub>2</sub> evolution was observed</i>. The precipitate was removed by suction filtration, and the organic layer was separated. The aqueous layer was extracted with EtOAc (2×), and the combined organic phase was washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and filtered. Concentration to one-quarter volume and filtration of the precipitate afforded 2-chloro-1-(3,4-diaminophenyl)ethanone as a brick red solid (10.0 g, 59%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.17 (dd, <i>J =</i> 8.3, 2.3 Hz, 1H), 7.14 (d, <i>J =</i> 2.0 Hz, 1H), 6.51 (d, <i>J =</i> 8.0 Hz, 1H), 5.57 (br s, 2H), 4.85 (s, 2H), 4.78 (br s, 2H). LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>8</sub>H<sub>10</sub>ClN<sub>2</sub>O, 185.05; found, 185.02 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>8</sub>H<sub>10</sub>ClN<sub>2</sub>O, 185.0482; found, 185.0480 [M + H]<sup>+</sup>.</div><div class="NLM_p">HATU (38.5 g, 101 mmol) was added portionwise to a vigorously stirred solution of 2-chloro-1-(3,4-diaminophenyl)ethanone (17.0 g, 92.0 mmol), <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline (19.8 g, 92.0 mmol), and DIEA (17.6 mL, 101 mmol) in DMF (200 mL). After 6 h, the mixture was concentrated in vacuo to remove the solvent, and the residue was taken up in EtOAc, washed with a sat. aq. NaHCO<sub>3</sub> solution and brine, and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. Evaporation of the solvent yielded a viscous brown oil that was taken up in glacial acetic acid (100 mL) and heated at 60 °C for 20 h. The solvent was removed in vacuo, and the residue was taken up in EtOAc, washed carefully with a sat. aq. NaHCO<sub>3</sub> solution and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was then preadsorbed onto silica gel and subjected to flash chromatography (silica gel; 50–100% EtOAc/hexanes) to furnish <i>S</i>-<i>tert</i>-butyl 2-(6-(2-chloroacetyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)pyrrolidine-1-carboxylate as a yellow foam (22.4 g, 67%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.20 (s, 1H), 7.81 (dd, <i>J =</i> 8.3, 2.3 Hz, 1H), 7.59 (d, <i>J =</i> 8.0 Hz, 1H), 5.24 (s, 2H), 4.99/4.93 (s, 1H), 3.60 (br s, 1H), 3.46–3.41 (m, 1H), 2.36–2.30 (m, 1H), 2.01–1.89 (m, 3H), 1.39/1.06 (s, 9H). LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>23</sub>ClN<sub>3</sub>O<sub>3</sub>, 364.14; found, 364.20 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>23</sub>ClN<sub>3</sub>O<sub>3</sub>, 364.1415; found, 364.1428 [M + H]<sup>+</sup>.</div><div class="NLM_p">Sodium azide (1.79 g, 27.5 mmol) was added in one portion to a stirred solution of (<i>S</i>)-<i>tert</i>-butyl 2-(6-(2-chloroacetyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)pyrrolidine-1-carboxylate (10.0 g, 27.5 mmol) in CH<sub>3</sub>CN (200 mL), and the resultant mixture was stirred at 60 °C for 16 h. The reaction mixture was cooled to rt, and the solvent was removed in vacuo. The residue was diluted with EtOAc and washed with H<sub>2</sub>O and brine prior to being dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and filtered. Concentration of the filtrate afforded (<i>S</i>)-<i>tert</i>-butyl 2-(6-(2-azidoacetyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)pyrrolidine-1-carboxylate (6.8 g, 48%) as a golden-orange foam, which was used in the next step without further purification. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.22 and 8.03 (2s, 1H), 7.80–7.75 (m, 1H), 7.65/7.56 (d, <i>J =</i> 8.5 Hz, 1H), 4.99–4.93 (m, 3H), 3.60 (br s, 1H), 3.46–3.41 (m, 1H), 2.38–2.27 (m, 1H), 2.01–1.89 (m, 3H), 1.40/1.06 (s, 9H). LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>23</sub>N<sub>6</sub>O<sub>3</sub>, 371.19; found, 371.32 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>23</sub>N<sub>6</sub>O<sub>3</sub>, 371.1832; found, 371.1825 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Tin(II) chloride dihydrate (3.84 g, 17.0 mmol) was added to a stirred solution of (<i>S</i>)-<i>tert</i>-butyl 2-(6-(2-azidoacetyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-pyrrolidine-1-carboxylate (2.10 g, 5.67 mmol) in MeOH (50 mL). The reaction mixture was heated at 60 °C for 8 h and stirred at rt for 12 h before it was concentrated in vacuo to afford title compound <b>23</b> contaminated with tin salts as a tan solid (5.96 g, above theoretical yield). It was used in the next step without further purification. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>25</sub>N<sub>4</sub>O<sub>3</sub>, 345.19; found, 345.37 [M + H]<sup>+</sup>.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (<i>S</i>)-2-(1-(<i>tert</i>-Butoxycarbonyl)pyrrolidin-2-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole-6-carboxylic acid (<b>25</b>)</h3><div class="NLM_p">Isobutyl chloroformate (8.1 mL, 90.3 mmol) was added dropwise to a cold (0 °C), stirred solution of <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline (19.4 g, 90.3 mmol) and <i>N</i>-methylmorpholine (9.9 mL, 90.3 mmol) in THF (150 mL). After 25 min at 0 °C, this suspension was cannulated into a cold (0 °C) solution of methyl 3,4-diaminobenzoate (<b>24</b>) (15.0 g, 90.3 mmol) and DIEA (15.7 mL, 90.3 mmol) in THF (250 mL). The reaction mixture was allowed to gradually warm to rt, where it was stirred for 18 h before additional <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline (5.8 g), isobutyl chloroformate (2.4 mL), <i>N</i>-methylmorpholine (3.0 mL), and DIEA (4.2 mL) were added to ensure complete consumption of the starting material. After being stirred for an additional 2 h, the mixture was diluted with EtOAc and washed with a sat. aq. NaHCO<sub>3</sub> solution and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and filtered. Concentration of the filtrate gave a residue that was taken up in glacial acetic acid (200 mL) and heated at 60 °C for 6 h. The solvent was removed in vacuo, and the residue was diluted with EtOAc, washed carefully with a sat. aq. NaHCO<sub>3</sub> solution and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated in vacuo. The residue was purified by flash chromatography (silica gel; 10–100% EtOAc/hexanes) to afford (<i>S</i>)-methyl 2-(1-(<i>tert</i>-butoxycarbonyl)-pyrrolidin-2-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole-6-carboxylate as a tan foam (31.2 g). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.11 (s, 1H), 7.79 (dd, <i>J</i> = 8.4, 1.4 Hz, 1H), 7.58 (d, <i>J</i> = 8.4 Hz, 1H), 5.06–4.88 (2 m, 1H), 3.86 (s, 3H), 3.65–3.55 (m, 1H), 3.46–3.39 (m, 1H), 2.41–2.25 (m, 1H), 2.06–1.78 (m, 3H), 1.40 and 1.05 (2s, 9H). LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>24</sub>N<sub>3</sub>O<sub>4</sub>, 346.18; found, 346.19 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>24</sub>N<sub>3</sub>O<sub>4</sub>, 346.1761; found, 346.1749 [M + H]<sup>+</sup>.</div><div class="NLM_p last">A solution of 5 N NaOH (18.1 mL, 90.5 mmol) was added to a stirred solution of (<i>S</i>)-methyl 2-(1-(<i>tert</i>-butoxy-carbonyl)pyrrolidin-2-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole-6-carboxylate (31.2 g, 90.3 mmol) in MeOH (90 mL), and the mixture was stirred for 16 h at rt. The mixture was washed with Et<sub>2</sub>O followed by EtOAc. The aqueous phase was acidified with 6 N HCl to pH ∼5 and extracted with EtOAc. The organic phase was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. Title compound <b>25</b> was retrieved as a tan foam (33.7 g, combined yield for two steps is above theoretical value) and was used in the next step without further purification. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.60–12.40 (br m, 2H), 8.08 (br s, 1H), 7.78 (dd, <i>J</i> = 8.4, 1.1 Hz, 1H), 7.55 (d, <i>J</i> = 8.2 Hz, 1H), 5.00–4.92 (2m, 1H), 3.65–3.54 (m, 1H), 3.47–3.40 (m, 1H), 2.43–2.20 (m, 1H), 2.06–1.80 (m, 3H), 1.39 and 1.05 (2s, 9H). LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>22</sub>N<sub>3</sub>O<sub>4</sub>, 332.16; found, 332.14 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>22</sub>N<sub>3</sub>O<sub>4</sub>, 322.1610; found, 322.1603 [M + H]<sup>+</sup>.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (1<i>R</i>)-2-((2<i>S</i>)-2-(5-(2-(2-((2<i>S</i>)-1-((2<i>R</i>)-2-(Dimethylamino)-2-phenylacetyl)-2-pyrrolidinyl)-1<i>H</i>-benzimidazol-6-yl)-1,3-oxazol-5-yl)-1<i>H</i>-benzimidazol-2-yl)-1-pyrrolidinyl)-<i>N</i>,<i>N</i>-dimethyl-2-oxo-1-phenylethanamine (<b>27</b>)</h3><div class="NLM_p">HATU (0.74 g, 1.9 mmol) was added in one portion to a stirred solution of aminoketone <b>23</b> (0.62 g, ∼1.6 mmol), carboxylic acid <b>25</b> (0.54 g, 1.6 mmol), and DIEA (0.56 mL, 3.2 mmol) in anhydrous DMF (15 mL). The reaction mixture was stirred at rt for 2 h before it was diluted with EtOAc and washed with a sat. aq. NaHCO<sub>3</sub> solution and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The residue was purified by flash chromatography (silica gel; 5–100% B/A, where A = CH<sub>2</sub>Cl<sub>2</sub> and B = 10% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to afford (<i>S</i>)-<i>tert</i>-butyl 2-(6-(2-(2-((<i>S</i>)-1-(<i>tert</i>-butoxycarbonyl)pyrrolidin-2-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-5-yl)-2-oxoethyl-carbamoyl)-1<i>H</i>-benzo[<i>d</i>]-imidazol-2-yl)pyrrolidine-1-carboxylate as a yellow oil (0.90 g, 84%), which was used in the next step directly. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>44</sub>N<sub>6</sub>O<sub>7</sub>, 658.34; found, 658.22 [M + H]<sup>+</sup>.</div><div class="NLM_p">A solution of crude (<i>S</i>)-<i>tert</i>-butyl 2-(6-(2-(2-((<i>S</i>)-1-(<i>tert</i>-butoxycarbonyl)pyrrolidin-2-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-5-yl)-2-oxoethylcarbamoyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)pyrrolidine-1-carboxylate (0.88 g, 1.3 mmol), Ph<sub>3</sub>P (0.70 g, 2.7 mmol), and Et<sub>3</sub>N (0.85 mL, 6.1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (90 mL) was stirred at rt for 5 min before hexachloroethane (0.60 g, 2.6 mmol) was added portion wise. The reaction mixture was stirred for 4 h before additional hexachloroethane (0.30 g) was added followed by an additional portion of Ph<sub>3</sub>P (0.25 g) and hexachloroethane (0.20 g). After being stirred for an additional 16 h at rt, the solvent was removed in vacuo. The residue was then diluted with EtOAc and washed with a sat. aq. NaHCO<sub>3</sub> solution and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The resultant residue was taken up in a minimal amount of CH<sub>2</sub>Cl<sub>2</sub> and subjected to flash chromatography (silica gel; 0–10% B, where solvent A = EtOAc and solvent B = 10% MeOH/EtOAc) to afford <b>26</b> as a light yellow solid (432 mg, 42% for two steps). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.53/12.44/12.34 (s, 2H), 8.26 (d, <i>J</i> = 7.0 Hz, 0.5H), 8.13 (br s, 0.5H), 8.03 (d, <i>J</i> = 5.8 Hz, 0.5H), 7.93–7.89 (m, 1H), 7.85 (br s, 0.5H), 7.74–7.54 (series of m, 3.5H), 5.01/4.94 (br s, 2H), 3.62 (br s, 2H), 3.44 (br s, 2H), 2.37–2.30 (m, 2H), 2.04–1.91 (m, 6H), 1.41 and 1.08 (2s, 18H). LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>42</sub>N<sub>7</sub>O<sub>5</sub>, 640.32; found, 640.87 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>42</sub>N<sub>7</sub>O<sub>5</sub>, 640.3247; found, 640.3231 [M + H]<sup>+</sup>.</div><div class="NLM_p">The HCl salt of 5-(2-((<i>S</i>)-pyrrolidin-2-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-5-yl)-2-(2-((S)-pyrrolidin-2-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-6-yl)oxazole was prepared as a light yellowish-tan solid from <b>26</b> in a similar manner as described in the preparation of <b>8</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.43 (br s, 2H), 9.61–9.33 (m, 2H), 8.34 (s, 1H), 8.11 (s, 1H), 8.06 (dd, <i>J</i> = 8.6, 1.5 Hz, 1H), 7.88 (s, 1H), 7.84–7.73 (m, 3H), 5.03 (d, <i>J</i> = 5.3 Hz, 2H), 3.56 (s, 2H), 3.49–3.30 (m, 4H), 2.30 (dt, <i>J</i> = 12.9, 7.6 Hz, 2H), 2.20–2.00 (m, 4H). LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>26</sub>N<sub>7</sub>O, 440.22; found, 440.12 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>26</sub>N<sub>7</sub>O, 440.2199; found, 440.2218 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Title compound <b>27</b> (TFA salt, yellow solid) was prepared from the HCl salt of 5-(2-((<i>S</i>)-pyrrolidin-2-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-5-yl)-2-(2-((<i>S</i>)-pyrrolidin-2-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-6-yl)oxazole and (<i>R</i>)-2-(dimethylamino)-2-phenylacetic acid·HCl according to the procedure described for the preparation of <b>9a</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.16 (br s, 2H), 8.26–7.57 (series of m, 17H), 5.53–5.52 (m, 1H), 5.26–5.24 (m, 1H), 4.09 (br s, 2H), 3.18–3.14 (m, 1H), 2.95–2.95 (m, 3H), 2.45 (br s, 12H), 2.33 (m, 1H), 2.25–2.20 (m, 2H), 2.14–1.93 (m, 5H). LC (method D, except that column 3 was used): <i>t</i><sub>R</sub> = 1.73 min. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>45</sub>H<sub>48</sub>N<sub>9</sub>O<sub>3</sub>, 762.39; found, 762.31 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>45</sub>H<sub>48</sub>N<sub>9</sub>O<sub>3</sub>, 762.3880; found, 762.3906 [M + H]<sup>+</sup>.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (<i>S</i>)-1-((<i>S</i>)-2-(Dimethylamino)-2-phenylacetyl)-<i>N</i>-(4-(5-(2-((<i>S</i>)-1-((<i>R</i>)-2-(dimethylamino)-2-phenyl-acetyl)pyrrolidin-2-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-6-yl)-oxazol-2-yl)phenyl)pyrrolidine-2-carboxamide (<b>31a</b>)</h3><div class="NLM_p">EDCI (4.22 g, 22.0 mmol) was added to a mixture of <b>28a</b> (2.74 g, 20.0 mmol) and <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline (4.73 g, 22.0 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (40 mL). The reaction mixture was stirred at rt for 16 h, diluted with CH<sub>2</sub>Cl<sub>2</sub> (30 mL), washed with 1 N HCl and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and evaporated in vacuo. The residue was preadsorbed onto silica gel and purified by flash chromatography (silica gel; 20–100% B/A, where solvent A = 1% acetic acid/hexanes and solvent B = 1% acetic acid/EtOAc) to yield <b>29</b> as a white solid (2.97 g, 44%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.78–12.45 (m, 1H), 10.44–10.19 (m, 1H), 7.95–7.83 (m, 2H), 7.78–7.63 (m, 2H), 4.21 (dd, <i>J</i> = 8.1, 4.5 Hz, 1H), 3.53–3.21 (m, 2H), 2.27–2.13 (m, 1H), 1.97–1.72 (m, 3H), 1.39 and 1.25 (2s, 9H). LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>23</sub>N<sub>2</sub>O<sub>5</sub>, 335.16; found, 335.25 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>21</sub>N<sub>2</sub>O<sub>5</sub>, 333.1450; found, 333.1467 [M – H]<sup>−</sup>.</div><div class="NLM_p">HATU (0.45 g, 1.2 mmol) was added in one portion to a stirred solution of aminoketone <b>23</b> (0.34 g, 1.0 mmol), acid <b>29</b> (0.33 g, 1.0 mmol), and DIEA (0.70 mL, 4.0 mmol) in DMF (10 mL). Note: a second coupling reaction was performed in tandem on 160 mg (0.42 mmol) of <b>23</b> using proportionally the same amount of reagents. The reaction mixtures were stirred at rt for 16 h. They were then combined, diluted with EtOAc, washed with a sat. aq. NaHCO<sub>3</sub> solution and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated to afford crude (<i>S</i>)-<i>tert</i>-butyl 2-(4-(2-(2-((<i>S</i>)-1-(<i>tert</i>-butoxycarbonyl)pyrrolidin-2-yl)-1<i>H</i>-benzo[<i>d</i>]-imidazol-6-yl)-2-oxoethylcarbamoyl)phenylcarbamoyl)-pyrrolidine-1-carboxylate as a brown viscous oil (1.65 g, above theoretical yield), which was submitted to the next step without further purification. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>45</sub>N<sub>6</sub>O<sub>7</sub>, 661.34; found, 661.42 [M + H]<sup>+</sup>.</div><div class="NLM_p">A solution of crude (S)-<i>tert</i>-butyl 2-(4-(2-(2-((<i>S</i>)-1-(<i>tert</i>-butoxycarbonyl)pyrrolidin-2-yl)-1<i>H</i>-benzo[<i>d</i>]-imidazol-6-yl)-2-oxoethyl-carbamoyl)phenylcarbamoyl)pyrrolidine-1-carboxylate (1.65 g), Ph<sub>3</sub>P (1.31 g, 5.0 mmol), and Et<sub>3</sub>N (1.40 mL, 10.0 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (25 mL) was stirred at rt for 5 min before hexachloroethane (1.18 g, 5.0 mmol) was added in one portion. The reaction mixture was stirred for 4 h and then preadsorbed onto silica gel and purified by flash chromatography (silica gel; 50–100% EtOAc/hexanes followed by 0–10% MeOH/EtOAc) to afford <b>30</b> as a brown foam, which was submitted to the next step directly. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>43</sub>N<sub>6</sub>O<sub>6</sub>, 643.32; found, 643.41 [M + H]<sup>+</sup>.</div><div class="NLM_p">A cold (0 °C) solution of 4 N HCl in dioxane (10 mL) was added to a stirred solution of biscarbamate <b>30</b> in MeOH (5 mL), the resultant mixture was allowed to warm to rt and stirred for 2 h before Et<sub>2</sub>O was added, and the suspension was suction-filtered and dried in vacuo to afford the HCl salt of (<i>S</i>)-<i>N</i>-(4-(5-(2-((<i>S</i>)-pyrrolidin-2-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-6-yl)oxazol-2-yl)phenyl)pyrrolidine-2-carboxamide as a brown solid (127.2 mg, 9.0%). The filtrate was purified by flash chromatography (silica gel; 1:9:90 mixture of NH<sub>4</sub>OH/MeOH/CH<sub>2</sub>Cl<sub>2</sub>) to yield an additional mass of the product in a free-base form as a tan solid (68.2 mg, 6.2%). For the purpose of characterization, a portion of the free-base form was further purified by reverse-phase HPLC (MeOH/H<sub>2</sub>O/TFA) to afford the TFA salt of the product as a light yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.84 (s, 1H), 9.82 (br s, 1H), 9.40 (br s, 2H), 9.27 (br s, 1H), 8.73 (br s, 1H), 8.12 (d, <i>J</i> = 8.8 Hz, 2H), 8.05 (s, 1H), 7.84–7.78 (m, 3H), 7.75–7.72 (m, 2H), 5.04–4.96 (m, 2H), 4.43–4.35 (m, 2H), 3.50–3.21 (m, 4H), 2.27–1.87 (series of m, 6H). LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>27</sub>N<sub>6</sub>O<sub>2</sub>, 443.22; found, 443.31 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>27</sub>N<sub>6</sub>O<sub>2</sub>, 443.2195; found, 443.2206 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Title compound <b>31a</b> (TFA salt, reddish-tan solid) was prepared from the HCl salt of (<i>S</i>)-<i>N</i>-(4-(5-(2-((<i>S</i>)-pyrrolidin-2-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-5-yl)oxazol-2-yl)phenyl)-pyrrolidine-2-carboxamide and (<i>R</i>)-2-(dimethylamino)-2-phenylacetic acid·HCl according to the procedure described for the preparation of <b>9a</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.52/10.44 (two s, 1H), 10.25 (br s, 1H), 8.46 (s, 1H), 8.08–7.56 (series of m, 17H), 5.55–5.52 (m, 1H), 5.24–5.22 (m, 1H), 4.51–4.48 (m, 1H), 4.09 (br s, 1H), 3.97–3.92 (m, 2H), 3.24–3.15 (m, 2H), 2.95 (br s, 6H), 2.45 (br s, 6H), 2.36–2.09 (m, 3H), 2.02–1.86 (m, 5H). LC (Method E): <i>t</i><sub>R</sub> = 1.92 min. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>45</sub>H<sub>49</sub>N<sub>8</sub>O<sub>4</sub>, 765.39; found, 765.53 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>45</sub>H<sub>49</sub>N<sub>8</sub>O<sub>4</sub>, 765.3877; found, 765.3843 [M + H]<sup>+</sup>.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (2<i>R</i>)-1-[(2<i>S</i>)-2-{5-[2-(3-Aminophenyl)-1,3-oxazol-5-yl]-1<i>H</i>-1,3-benzodiazol-2-yl}pyrrolidin-1-yl]-2-(dimethylamino)-2-phenylethan-1-one (<b>33</b>)</h3><div class="NLM_p"><i>tert</i>-Butyl (2<i>S</i>)-2-{6-[2-(3-{[(<i>tert</i>-butoxy)carbonyl]amino}phenyl)-1,3-oxazol-5-yl]-1<i>H</i>-1,3-benzodiazol-2-yl}pyrrolidine-1-carboxylate was prepared in two steps as a light yellow solid from aminoketone <b>23</b> and acid <b>28b</b> in a similar manner as described in the preparation of benzimidazole <b>30</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.58 (s, 1H), 8.35 (s, 1H), 8.04 (s, 1H), 7.90 (s, 1H), 7.84 (d, <i>J</i> = 8.6 Hz, 1H), 7.79 (d, <i>J</i> = 8.6 Hz, 1H), 7.71 (d, <i>J</i> = 7.6 Hz, 1H), 7.53 (d, <i>J</i> = 8.2 Hz, 1H), 7.45 (t, <i>J</i> = 7.9 Hz, 1H), 5.30/5.08 (br s, 1H), 3.62 (br s, 1H), 3.49–3.46 (m, 1H), 2.46–2.41 (m, 1H), 2.11–2.08 (m, 1H), 2.02–1.97 (m, 2H), 1.51 (s, 9H), 1.41/1.10 (s, 9H). LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>36</sub>N<sub>5</sub>O<sub>5</sub>, 546.27; found, 546.10 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>36</sub>N<sub>5</sub>O<sub>5</sub>, 546.2716; found, 546.2728 [M + H]<sup>+</sup>.</div><div class="NLM_p">Compound <b>32</b> was prepared from the above precursor as a yellowish-orange solid in a similar manner as described in the preparation of <b>8</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.41 (br s, 1H), 9.45 (br s, 1H), 8.07 (s, 1H), 8.01 (s, 1H), 7.99 (s, 1H), 7.90 (s, 1H), 7.77 (s, 2H), 7.62 (t, <i>J</i> = 7.6 Hz, 1H), 7.43 (d, <i>J</i> = 8.2 Hz, 1H), 5.02 (t, <i>J</i> = 7.3 Hz, 1H), 3.46–3.41 (m, 1H), 3.39–3.35 (m, 1H), 2.55–2.52 (m, 1H), 2.33–2.26 (m, 1H), 2.17–2.11 (m, 1H), 2.10–2.04 (m, 1H). LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>20</sub>N<sub>5</sub>O, 346.17; found, 346.00 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>20</sub>N<sub>5</sub>O, 346.1668; found, 346.1672 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Title compound <b>33</b> was prepared as an off-white solid from <b>32</b> and (<i>R</i>)-2-(dimethylamino)-2-phenylacetic acid·HCl (1.0 equiv) in a similar manner as described in the preparation of <b>9a</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.91 (br s, 1H), 7.72 (s, 1H), 7.62 (m, 6H), 7.32 (s, 1H), 7.23 (d, <i>J</i> = 7.6 Hz, 1H), 7.19 (t, <i>J</i> = 7.9 Hz, 1H), 6.93/6.76 (m, 1H), 6.71 (d, <i>J</i> = 7.6 Hz, 1H), 5.38 (br s, 1H), 5.21–5.19 (m, 1H), 4.10–4.07 (m, 1H), 3.20–3.17 (m, 1H), 2.89 (br s, 6H), 2.24–2.16 (m, 1H), 2.15–2.09 (m, 1H), 2.03–2.00 (m, 1H), 1.96–1.90 (m, 1H). LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>29</sub>N<sub>6</sub>O<sub>2</sub>, 505.24; found, 505.26 [M – H]<sup>−</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>29</sub>N<sub>6</sub>O<sub>2</sub>, 505.2352; found, 505.2358 [M – H]<sup>−</sup>.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (<i>S</i>)-1-((<i>R</i>)-2-(Dimethylamino)-2-phenylacetyl)-<i>N</i>-(3-(5-(2-((<i>S</i>)-1-((<i>R</i>)-2-(dimethylamino)-2-phenylacetyl)pyrrolidin-2-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-6-yl)-oxazol-2-yl)phenyl)pyrrolidine-2-carboxamide (<b>31b</b>)</h3><div class="NLM_p">HATU (12.6 g, 33.0 mmol) was added in one portion to a stirred suspension of (<i>R</i>)-2-(dimethylamino)-2-phenylacetic acid·HCl (7.13 g, 33.2 mmol), (<i>S</i>)-<i>tert</i>-butyl pyrrolidine-2-carboxylate (2.15 g, 10.0 mmol), and <i>N</i>-methylmorpholine (7.30 mL, 66.0 mmol) in anhydrous DMF (100 mL). The reaction mixture was stirred at rt for 16 h and was then diluted with EtOAc and washed with a sat. aq. NaHCO<sub>3</sub> solution and water, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The resultant crude material was purified by flash chromatography (silica gel; 10% MeOH/EtOAc) to afford two batches of <i>tert</i>-butyl (2<i>S</i>)-1-[(2<i>R</i>)-2-(dimethylamino)-2-phenylacetyl]pyrrolidine-2-carboxylate: pure material (light yellow foam, 1.20 g, 10.2%) and slightly impure material (orange solid, 7.15 g, 65.2%). The later material was advanced to the next step. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>21</sub>N<sub>2</sub>O<sub>3</sub>, 333.22; found, 333.12 [M + H]<sup>+</sup>.</div><div class="NLM_p">The slightly impure product (7.15 g, 21.5 mmol) was taken up in dioxane (20 mL) and treated with a cold (0 °C) solution of 4 N HCl in dioxane (50 mL). The mixture was allowed to warm to rt and stirred for 4 h. Et<sub>2</sub>O (50 mL) was added, and the resultant heterogeneous mixture was stirred for 0.5 h. The precipitate was suction-filtered and rinsed with Et<sub>2</sub>O to furnish (2<i>S</i>)-1-[(2<i>R</i>)-2-(dimethylamino)-2-phenylacetyl]pyrrolidine-2-carboxylic acid as a peach-colored, hygroscopic solid (3.12 g, 46%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.82 (br s, 1H), 10.38/10.29 (two overlapping br s, 1H), 7.61–7.57 (m, 1.9H), 7.54–7.52 (m, 2.7H), 7.49–7.43 (m, 0.4H), 5.65 (d, <i>J</i> = 8.8 Hz, 0.94H), 5.55 (d, <i>J</i> = 8.1 Hz, 0.06H), 4.95 (d, <i>J</i> = 8.0 Hz, 0.05H), 4.29 (dd, <i>J</i> = 8.7, 2.8 Hz, 0.95H), 3.95–3.90 (m, 1H), 3.13–3.07 (m, 1H), 2.93/2.88 (two overlapping d, <i>J</i> = 4.2 and 5.9 Hz, 3H), 2.45/2.40 (two overlapping d, <i>J</i> = 4.4 and 4.6 Hz, 3H), 2.13–2.03 (m, 1H), 1.93–1.79 (m, 3H). LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>21</sub>N<sub>2</sub>O<sub>3</sub>, 277.16; found, 277.02 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Title compound <b>31b</b> (TFA salt, straw-colored solid) was prepared from aniline <b>33</b> and (2<i>S</i>)-1-[(2<i>R</i>)-2-(dimethylamino)-2-phenylacetyl]pyrrolidine-2-carboxylic acid according to the procedure described for the preparation of <b>9a</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.46/10.36 (s, 1H), 10.26 (br s, 1H), 8.46 (s, 1H), 8.05–7.39 (series of m, 17H), 5.55–5.52 (m, 1H), 5.43 and 5.23 (two dd, <i>J =</i> 7.9, 2.4, 1H), 4.51–4.48 (m, 1H), 4.09–4.06 (m, 1H), 3.97–3.83 (m, 2H), 3.61–3.56 (m, 1H), 3.23–3.14 (m, 1H), 2.96 (br s, 6H), 2.46 (br s, 6H), 2.23–2.09 (m, 3H), 2.04–1.87 (m, 5H). LC (method E): <i>t</i><sub>R</sub> = 1.91 min. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>45</sub>H<sub>49</sub>N<sub>8</sub>O<sub>4</sub>, 765.39; found, 765.35 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>45</sub>H<sub>49</sub>N<sub>8</sub>O<sub>4</sub>, 765.3877; found, 765.3887 [M + H]<sup>+</sup>.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (2<i>S</i>)-1-[(2<i>R</i>)-2-(dimethylamino)-2-phenylacetyl]-<i>N</i>-[3-(2-{3-[(2<i>S</i>)-1-[(2<i>R</i>)-2-(dimethylamino)-2-phenylacetyl]pyrrolidine-2-amido]phenyl}-1,3-oxazol-5-yl)phenyl]pyrrolidine-2-carboxamide (<b>38a</b>)</h3><div class="NLM_p">HATU (1.14 g, 2.99 mmol) was added in one portion to a stirred solution of aminoketone <b>34</b> (0.65 g, 3.0 mmol), acid <b>35</b> (1.0 g, 3.0 mmol), and DIEA (1.1 mL, 6.0 mmol) in DMF (10 mL). The mixture was stirred for 1 h before additional <b>35</b> (100 mg), HATU (140 mg), and DIEA (0.1 mL) were added. The mixture was stirred further for 1 h before the solvent was removed in vacuo. The residue was taken up in EtOAc and was washed with 0.1 N HCl, sat. aq. NaHCO<sub>3</sub> solution, and brine. The organic phase was dried over anhydrous MgSO<sub>4</sub> and evaporated in vacuo to afford (<i>S</i>)-<i>tert</i>-butyl 2-(3-(2-(3-nitrophenyl)-2-oxoethylcarbamoyl)phenylcarbamoyl)pyrrolidine-1-carboxylate (2.22 g) as a yellow foam, which was submitted to the next step without further purification. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>29</sub>N<sub>4</sub>O<sub>7</sub>, 397.15; found, 397.50 [M + H-Boc]<sup>+</sup>.</div><div class="NLM_p">A solution of crude (<i>S</i>)-<i>tert</i>-butyl 2-(3-(5-(3-nitrophenyl)oxazol-2-yl)phenylcarbamoyl)-pyrrolidine-1-carboxylate (2.22 g), Ph<sub>3</sub>P (1.57 g, 5.98 mmol), and Et<sub>3</sub>N (1.7 mL, 12 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15 mL) was stirred at rt for 5 min before hexachloroethane (1.42 g, 5.98 mmol) was added in one portion. The reaction mixture was stirred for 16 h before it was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with 0.1 N HCl, sat. aq. NaHCO<sub>3</sub> solution, and brine, dried over anhydrous MgSO<sub>4</sub>, and concentrated in vacuo. The crude residue was purified by flash chromatography (silica gel; 2–100% EtOAc/hexanes) to afford <b>36</b> as a tan foam (0.34 g, 24% for two steps). The product was slightly impure but was carried forward directly to the next step. For the purpose of characterization, a portion of the product was purified by reverse-phase HPLC (CH<sub>3</sub>CN/H<sub>2</sub>O/NH<sub>4</sub>OAc) to yield a more pure sample of the target product as a light yellow solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.73 (br s, 1H), 8.54 (s, 1H), 8.24 (s, 1H), 8.20 (dd, <i>J</i> = 8.1, 1.2 Hz, 1H), 8.05 (d, <i>J</i> = 7.9 Hz, 1H), 7.86 (br s, 1H), 7.72 (br s, 1H), 7.65 (t, <i>J</i> = 7.9 Hz, 1H), 7.60 (s, 1H), 7.45 (br s, 1H), 4.54 (br s, 1H), 3.51 (br s, 1H), 3.42 (br. s, 1H), 2.04–1.97 (m, 3H), 1.67 (br s, 1H), 1.55 (s, 9H). LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>27</sub>N<sub>4</sub>O<sub>6</sub>, 501.19; found, 501.68 [M + Na]<sup>+</sup>.</div><div class="NLM_p">A suspension of impure <b>36</b> (1.43 g, ∼2.99 mmol) in MeOH (15 mL) was subjected to Parr hydrogenation at 20 psi H<sub>2</sub> over 10% Pd/C (318 mg) for 16 h at rt before it was suction-filtered through Celite and concentrated in vacuo. The resultant material was purified by reverse-phase HPLC (CH<sub>3</sub>CN/H<sub>2</sub>O/NH<sub>4</sub>OAc) to afford (<i>S</i>)-<i>tert</i>-butyl 2-(3-(5-(3-aminophenyl)oxazol-2-yl)phenylcarbamoyl)pyrrolidine-1-carboxylate as light yellow solid (32.0 mg, 2.3% for three steps from <b>34</b> and <b>35</b>). <sup>1</sup>H NMR (500 MHz, MeOH-<i>d</i><sub>4</sub>) δ 8.93 (br s, 1H), 7.84–7.79 (m, 1H), 7.74–7.69 (m, 1H), 7.51–7.45 (m, 2H), 7.19 (t, <i>J</i> = 7.8 Hz, 1H), 7.15–7.15 (m, 1H), 7.10 (d, <i>J</i> = 7.5 Hz, 1H), 6.74 (d, <i>J</i> = 6.7 Hz, 1H), 4.41–4.40/4.34–4.31 (m, 1H), 3.63–3.58 (m, 1H), 3.53–3.49 (m, 1H), 2.39–2.31 (m, 1H), 2.11–2.04 (m, 2H), 1.95–1.91 (m, 1H), 1.50/1.40 (s, 9H). LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>29</sub>N<sub>4</sub>O<sub>4</sub>, 449.22; found, 449.68 [M + H]<sup>+</sup>.</div><div class="NLM_p">HATU (30.1 mg, 0.079 mmol) was added in one portion to a stirred mixture of (<i>S</i>)-<i>tert</i>-butyl 2-(3-(5-(3-aminophenyl)oxazol-2-yl)phenylcarbamoyl)pyrrolidine-1-carboxylate (32.3 mg, 0.072 mmol), <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline (17.1 mg, 0.079 mmol), and DIEA (0.05 mL, 0.3 mmol) in DMF (1 mL). The mixture was stirred at rt for 1 h before the solvent was removed with a stream of N<sub>2</sub>, and the residue was purified by reverse-phase HPLC (CH<sub>3</sub>CN/H<sub>2</sub>O/NH<sub>4</sub>OAc) to afford <b>37a</b> as a light tan solid (18.0 mg, 37%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.25 (s, 1H), 10.19 (s, 1H), 8.41–8.36 (m, 1H), 8.10–8.05 (m, 1H), 7.81–7.73 (m, 3H), 7.64–7.58 (m, 1H), 7.54 (m, 2H), 7.47–7.44 (m, 1H), 4.34–4.29/4.25–4.22 (m, 2H), 3.48–3.45 (m, 2H), 3.39–3.34 (m, 2H), 2.26–2.18 (m, 2H), 1.96–1.86 (m, 4H), 1.85–1.80 (m, 2H), 1.41/1.30 (s, 18H). LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>44</sub>N<sub>5</sub>O<sub>7</sub>-Boc, 546.27; found, 546.78 [M + H-Boc]<sup>+</sup>.</div><div class="NLM_p">To a cold (0 °C) solution of <b>37a</b> (18.0 mg, 0.028 mmol) in MeOH (0.5 mL) was added 4 N HCl in dioxane (1 mL). The reaction mixture was allowed to warm to rt and stirred for 2 h before it was evaporated to dryness. The HCl salt of (2<i>S</i>)-<i>N</i>-[3-(2-{3-[(2<i>S</i>)-pyrrolidine-2-amido]phenyl}-1,3-oxazol-5-yl)phenyl]pyrrolidine-2-carboxamide was isolated as a light yellow solid (15.0 mg, 100%) and was carried forward directly. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>28</sub>N<sub>5</sub>O<sub>3</sub>, 446.22; found, 446.61 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Title compound <b>38a</b> (off-white solid) was prepared from the HCl salt of (2<i>S</i>)-<i>N</i>-[3-(2-{3-[(2<i>S</i>)-pyrrolidine-2-amido]phenyl}-1,3-oxazol-5-yl)phenyl]pyrrolidine-2-carboxamide and (<i>R</i>)-2-(dimethylamino)-2-phenylacetic acid·HCl according to the procedure described for the preparation of <b>9a</b> with the exception that the reverse-phase HPLC purification used a different solvent system (CH<sub>3</sub>CN/H<sub>2</sub>O/NH<sub>4</sub>OAc). <sup>1</sup>H NMR (500 MHz, MeOH-<i>d</i><sub>4</sub>) δ 10.34 (s, 1H), 10.29 (s, 1H), 8.41 (s, 1H), 8.12 (s, 1H), 7.88 (d, <i>J</i> = 7.8 Hz, 1H), 7.76 (d, <i>J</i> = 8.1 Hz, 1H), 7.65–7.58 (m, 13H), 7.54 (t, <i>J</i> = 8.1 Hz, 1H), 7.49 (t, <i>J</i> = 7.9 Hz, 1H), 5.37 (d, <i>J</i> = 1.7 Hz, 2H), 4.61–4.58 (m, 2H), 3.97–3.92 (m, 2H), 3.27–3.22 (m, 2H), 3.10 (br s, 6H), 2.58 (br s, 6H), 2.31–2.24 (m, 2H), 2.21–2.07 (m, 4H), 1.95–1.90 (m, 2H). LC (method F): <i>t</i><sub>R</sub> = 3.29 min. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>45</sub>H<sub>50</sub>N<sub>7</sub>O<sub>5</sub>, 768.39; found, 768.28. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>45</sub>H<sub>50</sub>N<sub>7</sub>O<sub>5</sub>, 768.3873; found, 768.3848 [M + H]<sup>+</sup>.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (2<i>S</i>)-1-[(2<i>R</i>)-2-(Dimethylamino)-2-phenylacetyl]-<i>N</i>-[4-(2-{3-[(2<i>S</i>)-1-[(2<i>R</i>)-2-(dimethylamino)-2-phenylacetyl]pyrrolidine-2-amido]phenyl}-1,3-oxazol-5-yl)phenyl]pyrrolidine-2-carboxamide (<b>38b</b>)</h3><div class="NLM_p"><i>N</i>-Methylmorpholine (2.54 mL, 23.1 mmol) was added to a solution of aminoketone <b>39</b> (1.00 g, 4.62 mmol), benzoic acid <b>40</b> (1.21 g, 5.08 mmol), and HOAT (0.691 g, 5.08 mmol) in DMF (30 mL), and, 5 min later, EDCI (1.33 g, 6.92 mmol) was added in one portion. The reaction mixture was stirred at rt for 4 h, diluted with EtOAc, and washed sequentially with H<sub>2</sub>O, 1 N HCl, sat. aq. NaHCO<sub>3</sub>, H<sub>2</sub>O, and brine. After drying over MgSO<sub>4</sub>, the mixture was concentrated under reduced pressure, and the residue was purified by flash chromatography (silica gel; 30–100% EtOAc/hexanes) to afford <i>tert</i>-butyl <i>N</i>-(3-{[2-(4-nitrophenyl)-2-oxoethyl]carbamoyl}phenyl)carbamate as a dark orange solid (0.131 g). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.51 (s, 1H), 8.85 (t, <i>J</i> = 5.4 Hz, 1H), 8.39–8.35 (m, 2H), 8.29–8.23 (m, 2H), 8.01 (s, 1H), 7.55 (app dd, <i>J</i> = 7.9, 1.3 Hz, 1H), 7.47 (app dt, <i>J</i> = 8.0, 1.1 Hz, 1H), 7.36 (app t, <i>J</i> = 7.9 Hz, 1H), 4.80 (d, <i>J</i> = 5.5 Hz, 2H), 1.48 (s, 9H). LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>22</sub>N<sub>3</sub>O<sub>6</sub>, 400.15; found, 400.33 [M + H]<sup>+</sup>.</div><div class="NLM_p">THF (3 mL) was added to a mixture of Burgess reagent (0.156 g, 0.656 mmol) and the above product (0.131 g, 0.328 mmol) in a pressure vial, and the deep-orange solution heated at 100 °C under microwave radiation (Biotage Initiator) for 15 min. The reaction mixture was concentrated under reduced pressure, and the residue was purified by flash chromatography (silica gel; 10–30% EtOAc/hexanes) to afford <b>41</b> as an orange solid (0.1 g). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.63 (s, 1H), 8.37 (d, <i>J</i> = 8.8 Hz, 2H), 8.34 (s, 1H), 8.16 (s, 1H), 8.08 (d, <i>J</i> = 8.8 Hz, 2H), 7.74 (d, <i>J</i> = 7.7 Hz, 1H), 7.59 (d, <i>J</i> = 8.4 Hz, 1H), 7.50–7.43 (m, 1H), 1.51 (s, 9H). LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>20</sub>N<sub>3</sub>O<sub>5</sub>, 382.14; found, 382.28 [M + H]<sup>+</sup>.</div><div class="NLM_p">Compound <b>41</b> (0.10 g, 0.26 mmol) was dissolved in a mixture of EtOH (5 mL) and THF (5 mL), and the yellow solution was hydrogenated on an H-Cube hydrogenator over 10% Pd/C (1 bar, 25 °C, 1 mL/min flow rate). After the solution passed through the system, THF was used to purge the line. The solution was concentrated under reduced pressure to afford carbamate <b>42</b> as a yellow oil (90 mg), which was used in the next step without further purification. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>22</sub>N<sub>3</sub>O<sub>3</sub>, 352.11; found, 352.34 [M + H]<sup>+</sup>.</div><div class="NLM_p">TFA (2.0 mL, 26 mmol) was added to a solution of carbamate <b>42</b> (90.0 mg, 0.256 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL), and the resulting orange solution was stirred at rt for 30 min. The volatile component was removed under reduced pressure, and the residue was free-based using an MCX cartridge (MeOH wash; 2 N NH<sub>3</sub>/MeOH elution) to afford dianiline <b>43</b> as yellow gum (54 mg), which was used in the next step without further purification. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>14</sub>N<sub>3</sub>O, 252.11; found, 252.30 [M + H]<sup>+</sup>.</div><div class="NLM_p">A mixture of dianiline <b>43</b> (54.0 mg, 0.215 mmol), <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline (95.0 mg, 0.441 mmol), and EEDQ (112 mg, 0.451 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was stirred at rt overnight. The volatile component was removed under reduced pressure, and the residue was purified by reverse-phase HPLC (MeOH/water/TFA) to afford <i>bis</i>-carbamate <b>37b</b> as a yellow solid (120 mg). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.24/10.20 (two s, 2H), 8.41–8.37 (m, 1H), 7.81–7.71 (m, 7H), 7.53–7.49 (m, 1H), 4.31–4.28 (m, 0.72H), 4.25–4.21 (m, 1.28H), 3.49–3.42 (m, 2H), 3.39–3.34 (m, 2H), 2.30–2.13 (m, 2H), 1.99–1.75 (m, 6H), 1.42/1.41 (two s, 6.3H), 1.30/1.29 (two s, 11.7H). LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>44</sub>N<sub>5</sub>O<sub>7</sub>, 646.32; found, 646.50 [M + H]<sup>+</sup>.</div><div class="NLM_p">HCl (4 N in dioxane) (1.0 mL, 4.0 mmol) was added to a solution of biscarbamate <b>37b</b> (117 mg, 0.181 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (8 mL), and the resulting yellow suspension was stirred at rt for 1.5 h. The solvent was removed under reduced pressure to afford the HCl salt of (2<i>S</i>)-<i>N</i>-[3-(5-{4-[(2<i>S</i>)-pyrrolidine-2-amido]phenyl}-1,3-oxazol-2-yl)phenyl]pyrrolidine-2-carboxamide as a yellow solid (72 mg), which was used in the next step without further purification. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.94 (br s, 2H), 9.61 (br s, 2H), 8.73 (m, 2H), 8.43 (br s, 1H), 7.86–7.76 (m, 7H), 7.56 (t, <i>J</i> = 8.0 Hz, 1H), 4.41 (app br s, 2H), 3.31 (m, 4H), 2.48–2.39 (m, 2H), 2.08–1.94 (m, 6H). LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>28</sub>N<sub>5</sub>O<sub>3</sub>, 446.22; found, 446.40 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Title compound <b>38b</b> (TFA salt, off-white solid) was prepared from the HCl salt of (2<i>S</i>)-<i>N</i>-[3-(5-{4-[(2<i>S</i>)-pyrrolidine-2-amido]phenyl}-1,3-oxazol-2-yl)phenyl]pyrrolidine-2-carboxamide and (<i>R</i>)-2-(dimethylamino)-2-phenylacetic acid·HCl according to the procedure described for the preparation of <b>9a</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.50/10.46 (two s, 2H), 10.28 (br s, 2H), 8.38 (s, 1H), 7.82–7.75 (m, 7H), 7.61–7.52 (m, 11H), 5.56 (m, 2H), 4.49 (m, 2H), 3.95 (m, 2H), 3.23 (m, 2H), 2.96 (m, 6H), 2.47 (app d, <i>J</i> = 4.1 Hz, 6H), 2.24–2.15 (m, 2H), 2.07–1.84 (m, 6H). LC (method I): <i>t</i><sub>R</sub> = 1.25 min. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>45</sub>H<sub>50</sub>N<sub>7</sub>O<sub>5</sub>, 768.39; found, 768.50 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>45</sub>H<sub>50</sub>N<sub>7</sub>O<sub>5</sub>, 768.3873; found, 768.3851 [M + H]<sup>+</sup>.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 2-[(2<i>S</i>)-Pyrrolidin-2-yl]-5-[4-(4-{2-[(2<i>S</i>)-pyrrolidin-2-yl]-1<i>H</i>-imidazol-5-yl}phenyl)phenyl]-1<i>H</i>-imidazole (<b>49</b>)</h3><div class="NLM_p last">For the preparation of title compound <b>49</b>, see the supplemental section of ref <a onclick="showRef(event, 'cit3a'); return false;" href="javascript:void(0);" class="ref cit3a">3a</a>.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 2-Phenyl-1-[(2<i>S</i>)-2-{5-[4-(4-{2-[(2<i>S</i>)-1-(2-phenylacetyl)pyrrolidin-2-yl]-1<i>H</i>-imidazol-5-yl}phenyl)phenyl]-1<i>H</i>-imidazol-2-yl}pyrrolidin-1-yl]ethan-1-one (<b>50a</b>)</h3><div class="NLM_p last">Title compound <b>50a</b> (TFA salt, white foam) was prepared from <b>49</b> and phenylacetic acid according to the procedure described for the preparation of <b>9a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 14.51 (very br s, ∼2H), 8.12 (s, 2H), 7.97–7.88 (m, 8H), 5.50/5.22–5.19 (2 m, 2H, likely rotamers), 3.92–3.87 (m, 2H), 3.80–3.63 (m, 6H), 2.43–2.23 (m, 2H), 2.12–2.02 (m, 6H). LC (method G): <i>t</i><sub>R</sub> = 1.67 min. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>42</sub>H<sub>41</sub>N<sub>6</sub>O<sub>2</sub>, 661.33; found 661.53 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>42</sub>H<sub>41</sub>N<sub>6</sub>O<sub>2</sub>, 661.3291; found 661.3264 [M + H]<sup>+</sup>.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Methyl <i>N</i>-[(1<i>R</i>)-2-[(2<i>S</i>)-2-{5-[4-(4-{<i>2</i>-[(2<i>S</i>)-1-[(2<i>R</i>)-2-[(Methoxycarbonyl)amino]-2-phenylacetyl]pyrrolidin-2-yl]-1<i>H</i>-imidazol-5-yl}phenyl)phenyl]-1<i>H</i>-imidazol-2-yl}pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate (<b>50b</b>)</h3><div class="NLM_p last">Title compound <b>50b</b> (TFA salt, off-white solid) was prepared from <b>49</b> and (2<i>R</i>)-2-[(methoxycarbonyl)amino]-2-phenylacetic acid according to the procedure described for the preparation of <b>9a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 14.48 (app br s, ∼2H), 8.18 (br s, 1.79H), 8.10 (br s, 0.21H), 7.99–7.91 (m, 7H), 7.89–7.70 (2 overlapping br m, 3H), 7.42–7.28 (m, 9H), 7.05 (m, 1H), 5.74 (br m, 0.17H), 5.54–5.49 (m, 1.68H), 5.41 (m, 0.32H), 5.21 (m, 1.83H), 3.93 (br m, 1.72H), 3.81 (br m, 0.28H), 3.54/3.53 (2 overlapping s, 6H), 3.20–3.15 (m, 2H), 2.31–2.21 (br m, 2H), 2.10–1.85 (2 overlapping m, 6H). LC (method H): <i>t</i><sub>R</sub> = 1.36 min. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>46</sub>H<sub>47</sub>N<sub>8</sub>O<sub>6</sub>, 807.36; found 807.40 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>46</sub>H<sub>47</sub>N<sub>8</sub>O<sub>6</sub>, 807.3619; found 807.3587 [M + H]<sup>+</sup>.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (2<i>R</i>)-2-(Dimethylamino)-1-[(2<i>S</i>)-2-{5-[4-(4-{2-[(2<i>S</i>)-1-[(2<i>R</i>)-2-(dimethylamino)-2-phenylacetyl]pyrrolidin-2-yl]-1<i>H</i>-imidazol-5-yl}phenyl)phenyl]-1<i>H</i>-imidazol-2-yl}pyrrolidin-1-yl]-2-phenylethan-1-one (<b>50c</b>)</h3><div class="NLM_p last">Title compound <b>50c</b> (TFA salt, off-white foam) was prepared from <b>49</b> and (2<i>R</i>)-2-(dimethylamino)-2-phenylacetic acid according to the procedure described for the preparation of <b>9a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.3 (very broad s, ∼2H), 8.09 (br m, 2H), 7.99–7.88 (m, 7.44), 7.74 (br m, 0.56H), 7.68–7.56 (m, 9.12H), 7.24–7.10 (m, 0.88H), 5.80 (m, 0.2H), 5.51 (s, 0.2H), 5.47 (s, 1.8H), 5.23 (m, 1.8H), 4.03 (m, 1.8H), 3.85 (m, 0.2H), 3.60 (m, 0.2H), 3.06 (m, 1.8H), 2.97–1.76 (overlapping br s and m, 20H). Note that it was not feasible to provide segmented integration for the upfield region because the signal for the dimethylamine moiety (∼2.88 ppm) was very broad and overlapped with other signals, including that of the solvent. LC (method B): <i>t</i><sub>R</sub> = 2.34 min. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>46</sub>H<sub>51</sub>N<sub>8</sub>O<sub>2</sub>, 747.41; found 747.46 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>46</sub>H<sub>51</sub>N<sub>8</sub>O<sub>2</sub>, 747.4135; found, 747.4107 [M + H]<sup>+</sup>.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (2<i>S</i>)-2-(Dimethylamino)-1-[(2<i>S</i>)-2-{5-[4-(4-{2-[(2<i>S</i>)-1-[(2<i>S</i>)-2-(dimethylamino)-2-phenylacetyl]pyrrolidin-2-yl]-1<i>H</i>-imidazol-5-yl}phenyl)phenyl]-1<i>H</i>-imidazol-2-yl}pyrrolidin-1-yl]-2-phenylethan-1-one (<b>50d</b>)</h3><div class="NLM_p last">Title compound <b>50d</b> (TFA salt, off-white foam) was prepared from <b>49</b> and (2<i>S</i>)-2-(dimethylamino)-2-phenylacetic acid according to the procedure described for the preparation of <b>9a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.17 (br s, 2H), 8.04–7.72 (m, 10H), 7.61–7.32 (m, 10H), 5.52/5.27/5.00/4.91 (4 m, 4H, the first two signals were relatively dominant), 3.91–3.78 (m, 2H), 3.43/3.20 (2 m, 2H, the later signal was dominant), 2.93 (app br s, ∼5H), 2.58–1.71 (collection of m, 15H, partially overlapped with solvent signal). Note that for some regions individual integration was not feasible because of baseline shift and signal broadening. LC (method G): <i>t</i><sub>R</sub> = 1.28 min. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>46</sub>H<sub>51</sub>N<sub>8</sub>O<sub>2</sub>, 747.41; found, 747.64 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>46</sub>H<sub>51</sub>N<sub>8</sub>O<sub>2</sub>,747.4135; found, 747.4110 [M + H]<sup>+</sup>.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Methyl <i>N</i>-[(1<i>R</i>)-2-[(2<i>S</i>)-2-{5-[4-(4-{2-[(2<i>S</i>)-1-[(2<i>R</i>)-2-(Dimethylamino)-2-phenylacetyl]pyrrolidin-2-yl]-1<i>H</i>-imidazol-5-yl}phenyl)phenyl]-1<i>H</i>-imidazol-2-yl}pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate (<b>54a</b>)</h3><div class="NLM_p">To a mixture of amine <b>44</b> (10 g, 40 mmol), <i>N</i>-Cbz-<span class="smallcaps smallerCapital">l</span>-proline (11.9 g, 47.7 mmol), and HATU (15.9 g, 41.8 mmol) in DMF (155 mL) was added DIEA (14.0 mL, 80.2 mmol) dropwise. The reaction mixture was stirred at rt for 1 h. The volatile component was removed in vacuo, and the residue was dissolved in EtOAc and washed with H<sub>2</sub>O (3×). The organic phase was dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to afford a white solid. The solid was first recrystallized from EtOAc and then from MeOH to afford ketoamide <b>45b</b> as white needles (11.5 g, 65%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.42–8.18 (m, 1H), 8.03–7.83 (m, 2H), 7.75 (d, <i>J</i> = 8.2 Hz, 2H), 7.44–7.21 (m, 5H), 5.16–4.93 (m, 2H), 4.65–4.41 (m, 2H), 4.40–4.22 (m, 1H), 3.60–3.43 (m, 1H), 3.43–3.33 (m, 1H), 2.26–2.02 (m, 1H), 1.98–1.74 (m, 3H). LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>22</sub>N<sub>2</sub>O<sub>4</sub>Br, 445.08; found, 444.82 [M + H]<sup>+</sup>.</div><div class="NLM_p">A mixture of ketoamide <b>45b</b> (11.5 g, 25.8 mmol) and NH<sub>4</sub>OAc (9.95 g, 129 mmol) in xylenes was heated at 140 °C in a sealed vessel for 3 h. The reaction mixture was allowed to cool to rt, and the volatile component was removed in vacuo. The residue was partitioned between EtOAc and H<sub>2</sub>O, and the aqueous phase was extracted with EtOAc. The combined organic phase was washed with a solution of sat. aq. NaHCO<sub>3</sub>, dried over MgSO<sub>4,</sub> filtered, and concentrated in vacuo. The residue was purified by flash chromatography (silica gel; 50% EtOAc/hexanes) to afford imidazole <b>46c</b> as a light yellow foam (8.7 g, 79%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.38–11.76 (m, 1H), 7.80–7.64 (m, 2H), 7.64–7.44 (m, 3H), 7.44–7.34 (m, 2H), 7.34–7.22 (m, 1H), 7.22–7.11 (m, 1H), 7.06–6.83 (m, 1H), 5.21–5.00 (m, 2H), 5.00–4.88 (m, 1H), 3.69–3.54 (m, 1H), 3.54–3.36 (m, 1H), 2.37–2.13 (m, 1H), 2.09–1.94 (m, 2H), 1.95–1.75 (m, 1H). LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>21</sub>N<sub>3</sub>O<sub>2</sub>Br, 426.08; found, 426.06 [M + H]<sup>+</sup>.</div><div class="NLM_p">To a mixture of imidazole <b>46c</b> (8.52 g, 20.0 mmol), boronate <b>47</b> (see supplemental section of ref <a onclick="showRef(event, 'cit3a'); return false;" href="javascript:void(0);" class="ref cit3a">3a</a> for preparation; 8.82 g, 20.0 mmol), and NaHCO<sub>3</sub> (5.58 g, 66.4 mmol) in 1,2-dimethoxyethane (170 mL) and H<sub>2</sub>O (53 mL) was added Pd(Ph<sub>3</sub>P)<sub>4</sub> (0.83 g, 0.72 mmol). The reaction mixture was heated at 80 °C for 15 h. The volatile component was removed in vacuo, the residue was taken up in 20% MeOH/CHCl<sub>3</sub> and washed with H<sub>2</sub>O, and the aqueous phase was re-extracted with 20% MeOH/CHCl<sub>3</sub>. The combined organic phase was washed with a sat. aq. NaHCO<sub>3</sub> solution, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. Silica gel mesh was prepared from the residue and subjected to flash chromatography (silica gel; 50–100% EtOAc/hexanes) to afford coupled product <b>51a</b> as a tan solid (7.04 g, 53%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.49–11.49 (m, 2H), 7.99–7.79 (m, 3H), 7.79–7.64 (m, 4H), 7.64–7.45 (m, 2H), 7.44–7.23 (m, 3H), 7.21–7.07 (m, 2H), 7.07–6.90 (m, 1H), 5.19–4.68 (m, 4H), 3.72–3.60 (m, 1H), 3.60–3.50 (m, 1H), 3.50–3.41 (m, 1H), 3.41–3.33 (m, 1H), 2.41–2.12 (m, 2H), 2.12–1.95 (m, 3H), 1.95–1.73 (m, 3H), 1.41 (br s, 4H), 1.17 (br s, 5H). LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>39</sub>H<sub>43</sub>N<sub>6</sub>O<sub>4</sub>, 659.33; found, 659.32 [M + H]<sup>+</sup>.</div><div class="NLM_p">A mixture of <b>51a</b> (6.94 g, 10.5 mmol), 20% Pd(OH)<sub>2</sub> (1.388 g), and K<sub>2</sub>CO<sub>3</sub> (6.94 g, 50.2 mmol) in MeOH (100 mL) was exposed to hydrogen gas at 60 psi in a Parr bottle for 3 h. The reaction mixture was filtered over Celite, and the filtrate was concentrated in vacuo. The residue was taken up in CH<sub>2</sub>Cl<sub>2</sub> and washed with H<sub>2</sub>O, and the organic phase was dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to afford impure <b>51b</b> as an off-white foam (5.08 g), which was used in the next step without further purification. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>37</sub>N<sub>6</sub>O<sub>2</sub>, 525.30; found, 525.30 [M + H]<sup>+</sup>.</div><div class="NLM_p">To a solution of pyrrolidine <b>51b</b> (0.40 g, 0.76 mmol), (<i>R</i>)-2-((methoxycarbonyl)amino)-2-phenylacetic acid (0.198 g, 0.946 mmol), and DIEA (0.27 mL, 1.5 mmol) in DMF (5.5 mL) was added HATU (0.294 g, 0.773 mmol). The mixture was stirred at rt for 1 h. Most of the volatile component was removed in vacuo, and the residue was partitioned between an aqueous medium (10 mL H<sub>2</sub>O and 1 mL of sat. aq. NaHCO<sub>3</sub> solution) and organic medium (20 mL of EtOAc, 2 mL of CH<sub>2</sub>Cl<sub>2</sub>, and 2 mL of MeOH). The organic medium was washed with brine and evaporated in vacuo. The residue was dissolved in MeOH and submitted to reverse-phase HPLC purification (MeOH/H<sub>2</sub>O/TFA), and the dominant peak was repurified under the same conditions to remove closely eluting peaks. The final HPLC elute was treated with excess 2.0 N NH<sub>3</sub>/MeOH, and the volatile component was removed in vacuo. The residue was partitioned between an aqueous medium (10 mL of H<sub>2</sub>O and 1 mL of sat. aq. NaHCO<sub>3</sub> solution) and an organic medium (20 mL of EtOAc and 1 mL of MeOH), and the organic phase was washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to afford <b>52</b> as a white foam (146.2 mg, 26.8%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.23–1.77 (m, 2H), 8.03–6.94 (m, 16H), 5.56–5.40 (m, 1.26H), 5.14–5.07 (m, 0.74H), 4.89–4.76 (m, 1H), 3.91 (m, 0.7H), 3.62–3.52 (m, 4.6H), 3.39 (m, 1H), 3.15 (m, 0.7H), 2.29–1.85 (m, 8H), 3.60 (app br s, 3.6H), 1.18/1.17(two overlapping app s, 5.4H). LC (method B): <i>t</i><sub>R</sub> = 3.03 min. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>41</sub>H<sub>46</sub>N<sub>7</sub>O<sub>5</sub>, 716.36; found, 716.39 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>41</sub>H<sub>46</sub>N<sub>7</sub>O<sub>5</sub>, 716.3555; found, 716.3536 [M + H]<sup>+</sup>.</div><div class="NLM_p">Pyrrolidine <b>53</b> (free base, light yellow solid) was synthesized from <b>52</b> according to the procedure described for the preparation of <b>14a</b> with the exception that an increased concentration of TFA in CH<sub>2</sub>Cl<sub>2</sub> (i.e., 25%) was used. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.50–11.53 (m, 2H), 8.12–7.77 (m, 3.64H), 7.77–7.59 (m, 4.65H), 7.59–7.25 (m, 5.29H), 7.24–6.76 (m, 1.42H), 5.61–5.29 (m, 1.24H), 5.20–4.95 (m, 0.76H), 4.17 (t, <i>J</i> = 7.2 Hz, 0.88H), 4.00–3.78 (m, 0.66H), 3.67–3.46 (m, 3.46H), 3.25–3.06 (m, 1.43H), 3.06–2.92 (m, 1.34H), 2.92–2.73 (m, 1.23H), 2.46–2.12 (m, 0.57H), 2.12–1.96 (m, 3.39H), 1.96–1.82 (m, 2.07H), 1.82–1.60 (m, 1.94H). Note that the 1H signal is believed to have overlapped with that of water peak around 3.3 ppm. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>38</sub>N<sub>7</sub>O<sub>3</sub>, 616.30; found, 616.34 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>36</sub>H<sub>38</sub>N<sub>7</sub>O<sub>3</sub>, 616.3031; found, 616.3018 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Title compound <b>54a</b> (TFA salt, off-white foam) was prepared from pyrrolidine <b>53</b> and (<i>R</i>)-2-(dimethylamino)-2-phenylacetic acid·HCl according to the procedure described for the preparation of <b>9a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.29 (br s, 1H), 8.18–7.07 (series of s and m, 21H), 5.77 (m, 0.15H), 5.56–5.42 (m, 1.98H), 5.23 (m, 1.87H), 4.04 (m, 0.81H), 3.95 (m, 0.84H), 3.87–3.81 (m, 0.24H), 3.77–3.73(m, 0.11H), 3.57/3.55 (2 overlapping s, 3H), 3.24–3.14 (m, 0.75H), 3.10–3.30 (m, 1.1H), 3.03–2.71 (very br m, ∼3.15H), ∼2.6–2.34 (br signal overlapped with that of solvent, ∼3H), 2.31–2.18 (m, 2H), 2.14–1.78 (series of overlapping m, 6H). LC (method K): <i>t</i><sub>R</sub> = 1.85 min. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>46</sub>H<sub>49</sub>N<sub>8</sub>O<sub>4</sub>, 777.39; found, 777.32 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>46</sub>H<sub>49</sub>N<sub>8</sub>O<sub>4</sub>, 777.3877; found, 777.3847 [M + H]<sup>+</sup>.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Methyl <i>N</i>-[(1<i>R</i>)-2-Oxo-1-phenyl-2-[(2<i>S</i>)-2-{5-[4-(4-{2-[(2<i>S</i>)-1-(2-phenylacetyl) pyrrolidin-2-yl]-1<i>H</i>-imidazol-5-yl}phenyl)phenyl]-1<i>H</i>-imidazol-2-yl}pyrrolidin-1-yl]ethyl]carbamate (<b>54b</b>)</h3><div class="NLM_p last">Title compound <b>54b</b> (TFA salt, off-white foam) was prepared from pyrrolidine <b>53</b> and phenylacetic acid according to the procedure described for the preparation of <b>9a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 14.49 (very br s, 2H), 8.17–8.09 (m, 2H), 7.99–7.82 (m, 8H), 7.76–7.72 (m, 1H), 7.42–7.05 (m, 10H), 5.74 (5.74 (m, 0.08H), 5.55–5.51 (m, 0.82H), 5.40 (m, 0.18H), 5.20 (m, 1.92H), 3.96–3.87 (m, 1.75H), 3.80–3.61 (m, 3.0H), 3.54–3.46 (m, 3.5H), 3.21–3.15 (m, 0.75H), 2.44–1.86 (collections of m, 8H). LC (method H): <i>t</i><sub>R</sub> = 1.66 min. LC/MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>44</sub>H<sub>44</sub>N<sub>7</sub>O<sub>4</sub>,734.34; found 734.39 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>44</sub>H<sub>44</sub>N<sub>7</sub>O<sub>4</sub>, 734.3445; found, 734.3433 [M + H]<sup>+</sup>.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Ames Mutagenicity Assay</h3><div class="NLM_p last">The Ames assay was conducted in <i>Salmonella typhimurium</i> (TA 100 strain) according to the following protocol: a DMSO solution of test compound (1, 3.2, 10, 32, 100, 320, and 1000 μg/well, <i>n</i> = 3) and bacteria (with or without rat S9 liver fractions) are mixed into top agar containing trace amounts of histidine, poured into a 100 mm dish, and incubated for 48 h at 37 °C along with positive (<i>n</i> = 3) and solvent (<i>n</i> = 6)-control groups. 2-Aminoanthracene and sodium azide were used as positive controls for the studies with and without metabolic activation, respectively. The total number of revertant bacteria colonies per dish per treatment condition is compared with that of the solvent control dish, and a 2-fold or greater increase in the mean revertant colonies is judged as a positive response.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm4016203" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44367" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44367" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Makonen Belema</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6a070b0105040f0444080f060f070b2a08071944090507"><span class="__cf_email__" data-cfemail="c8a5a9a3a7a6ada6e6aaada4ada5a988aaa5bbe6aba7a5">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Van N. Nguyen</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey L. Romine</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Denis R. St. Laurent</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Omar D. Lopez</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason T. Goodrich</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter T. Nower</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donald R. O’Boyle</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julie A. Lemm</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert A. Fridell</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Min Gao</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hua Fang</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rudolph G. Krause</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ying-Kai Wang</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">A. Jayne Oliver</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew C. Good</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jay O. Knipe</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicholas A. Meanwell</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lawrence B. Snyder</span> - <span class="hlFld-Affiliation affiliation">†Departments of Discovery Chemistry, ‡Virology, §Lead Discovery and Optimization, ∥Computer-Assisted
Drug Design, and ⊥Metabolism and Pharmacokinetics, Bristol-Myers
Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1576e7747-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05241" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05241" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank members of our analytical group (Dieter Drexler, Xiaohu Huang, and Julia M. Nielson) for conducting HRMS, NMR, and LC/MS analyses. We thank the editor for suggesting the inclusion of ref <a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">7</a>.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i41" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i41"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="DEF-LIST-d1576e7755-autogenerated"><div id="ac_i42" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i42"> Abbreviations Used</h2><tr><td class="NLM_term">DIAD</td><td class="NLM_def"><p class="first last">diisopropyl azodicarboxylate</p></td></tr><tr><td class="NLM_term">DIEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-(3-dimethylaminopropyl)-3-ethylcarbodiimide·HCl</p></td></tr><tr><td class="NLM_term">EEDQ</td><td class="NLM_def"><p class="first last"><i>N</i>-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HOAT</td><td class="NLM_def"><p class="first last">1-hydroxy-7-azabenzotriazole</p></td></tr><tr><td class="NLM_term">HOBT</td><td class="NLM_def"><p class="first last">1-hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">sat. aq.</td><td class="NLM_def"><p class="first last">saturated aqueous</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature.</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17881" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17881" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 20 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Scheel, T. K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span> </span><span class="NLM_article-title">Understanding the hepatitis C virus life cycle paves the way for highly effective therapies</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">849</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm4016203&amp;key=10.1038%2Fnm.3248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm4016203&amp;key=23836234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm4016203&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKru7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=837-849&author=T.+K.+H.+Scheelauthor=C.+M.+Rice&title=Understanding+the+hepatitis+C+virus+life+cycle+paves+the+way+for+highly+effective+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the hepatitis C virus life cycle paves the way for highly effective therapies</span></div><div class="casAuthors">Scheel, Troels K. H.; Rice, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">837-849</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  More than two decades of intense research has provided a detailed understanding of hepatitis C virus (HCV), which chronically infects 2% of the world's population.  This effort has paved the way for the development of antiviral compds. to spare patients from life-threatening liver disease.  An exciting new era in HCV therapy dawned with the recent approval of two viral protease inhibitors, used in combination with pegylated interferon-α and ribavirin; however, this is just the beginning.  Multiple classes of antivirals with distinct targets promise highly efficient combinations, and interferon-free regimens with short treatment duration and fewer side effects are the future of HCV therapy.  Ongoing and future trials will det. the best antiviral combinations and whether the current seemingly rich pipeline is sufficient for successful treatment of all patients in the face of major challenges, such as HCV diversity, viral resistance, the influence of host genetics, advanced liver disease and other co-morbidities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpde8altGxkeLVg90H21EOLACvtfcHk0lirEbHLW1OnoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKru7rI&md5=dabc9fbc7dc0bc56115d5ede0d8ae072</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1038%2Fnm.3248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3248%26sid%3Dliteratum%253Aachs%26aulast%3DScheel%26aufirst%3DT.%2BK.%2BH.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DUnderstanding%2520the%2520hepatitis%2520C%2520virus%2520life%2520cycle%2520paves%2520the%2520way%2520for%2520highly%2520effective%2520therapies%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D837%26epage%3D849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Manns, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Hahn, T.</span><span> </span><span class="NLM_article-title">Novel therapies for hepatitis C – one pill fits all?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=595-610&author=M.+P.+Mannsauthor=T.+von+Hahn&title=Novel+therapies+for+hepatitis+C+%E2%80%93+one+pill+fits+all%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManns%26aufirst%3DM.%2BP.%26aulast%3Dvon%2BHahn%26aufirst%3DT.%26atitle%3DNovel%2520therapies%2520for%2520hepatitis%2520C%2520%25E2%2580%2593%2520one%2520pill%2520fits%2520all%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D595%26epage%3D610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shah, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowdley, K. V.</span><span> </span><span class="NLM_article-title">Review of direct-acting antiviral agents for the treatment of chronic hepatitis C</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1107</span><span class="NLM_x">–</span> <span class="NLM_lpage">1121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm4016203&amp;key=10.1517%2F13543784.2013.806482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm4016203&amp;key=23735127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm4016203&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Ghur%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2013&pages=1107-1121&author=N.+Shahauthor=T.+Pierceauthor=K.+V.+Kowdley&title=Review+of+direct-acting+antiviral+agents+for+the+treatment+of+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Review of direct-acting antiviral agents for the treatment of chronic hepatitis C</span></div><div class="casAuthors">Shah, Nihar; Pierce, Tracey; Kowdley, Kris V.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1107-1121</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Rapid breakthroughs in the treatment of hepatitis C virus (HCV) infection have dramatically altered the treatment landscape for this chronic disease.  In 2011, the protease inhibitors (PIs) boceprevir and telaprevir in combination with peginterferon (peg-IFN) and ribavirin (RBV) were the first direct-acting antivirals (DAAs) approved in the United States for treatment of genotype (GT) 1 HCV.  Several DAAs currently in late-stage clin. trials, including NS3/NS4A serine PIs, NS5A inhibitors, NS5B polymerase inhibitors (both nucleoside and non-nucleoside) and cyclophilin inhibitors, both with and without peg-IFN and RBV, are promising for the treatment of HCV.  DAA regimens offer several advantages including that they specifically target HCV viral replication and thus appear to be less dependent on host characteristics, very high SVR rates accompanied by fewer side effects (SE) and lower pill burdens.  A review on the treatment of HCV is important and timely as the development on DAAs is progressing rapidly and the health-care providers need to be aware about this as these regimens are anticipated to become clin. available soon.  Areas covered: The literature was searched and reviewed using PubMed as well as data gathered from those presented at the international liver meetings, AASLD and EASL as well as CROI.  Expert opinion: With the potential of eliminating IFN and RBV, several DAAs under clin. development appear to be promising using novel approaches with good antiviral effects, shorter duration and lower SE profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXZExgJKmkr7Vg90H21EOLACvtfcHk0lirEbHLW1OnoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Ghur%252FO&md5=f761cff6a6710f4de9473db6509d20a9</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1517%2F13543784.2013.806482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2013.806482%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DN.%26aulast%3DPierce%26aufirst%3DT.%26aulast%3DKowdley%26aufirst%3DK.%2BV.%26atitle%3DReview%2520of%2520direct-acting%2520antiviral%2520agents%2520for%2520the%2520treatment%2520of%2520chronic%2520hepatitis%2520C%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2013%26volume%3D22%26spage%3D1107%26epage%3D1121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liang, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghany, M. G.</span><span> </span><span class="NLM_article-title">Current and future therapies for hepatitis C virus infection</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">1907</span><span class="NLM_x">–</span> <span class="NLM_lpage">1917</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm4016203&amp;key=10.1056%2FNEJMra1213651" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm4016203&amp;key=23675659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm4016203&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsl2gs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2013&pages=1907-1917&author=T.+J.+Liangauthor=M.+G.+Ghany&title=Current+and+future+therapies+for+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Current and future therapies for hepatitis C virus infection</span></div><div class="casAuthors">Liang, T. Jake; Ghany, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1907-1917</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  The recent approval of two direct-acting antiviral agents for hepatitis C viral (HCV) infection that specifically inhibit viral replication has dramatically increased the viral clearance rate.  It is anticipated that in the course of such a screening process, a large no. of persons will be found to be infected with HCV; this article reviews the current therapy for HCV infection and the landscape of drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4zjjmKeKrZrVg90H21EOLACvtfcHk0lhlKyfawZsk7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsl2gs78%253D&md5=6be058d0298a4441a180ac076d7293aa</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1056%2FNEJMra1213651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra1213651%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DT.%2BJ.%26aulast%3DGhany%26aufirst%3DM.%2BG.%26atitle%3DCurrent%2520and%2520future%2520therapies%2520for%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D368%26spage%3D1907%26epage%3D1917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettles, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belema, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridell, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano-Wu, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Boyle, D. R.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemm, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipe, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colonno, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasela, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">465</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm4016203&amp;key=10.1038%2Fnature08960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm4016203&amp;key=20410884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm4016203&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltVGhtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2010&pages=96-100&author=M.+Gaoauthor=R.+E.+Nettlesauthor=M.+Belemaauthor=L.+B.+Snyderauthor=V.+N.+Nguyenauthor=R.+A.+Fridellauthor=M.+H.+Serrano-Wuauthor=D.+R.+Langleyauthor=J.-H.+Sunauthor=D.+R.+O%E2%80%99Boyleauthor=J.+A.+Lemmauthor=C.+Wangauthor=J.+O.+Knipeauthor=C.+Chienauthor=R.+J.+Colonnoauthor=D.+M.+Graselaauthor=N.+A.+Meanwellauthor=L.+G.+Hamann&title=Chemical+genetics+strategy+identifies+an+HCV+NS5A+inhibitor+with+a+potent+clinical+effect"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect</span></div><div class="casAuthors">Gao, Min; Nettles, Richard E.; Belema, Makonen; Snyder, Lawrence B.; Nguyen, Van N.; Fridell, Robert A.; Serrano-Wu, Michael H.; Langley, David R.; Sun, Jin-Hua; O'Boyle, Donald R., II; Lemm, Julie A.; Wang, Chunfu; Knipe, Jay O.; Chien, Caly; Colonno, Richard J.; Grasela, Dennis M.; Meanwell, Nicholas A.; Hamann, Lawrence G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">7294</span>),
    <span class="NLM_cas:pages">96-100</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The worldwide prevalence of chronic hepatitis C virus (HCV) infection is estd. to be approaching 200 million people.  Current therapy relies upon a combination of pegylated interferon-α and ribavirin, a poorly tolerated regimen typically assocd. with less than 50% sustained virol. response rate in those infected with genotype 1 virus.  The development of direct-acting antiviral agents to treat HCV has focused predominantly on inhibitors of the viral enzymes NS3 protease and the RNA-dependent RNA polymerase NS5B.  Here we describe the profile of BMS-790052, a small mol. inhibitor of the HCV NS5A protein that exhibits picomolar half-max. effective concns. (EC50) towards replicons expressing a broad range of HCV genotypes and the JFH-1 genotype 2a infectious virus in cell culture.  In a phase I clin. trial in patients chronically infected with HCV, administration of a single 100-mg dose of BMS-790052 was assocd. with a 3.3 log10 redn. in mean viral load measured 24 h post-dose that was sustained for an addnl. 120 h in two patients infected with genotype 1b virus.  Genotypic anal. of samples taken at baseline, 24 and 144 h post-dose revealed that the major HCV variants obsd. had substitutions at amino-acid positions identified using the in vitro replicon system.  These results provide the first clin. validation of an inhibitor of HCV NS5A, a protein with no known enzymic function, as an approach to the suppression of virus replication that offers potential as part of a therapeutic regimen based on combinations of HCV inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAY7Lig0xT9LVg90H21EOLACvtfcHk0lhlKyfawZsk7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltVGhtbo%253D&md5=620427e987f2bccd153270cde2ef5027</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1038%2Fnature08960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08960%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DM.%26aulast%3DNettles%26aufirst%3DR.%2BE.%26aulast%3DBelema%26aufirst%3DM.%26aulast%3DSnyder%26aufirst%3DL.%2BB.%26aulast%3DNguyen%26aufirst%3DV.%2BN.%26aulast%3DFridell%26aufirst%3DR.%2BA.%26aulast%3DSerrano-Wu%26aufirst%3DM.%2BH.%26aulast%3DLangley%26aufirst%3DD.%2BR.%26aulast%3DSun%26aufirst%3DJ.-H.%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DD.%2BR.%26aulast%3DLemm%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DChien%26aufirst%3DC.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DChemical%2520genetics%2520strategy%2520identifies%2520an%2520HCV%2520NS5A%2520inhibitor%2520with%2520a%2520potent%2520clinical%2520effect%26jtitle%3DNature%26date%3D2010%26volume%3D465%26spage%3D96%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Belema, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Laurent, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Good, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nower, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valera, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Boyle, D. R.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridell, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemm, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipe, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, L. B.</span><span> </span><span class="NLM_article-title">HCV NS5A replication complex inhibitors. Part 5: Discovery of potent and pan-genotypic glycinamide cap derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4428</span><span class="NLM_x">–</span> <span class="NLM_lpage">4435</span><div class="note"><p class="first last">and references therein</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm4016203&amp;key=10.1016%2Fj.bmcl.2013.05.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm4016203&amp;key=23803586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm4016203&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVShtrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4428-4435&author=M.+Belemaauthor=V.+N.+Nguyenauthor=D.+R.+St.+Laurentauthor=O.+D.+Lopezauthor=Y.+Qiuauthor=A.+C.+Goodauthor=P.+T.+Nowerauthor=L.+Valeraauthor=D.+R.+O%E2%80%99Boyleauthor=J.-H.+Sunauthor=M.+Liuauthor=R.+A.+Fridellauthor=J.+A.+Lemmauthor=M.+Gaoauthor=J.+O.+Knipeauthor=N.+A.+Meanwellauthor=L.+B.+Snyder&title=HCV+NS5A+replication+complex+inhibitors.+Part+5%3A+Discovery+of+potent+and+pan-genotypic+glycinamide+cap+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">HCV NS5A replication complex inhibitors. Part 5: Discovery of potent and pan-genotypic glycinamide cap derivatives</span></div><div class="casAuthors">Belema, Makonen; Nguyen, Van N.; St. Laurent, Denis R.; Lopez, Omar D.; Qiu, Yuping; Good, Andrew C.; Nower, Peter T.; Valera, Lourdes; O'Boyle, Donald R.; Sun, Jin-Hua; Liu, Mengping; Fridell, Robert A.; Lemm, Julie A.; Gao, Min; Knipe, Jay O.; Meanwell, Nicholas A.; Snyder, Lawrence B.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4428-4435</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The isoquinolinamide series of HCV NS5A inhibitors exemplified by compds. (I) and (II) provided the first dual genotype-1a/1b (GT-1a/1b) inhibitor class that demonstrated a significant improvement in potency toward GT-1a replicons compared to that of the initial program lead, stilbene (III).  Structure-activity relationship (SAR) studies that uncovered an alternate phenylglycine-based cap series that exhibit further improvements in virol. profile, along with some insights into the pharmacophoric elements assocd. with the GT-1a potency, are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxZgPIvpbytrVg90H21EOLACvtfcHk0lhlKyfawZsk7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVShtrbO&md5=156e18764c9727e50bfd911f72d875d7</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.040%26sid%3Dliteratum%253Aachs%26aulast%3DBelema%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DV.%2BN.%26aulast%3DSt.%2BLaurent%26aufirst%3DD.%2BR.%26aulast%3DLopez%26aufirst%3DO.%2BD.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DGood%26aufirst%3DA.%2BC.%26aulast%3DNower%26aufirst%3DP.%2BT.%26aulast%3DValera%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DD.%2BR.%26aulast%3DSun%26aufirst%3DJ.-H.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DFridell%26aufirst%3DR.%2BA.%26aulast%3DLemm%26aufirst%3DJ.%2BA.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DSnyder%26aufirst%3DL.%2BB.%26atitle%3DHCV%2520NS5A%2520replication%2520complex%2520inhibitors.%2520Part%25205%253A%2520Discovery%2520of%2520potent%2520and%2520pan-genotypic%2520glycinamide%2520cap%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4428%26epage%3D4435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Kugler-Steigmeier, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friederich, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graf, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutz, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlatter, C.</span><span> </span><span class="NLM_article-title">Genotoxicity of aniline derivatives in various short-term tests</span> <span class="citation_source-journal">Mutat. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">211</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm4016203&amp;key=10.1016%2F0027-5107%2889%2990011-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm4016203&amp;key=2494442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm4016203&amp;key=1%3ACAS%3A528%3ADyaL1MXitVOmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=211&publication_year=1989&pages=279-289&author=M.+E.+Kugler-Steigmeierauthor=U.+Friederichauthor=U.+Grafauthor=W.+K.+Lutzauthor=P.+Maierauthor=C.+Schlatter&title=Genotoxicity+of+aniline+derivatives+in+various+short-term+tests"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Genotoxicity of aniline derivatives in various short-term tests</span></div><div class="casAuthors">Kugler-Steigmeier, M. E.; Friederich, U.; Graf, U.; Lutz, W. K.; Maier, P.; Schlatter, C.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Fundamental and Molecular Mechanisms of Mutagenesis</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">211</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">279-89</span>CODEN:
                <span class="NLM_cas:coden">MUREAV</span>;
        ISSN:<span class="NLM_cas:issn">0027-5107</span>.
    </div><div class="casAbstract">Various substituted aniline derivs. were tested for genotoxicity in several short-term tests to examine the hypothesis that a substitution at both ortho positions (2,6-disubstitution) could prevent genotoxicity due to steric hindrance of an enzymic activation to electrophilic intermediates.  In the Salmonella/microsome assay, 2,6-dialkylsubstituted anilines and 2,4,6-trimethylaniline (2,4,6-TMA) were weakly mutagenic in strain TA100 when 20% S9 mix was used, although effects were small compared to those of 2,4-dimethylaniline and 2,4,5-trimethylaniline (2,4,5-TMA).  In Drosophila melanogaster, however, 2,4,6-TMA and 2,4,6-trichloroaniline were mutagenic in the wing spot test at 2-3 times lower doses than 2,4,5-TMA.  In the 6-thioguanine resistance test in cultured fibroblasts, 2,4,6-TMA was again mutagenic at lower doses than 2,4,5-TMA.  Two methylene-bis-aniline derivs. were also tested with the above methods: 4,4'-methylene-bis-[(2-chloroaniline)] (MOCA) was moderately genotoxic in all 3 tests systems whereas 4,4'-methylene-bis-[(2-ethyl-6-methylaniline)] (MMEA) showed no genotoxicity at all.  DNA binding studies in rats, however, revealed that MOCA and MMEA produced DNA adducts in the liver at levels typically found for moderately strong genotoxic carcinogens.  Thus, the predictive value of the in vitro test systems and particularly the Salmonella/microsome assay is inadequate to detect genotoxicity in arom. amines.  Genotoxicity seems to be a general property of aniline derivs. and does not seem to be greatly influenced by substitution at both ortho positions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7X8K383lt8bVg90H21EOLACvtfcHk0lhN61T3gHGtzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXitVOmtbg%253D&md5=f362df1cf93da42f697b7ca4d19ff59f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2F0027-5107%2889%2990011-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0027-5107%252889%252990011-0%26sid%3Dliteratum%253Aachs%26aulast%3DKugler-Steigmeier%26aufirst%3DM.%2BE.%26aulast%3DFriederich%26aufirst%3DU.%26aulast%3DGraf%26aufirst%3DU.%26aulast%3DLutz%26aufirst%3DW.%2BK.%26aulast%3DMaier%26aufirst%3DP.%26aulast%3DSchlatter%26aufirst%3DC.%26atitle%3DGenotoxicity%2520of%2520aniline%2520derivatives%2520in%2520various%2520short-term%2520tests%26jtitle%3DMutat.%2520Res.%26date%3D1989%26volume%3D211%26spage%3D279%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="note"><p class="first last">For a glimpse into the type of studies required to assess and/or understand the risk-factors associated with the genotoxic liabilities of embedded anilines, see:</p></div><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Behnia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelius, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipkova, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnghar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washburn, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brigance, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stetsko, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henwood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wojciechowski, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, W. G.</span><span> </span><span class="NLM_article-title">Estimation of the extent of in vivo formation of a mutagenic aromatic amine from a potent thyromimetic compound: correlation of in vitro and in vivo findings</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">912</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx200087q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=905-912&author=K.+Behniaauthor=G.+Corneliusauthor=J.+Wangauthor=P.+Shipkovaauthor=S.+Johngharauthor=W.+Washburnauthor=R.+Briganceauthor=P.+Stetskoauthor=A.+Henwoodauthor=J.+P.+Wojciechowskiauthor=P.+Maratheauthor=A.+D.+Rodriguesauthor=W.+G.+Humphreys&title=Estimation+of+the+extent+of+in+vivo+formation+of+a+mutagenic+aromatic+amine+from+a+potent+thyromimetic+compound%3A+correlation+of+in+vitro+and+in+vivo+findings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1021%2Ftx200087q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200087q%26sid%3Dliteratum%253Aachs%26aulast%3DBehnia%26aufirst%3DK.%26aulast%3DCornelius%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DShipkova%26aufirst%3DP.%26aulast%3DJohnghar%26aufirst%3DS.%26aulast%3DWashburn%26aufirst%3DW.%26aulast%3DBrigance%26aufirst%3DR.%26aulast%3DStetsko%26aufirst%3DP.%26aulast%3DHenwood%26aufirst%3DA.%26aulast%3DWojciechowski%26aufirst%3DJ.%2BP.%26aulast%3DMarathe%26aufirst%3DP.%26aulast%3DRodrigues%26aufirst%3DA.%2BD.%26aulast%3DHumphreys%26aufirst%3DW.%2BG.%26atitle%3DEstimation%2520of%2520the%2520extent%2520of%2520in%2520vivo%2520formation%2520of%2520a%2520mutagenic%2520aromatic%2520amine%2520from%2520a%2520potent%2520thyromimetic%2520compound%253A%2520correlation%2520of%2520in%2520vitro%2520and%2520in%2520vivo%2520findings%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26spage%3D905%26epage%3D912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bylund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindgren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olofsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czene, S.</span><span> </span><span class="NLM_article-title">Metabolic profiling of TRPV1 antagonists of the benzothiazole amide series: Implications for in vitro genotoxicity assessment</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2013&pages=201-210&author=J.+Bylundauthor=C.+Peterssonauthor=A.+Lindgrenauthor=S.+Olofssonauthor=S.+Czene&title=Metabolic+profiling+of+TRPV1+antagonists+of+the+benzothiazole+amide+series%3A+Implications+for+in+vitro+genotoxicity+assessment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBylund%26aufirst%3DJ.%26aulast%3DPetersson%26aufirst%3DC.%26aulast%3DLindgren%26aufirst%3DA.%26aulast%3DOlofsson%26aufirst%3DS.%26aulast%3DCzene%26aufirst%3DS.%26atitle%3DMetabolic%2520profiling%2520of%2520TRPV1%2520antagonists%2520of%2520the%2520benzothiazole%2520amide%2520series%253A%2520Implications%2520for%2520in%2520vitro%2520genotoxicity%2520assessment%26jtitle%3DXenobiotica%26date%3D2013%26volume%3D43%26spage%3D201%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="note"><p class="first last">It is noteworthy that not all anilines are promutagenic. For a theoretical treatment and examples on how anilines’ genotoxic liability could be mitigated by incorporating appropriate substituents, see:</p></div><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shamovsky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borjesson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norden, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasselgren, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donovan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjo, P.</span><span> </span><span class="NLM_article-title">Explanation for main features of structure-genotoxicity relationships of aromatic amines by theoretical studies of their activation pathways in CYP1A2</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">16168</span><span class="NLM_x">–</span> <span class="NLM_lpage">16185</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja206427u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=16168-16185&author=I.+Shamovskyauthor=L.+Ripaauthor=L.+Borjessonauthor=C.+Meeauthor=B.+Nordenauthor=P.+Hansenauthor=C.+Hasselgrenauthor=M.+O%E2%80%99Donovanauthor=P.+Sjo&title=Explanation+for+main+features+of+structure-genotoxicity+relationships+of+aromatic+amines+by+theoretical+studies+of+their+activation+pathways+in+CYP1A2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1021%2Fja206427u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja206427u%26sid%3Dliteratum%253Aachs%26aulast%3DShamovsky%26aufirst%3DI.%26aulast%3DRipa%26aufirst%3DL.%26aulast%3DBorjesson%26aufirst%3DL.%26aulast%3DMee%26aufirst%3DC.%26aulast%3DNorden%26aufirst%3DB.%26aulast%3DHansen%26aufirst%3DP.%26aulast%3DHasselgren%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Donovan%26aufirst%3DM.%26aulast%3DSjo%26aufirst%3DP.%26atitle%3DExplanation%2520for%2520main%2520features%2520of%2520structure-genotoxicity%2520relationships%2520of%2520aromatic%2520amines%2520by%2520theoretical%2520studies%2520of%2520their%2520activation%2520pathways%2520in%2520CYP1A2%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D16168%26epage%3D16185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Birch, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groombridge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mee, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schramm, C.</span><span> </span><span class="NLM_article-title">Rationally designing safer anilines: The challenging case of 4-aminobiphenyls</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3923</span><span class="NLM_x">–</span> <span class="NLM_lpage">3933</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3001295" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3923-3933&author=A.+M.+Birchauthor=S.+Groombridgeauthor=R.+Lawauthor=A.+G.+Leachauthor=C.+D.+Meeauthor=C.+Schramm&title=Rationally+designing+safer+anilines%3A+The+challenging+case+of+4-aminobiphenyls"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1021%2Fjm3001295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3001295%26sid%3Dliteratum%253Aachs%26aulast%3DBirch%26aufirst%3DA.%2BM.%26aulast%3DGroombridge%26aufirst%3DS.%26aulast%3DLaw%26aufirst%3DR.%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DMee%26aufirst%3DC.%2BD.%26aulast%3DSchramm%26aufirst%3DC.%26atitle%3DRationally%2520designing%2520safer%2520anilines%253A%2520The%2520challenging%2520case%2520of%25204-aminobiphenyls%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3923%26epage%3D3933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hamann, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manfredi, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krystek, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augeri, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betebenner, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhns, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupisella, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darienzo, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Custer, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biller, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostrowski, J.</span><span> </span><span class="NLM_article-title">Tandem optimization of target activity and elimination of mutagenic potential in a potent series of <i>N</i>-aryl bicyclic hydantoin-based selective androgen receptor modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1860</span><span class="NLM_x">–</span> <span class="NLM_lpage">1864</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Fjm4016203&amp;key=10.1016%2Fj.bmcl.2007.01.076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm4016203&amp;key=17292608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm4016203&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis1OgtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1860-1864&author=L.+G.+Hamannauthor=M.+C.+Manfrediauthor=C.+Sunauthor=S.+R.+Krystekauthor=Y.+Huangauthor=Y.+Biauthor=D.+J.+Augeriauthor=T.+Wangauthor=Y.+Zouauthor=D.+A.+Betebennerauthor=A.+Furaauthor=R.+Seethalaauthor=R.+Gollaauthor=J.+E.+Kuhnsauthor=J.+A.+Lupisellaauthor=C.+J.+Darienzoauthor=L.+L.+Custerauthor=J.+L.+Priceauthor=J.+M.+Johnsonauthor=S.+A.+Billerauthor=R.+Zahlerauthor=J.+Ostrowski&title=Tandem+optimization+of+target+activity+and+elimination+of+mutagenic+potential+in+a+potent+series+of+N-aryl+bicyclic+hydantoin-based+selective+androgen+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Tandem optimization of target activity and elimination of mutagenic potential in a potent series of N-aryl bicyclic hydantoin-based selective androgen receptor modulators</span></div><div class="casAuthors">Hamann, Lawrence G.; Manfredi, Mark C.; Sun, Chongqing; Krystek, Stanley R.; Huang, Yanting; Bi, Yingzhi; Augeri, David J.; Wang, Tammy; Zou, Yan; Betebenner, David A.; Fura, Aberra; Seethala, Ramakrishna; Golla, Rajasree; Kuhns, Joyce E.; Lupisella, John A.; Darienzo, Celia J.; Custer, Laura L.; Price, Jennifer L.; Johnson, James M.; Biller, Scott A.; Zahler, Robert; Ostrowski, Jacek</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1860-1864</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Pharmacokinetic studies in cynomolgus monkeys with a novel prototype selective androgen receptor modulator revealed trace amts. of an aniline fragment released through hydrolytic metab.  This aniline fragment was detd. to be mutagenic in an Ames assay.  Subsequent concurrent optimization for target activity and avoidance of mutagenicity led to the identification of a pharmacol. superior clin. candidate without mutagenic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvKnarhfgrgbVg90H21EOLACvtfcHk0ljLgZCtRwtLlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis1OgtL4%253D&md5=5511a61de3af0ecc58d761a3bcb4bf12</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.01.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.01.076%26sid%3Dliteratum%253Aachs%26aulast%3DHamann%26aufirst%3DL.%2BG.%26aulast%3DManfredi%26aufirst%3DM.%2BC.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DKrystek%26aufirst%3DS.%2BR.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DBi%26aufirst%3DY.%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DBetebenner%26aufirst%3DD.%2BA.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DGolla%26aufirst%3DR.%26aulast%3DKuhns%26aufirst%3DJ.%2BE.%26aulast%3DLupisella%26aufirst%3DJ.%2BA.%26aulast%3DDarienzo%26aufirst%3DC.%2BJ.%26aulast%3DCuster%26aufirst%3DL.%2BL.%26aulast%3DPrice%26aufirst%3DJ.%2BL.%26aulast%3DJohnson%26aufirst%3DJ.%2BM.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DZahler%26aufirst%3DR.%26aulast%3DOstrowski%26aufirst%3DJ.%26atitle%3DTandem%2520optimization%2520of%2520target%2520activity%2520and%2520elimination%2520of%2520mutagenic%2520potential%2520in%2520a%2520potent%2520series%2520of%2520N-aryl%2520bicyclic%2520hydantoin-based%2520selective%2520androgen%2520receptor%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1860%26epage%3D1864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Barmeld, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">Small molecule conformational preferences derived from crystal structure data. A medicinal chemistry focused analysis</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci7002494" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=1-24&author=K.+A.+Barmeldauthor=B.+Kuhnauthor=D.+C.+Reuterauthor=M.+Stahl&title=Small+molecule+conformational+preferences+derived+from+crystal+structure+data.+A+medicinal+chemistry+focused+analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fci7002494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci7002494%26sid%3Dliteratum%253Aachs%26aulast%3DBarmeld%26aufirst%3DK.%2BA.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DReuter%26aufirst%3DD.%2BC.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DSmall%2520molecule%2520conformational%2520preferences%2520derived%2520from%2520crystal%2520structure%2520data.%2520A%2520medicinal%2520chemistry%2520focused%2520analysis%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2008%26volume%3D48%26spage%3D1%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Lin, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanza, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castonguay, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamenecka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Riper, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egger, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mumford, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCoss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagmann, W. K.</span><span> </span><span class="NLM_article-title">Bioisosteric replacement of anilide with benzoxazole: Potent and orally bioavailable antagonists of VLA-4</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2331</span><span class="NLM_x">–</span> <span class="NLM_lpage">2334</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=2331-2334&author=L.+S.+Linauthor=T.+J.+Lanzaauthor=L.+A.+Castonguayauthor=T.+Kameneckaauthor=E.+McCauleyauthor=G.+Van+Riperauthor=L.+A.+Eggerauthor=R.+A.+Mumfordauthor=X.+Tongauthor=M.+MacCossauthor=J.+A.+Schmidtauthor=W.+K.+Hagmann&title=Bioisosteric+replacement+of+anilide+with+benzoxazole%3A+Potent+and+orally+bioavailable+antagonists+of+VLA-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DL.%2BS.%26aulast%3DLanza%26aufirst%3DT.%2BJ.%26aulast%3DCastonguay%26aufirst%3DL.%2BA.%26aulast%3DKamenecka%26aufirst%3DT.%26aulast%3DMcCauley%26aufirst%3DE.%26aulast%3DVan%2BRiper%26aufirst%3DG.%26aulast%3DEgger%26aufirst%3DL.%2BA.%26aulast%3DMumford%26aufirst%3DR.%2BA.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DJ.%2BA.%26aulast%3DHagmann%26aufirst%3DW.%2BK.%26atitle%3DBioisosteric%2520replacement%2520of%2520anilide%2520with%2520benzoxazole%253A%2520Potent%2520and%2520orally%2520bioavailable%2520antagonists%2520of%2520VLA-4%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D2331%26epage%3D2334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Belema, M.; Good, A. C.; Goodrich, J. T.; Kakarla, R.; Li, G.; Lopez, O. D.; Nguyen, V. N.; Kapur, J.; Qiu, Y.; Romine, J. L.; St. Laurent, D. R.; Serrano-Wu, M. H.; Snyder, L. B.; Yang, F.</span><span> </span><span class="NLM_article-title">Bi-1<i>H</i>-benzimidazoles as hepatitis C virus inhibitors</span>. PCT Int. Patent WO2010-017401,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=M.+Belema&author=A.+C.+Good&author=J.+T.+Goodrich&author=R.+Kakarla&author=G.+Li&author=O.+D.+Lopez&author=V.+N.+Nguyen&author=J.+Kapur&author=Y.+Qiu&author=J.+L.+Romine&author=D.+R.+St.+Laurent&author=M.+H.+Serrano-Wu&author=L.+B.+Snyder&author=F.+Yang&title=Bi-1H-benzimidazoles+as+hepatitis+C+virus+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBelema%26aufirst%3DM.%26atitle%3DBi-1H-benzimidazoles%2520as%2520hepatitis%2520C%2520virus%2520inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Nobel, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lommerse, J. P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span> </span><span class="NLM_article-title">Hydrogen bonding properties of oxygen and nitrogen acceptors in aromatic heterocycles</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2060</span><span class="NLM_x">–</span> <span class="NLM_lpage">2074</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1997&pages=2060-2074&author=I.+Nobelauthor=S.+L.+Priceauthor=J.+P.+M.+Lommerseauthor=R.+Taylor&title=Hydrogen+bonding+properties+of+oxygen+and+nitrogen+acceptors+in+aromatic+heterocycles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNobel%26aufirst%3DI.%26aulast%3DPrice%26aufirst%3DS.%2BL.%26aulast%3DLommerse%26aufirst%3DJ.%2BP.%2BM.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DHydrogen%2520bonding%2520properties%2520of%2520oxygen%2520and%2520nitrogen%2520acceptors%2520in%2520aromatic%2520heterocycles%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1997%26volume%3D18%26spage%3D2060%26epage%3D2074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">For details on the biological assays, see:</p></div><span class="NLM_contrib-group">Laurent, D. R.; Serrano-Wu, M. H.; Belema, M.; Ding, M.; Fang, H.; Gao, M.; Goodrich, J. T.; Krause, R. G.; Lemm, J. A.; Liu, M.; Lopez, O.; Nguyen, V. N.; Nower, P. T.; O’Boyle, D. R.; Pearce, B. C.; Romine, J. L.; Valera, L.; Sun, J.-H.; Wang, Y.-K.; Yang, F.; Yang, X.; Meanwell, N. A.; Snyder, L. B.</span><span> </span><span class="NLM_article-title">HCV NS5A replication complex inhibitors. Part 4. Optimization for genotype 1a replicon inhibitory activity</span>.  <span class="citation_source-journal">J. Med. Chem.</span> [Online early access]. DOI: <span class="refDoi"> DOI: 10.1021/jm301796k</span> . Published Online: April 10,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/jm301796k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=D.+R.+Laurent&author=M.+H.+Serrano-Wu&author=M.+Belema&author=M.+Ding&author=H.+Fang&author=M.+Gao&author=J.+T.+Goodrich&author=R.+G.+Krause&author=J.+A.+Lemm&author=M.+Liu&author=O.+Lopez&author=V.+N.+Nguyen&author=P.+T.+Nower&author=D.+R.+O%E2%80%99Boyle&author=B.+C.+Pearce&author=J.+L.+Romine&author=L.+Valera&author=J.-H.+Sun&author=Y.-K.+Wang&author=F.+Yang&author=X.+Yang&author=N.+A.+Meanwell&author=L.+B.+Snyder&title=HCV+NS5A+replication+complex+inhibitors.+Part+4.+Optimization+for+genotype+1a+replicon+inhibitory+activity&doi=10.1021%2Fjm301796k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1021%2Fjm301796k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301796k%26sid%3Dliteratum%253Aachs%26aulast%3DLaurent%26aufirst%3DD.%2BR.%26atitle%3DHCV%2520NS5A%2520replication%2520complex%2520inhibitors.%2520Part%25204.%2520Optimization%2520for%2520genotype%25201a%2520replicon%2520inhibitory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26doi%3D10.1021%2Fjm301796k%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">No difference in replicon activity was observed when select compounds were tested as either free base or TFA salt.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=No+difference+in+replicon+activity+was+observed+when+select+compounds+were+tested+as+either+free+base+or+TFA+salt."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><div class="note"><p class="first last">For a report on the susceptibility of 2-methylbenzoxazole containing analogue to hydrolytic opening of the ring under assay sample-handling conditions, see:</p></div><span class="NLM_contrib-group">McElhinny, C. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewin, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascarella, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Runyon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brieaddy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, F. I.</span><span> </span><span class="NLM_article-title">Hydrolytic instability of the important orexin 1 receptor antagonist SB-334867: Possible confounding effects on in vivo and in vitro studies</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">6661</span><span class="NLM_x">–</span> <span class="NLM_lpage">6664</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6661-6664&author=C.+J.+McElhinnyauthor=A.+H.+Lewinauthor=S.+W.+Mascarellaauthor=S.+Runyonauthor=L.+Brieaddyauthor=F.+I.+Carroll&title=Hydrolytic+instability+of+the+important+orexin+1+receptor+antagonist+SB-334867%3A+Possible+confounding+effects+on+in+vivo+and+in+vitro+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcElhinny%26aufirst%3DC.%2BJ.%26aulast%3DLewin%26aufirst%3DA.%2BH.%26aulast%3DMascarella%26aufirst%3DS.%2BW.%26aulast%3DRunyon%26aufirst%3DS.%26aulast%3DBrieaddy%26aufirst%3DL.%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26atitle%3DHydrolytic%2520instability%2520of%2520the%2520important%2520orexin%25201%2520receptor%2520antagonist%2520SB-334867%253A%2520Possible%2520confounding%2520effects%2520on%2520in%2520vivo%2520and%2520in%2520vitro%2520studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D6661%26epage%3D6664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="note"><p class="first last">Incubation of <b>15a</b> and <b>16a</b> in replicon medium (5 μM, 37 °C, 48 h) followed by EtOAc extraction and LC/MS analyses revealed that the main peak for each corresponded with the respective parental compounds. It should be noted, however, that no attempt was made to ascertain their concentration or to determine if the putative hydrolysis products would have been extracted from the assay medium under the noted conditions.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lopez, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Laurent, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belema, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano-Wu, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodrich, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripka, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nower, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valera, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Boyle, D. R.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridell, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemm, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Good, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, L. B.</span><span> </span><span class="NLM_article-title">HCV NS5A replication complex inhibitors. Part 3: Discovery of potent analogs with distinct core topologies</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=779-784&author=O.+D.+Lopezauthor=V.+N.+Nguyenauthor=D.+R.+St.+Laurentauthor=M.+Belemaauthor=M.+H.+Serrano-Wuauthor=J.+T.+Goodrichauthor=F.+Yangauthor=Y.+Qiuauthor=A.+S.+Ripkaauthor=P.+T.+Nowerauthor=L.+Valeraauthor=M.+Liuauthor=D.+R.+O%E2%80%99Boyleauthor=J.-H.+Sunauthor=R.+A.+Fridellauthor=J.+A.+Lemmauthor=M.+Gaoauthor=A.+C.+Goodauthor=N.+A.+Meanwellauthor=L.+B.+Snyder&title=HCV+NS5A+replication+complex+inhibitors.+Part+3%3A+Discovery+of+potent+analogs+with+distinct+core+topologies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLopez%26aufirst%3DO.%2BD.%26aulast%3DNguyen%26aufirst%3DV.%2BN.%26aulast%3DSt.%2BLaurent%26aufirst%3DD.%2BR.%26aulast%3DBelema%26aufirst%3DM.%26aulast%3DSerrano-Wu%26aufirst%3DM.%2BH.%26aulast%3DGoodrich%26aufirst%3DJ.%2BT.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DRipka%26aufirst%3DA.%2BS.%26aulast%3DNower%26aufirst%3DP.%2BT.%26aulast%3DValera%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DD.%2BR.%26aulast%3DSun%26aufirst%3DJ.-H.%26aulast%3DFridell%26aufirst%3DR.%2BA.%26aulast%3DLemm%26aufirst%3DJ.%2BA.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DGood%26aufirst%3DA.%2BC.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DSnyder%26aufirst%3DL.%2BB.%26atitle%3DHCV%2520NS5A%2520replication%2520complex%2520inhibitors.%2520Part%25203%253A%2520Discovery%2520of%2520potent%2520analogs%2520with%2520distinct%2520core%2520topologies%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D779%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">It is noteworthy that a side product that is believed to be a regioisomer of <b>18</b>, and which would have ultimately yielded <b>38b</b>, is formed during the dinitration of 2,5-diphenyloxazole and was carried through the subsequent transformations until the penultimate step, where it was removed through recrystallization.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=It+is+noteworthy+that+a+side+product+that+is+believed+to+be+a+regioisomer+of+18%2C+and+which+would+have+ultimately+yielded+38b%2C+is+formed+during+the+dinitration+of+2%2C5-diphenyloxazole+and+was+carried+through+the+subsequent+transformations+until+the+penultimate+step%2C+where+it+was+removed+through+recrystallization."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="note"><p class="first last">There is an error in the replicon activity of the phenylacetyl cap analogue of <b>21</b> (i.e., (2<i>S</i>)-1-(2-phenylacetyl)-<i>N</i>-[4-(5-{4-[(2<i>S</i>)-1-(2-phenylacetyl)pyrrolidine-2-amido]phenyl}-1,3-oxazol-2-yl)phenyl]pyrrolidine-2-carboxamide) reported previously in ref <a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">14a</a> because of a sample contamination issue. The revised EC<sub>50</sub> value of this analogue toward GT-1b replicon is 429 nM.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="note"><p class="first last">Preparation of compound <b>31b</b> from 3-aminobenzoic acid according to the procedure described for its regioisomer, <b>31a</b>, resulted in a final product containing a significant amount of an unidentified impurity, which could not be removed readily. The alternate route provided a sample of <b>31b</b> in 90% HPLC purity.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><div class="note"><p class="first last">For an example of the use of imidazoles as amide isosteres, see:</p></div><span class="NLM_contrib-group">Breslin, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miskowski, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukla, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leister, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Winter, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somers, M. V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peeters, D. C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roevens, P. W. M.</span><span> </span><span class="NLM_article-title">Design, synthesis, and tripeptidyl peptidase II inhibitory activity of a novel series of (<i>S</i>)-2,3-dihydro-2-(4-alkyl-1<i>H</i>-imidazol-2-yl)-1<i>H</i>-indoles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5303</span><span class="NLM_x">–</span> <span class="NLM_lpage">5310</span><div class="note"><p class="first last">and ref <a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">10</a> cited therein</p></div></span><div class="citationLinks">[<a href="/doi/10.1021/jm0202831" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5303-5310&author=H.+J.+Breslinauthor=T.+A.+Miskowskiauthor=M.+J.+Kuklaauthor=W.+H.+Leisterauthor=H.+L.+De+Winterauthor=D.+A.+Gauthierauthor=M.+V.+F.+Somersauthor=D.+C.+G.+Peetersauthor=P.+W.+M.+Roevens&title=Design%2C+synthesis%2C+and+tripeptidyl+peptidase+II+inhibitory+activity+of+a+novel+series+of+%28S%29-2%2C3-dihydro-2-%284-alkyl-1H-imidazol-2-yl%29-1H-indoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm0202831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0202831%26sid%3Dliteratum%253Aachs%26aulast%3DBreslin%26aufirst%3DH.%2BJ.%26aulast%3DMiskowski%26aufirst%3DT.%2BA.%26aulast%3DKukla%26aufirst%3DM.%2BJ.%26aulast%3DLeister%26aufirst%3DW.%2BH.%26aulast%3DDe%2BWinter%26aufirst%3DH.%2BL.%26aulast%3DGauthier%26aufirst%3DD.%2BA.%26aulast%3DSomers%26aufirst%3DM.%2BV.%2BF.%26aulast%3DPeeters%26aufirst%3DD.%2BC.%2BG.%26aulast%3DRoevens%26aufirst%3DP.%2BW.%2BM.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520tripeptidyl%2520peptidase%2520II%2520inhibitory%2520activity%2520of%2520a%2520novel%2520series%2520of%2520%2528S%2529-2%252C3-dihydro-2-%25284-alkyl-1H-imidazol-2-yl%2529-1H-indoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5303%26epage%3D5310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Bachand, C.; Belema, M.; Deon, D. H.; Good, A. C.; Goodrich, J. T.; James, C. A.; Lavoie, R.; Lopez, O. D.; Martel, A.; Meanwell, N. A.; Nguyen, V. N.; Romine, J. L.; Ruediger, E. H.; Snyder, L. B.; St. Laurent, D. R.; Yang, F.; Langley, D. R.; Wang, G.; Hamann, L. G.</span><span> </span><span class="NLM_article-title">Hepatitis C virus inhibitors</span>. PCT Int. Patent WO2008-021927,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=C.+Bachand&author=M.+Belema&author=D.+H.+Deon&author=A.+C.+Good&author=J.+T.+Goodrich&author=C.+A.+James&author=R.+Lavoie&author=O.+D.+Lopez&author=A.+Martel&author=N.+A.+Meanwell&author=V.+N.+Nguyen&author=J.+L.+Romine&author=E.+H.+Ruediger&author=L.+B.+Snyder&author=D.+R.+St.+Laurent&author=F.+Yang&author=D.+R.+Langley&author=G.+Wang&author=L.+G.+Hamann&title=Hepatitis+C+virus+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBachand%26aufirst%3DC.%26atitle%3DHepatitis%2520C%2520virus%2520inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Walters, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murcko, M. A.</span><span> </span><span class="NLM_article-title">What do medicinal chemists actually make? A 50-year retrospective</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6405</span><span class="NLM_x">–</span> <span class="NLM_lpage">6416</span><div class="note"><p class="first last">and references cited therein</p></div></span><div class="citationLinks">[<a href="/doi/10.1021/jm200504p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm4016203&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFWjsr7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6405-6416&author=W.+P.+Waltersauthor=J.+Greenauthor=J.+R.+Weissauthor=M.+A.+Murcko&title=What+do+medicinal+chemists+actually+make%3F+A+50-year+retrospective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">What Do Medicinal Chemists Actually Make? A 50-Year Retrospective</span></div><div class="casAuthors">Walters, W. Patrick; Green, Jeremy; Weiss, Jonathan R.; Murcko, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6405-6416</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Despite the dramatically increasing costs of pharmaceutical R&D productivity, as measured by the no. of new drugs approved each year, has languished during the past decade.  Many different explanations have been proposed to account for this decline, such as increasing regulatory scrutiny, the inherent inefficiency of very large organizations, the pursuit of highly speculative targets identified from genomics, and more objective decision-making about advancing marginal compds. into latest age clin. trials.  Another factor often cited to help explain low pharmaceutical productivity is that, paradoxically, many compds. synthesized by medicinal chemists are not "druglike", at least as measured by various criteria.  The authors discuss the past, present and perspectives in the development of medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg5xuF4wHqKrVg90H21EOLACvtfcHk0ljAiHft4EvcOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFWjsr7O&md5=33109f9d55967be0d34f377f433621e4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm200504p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200504p%26sid%3Dliteratum%253Aachs%26aulast%3DWalters%26aufirst%3DW.%2BP.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DWeiss%26aufirst%3DJ.%2BR.%26aulast%3DMurcko%26aufirst%3DM.%2BA.%26atitle%3DWhat%2520do%2520medicinal%2520chemists%2520actually%2520make%253F%2520A%252050-year%2520retrospective%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6405%26epage%3D6416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><div class="note"><p class="first last">Although dimerically configured core/cap pharmacophore moieties appeared to be needed for potent GT-1a activity, it is noteworthy that a tool compound lacking the GT-1a potency-enhancing cap elements discussed in the text and exhibiting GT-1a EC<sub>50</sub> >10 μM binds to GT-1a protein:</p></div><span class="NLM_contrib-group">O’Boyle, D. R.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J. -H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nower, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemm, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridell, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romine, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belema, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurent, D. R.,  St.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano-Wu, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, M.</span><span> </span><span class="NLM_article-title">Characterizations of HCV NS5A replication complex inhibitors</span> <span class="citation_source-journal">Virology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">444</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=444&publication_year=2013&pages=343-354&author=D.+R.+O%E2%80%99Boyleauthor=J.+-H.+Sunauthor=P.+Nowerauthor=A.+J.+Lemmauthor=R.+A.+Fridellauthor=C.+Wangauthor=J.+L.+Romineauthor=M.+Belemaauthor=V.+N.+Nguyenauthor=D.+R.+Laurentauthor=M.+H.+Serrano-Wuauthor=L.+B.+Snyderauthor=N.+A.+Meanwellauthor=D.+R.+Langleyauthor=M.+Gao&title=Characterizations+of+HCV+NS5A+replication+complex+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DD.%2BR.%26aulast%3DSun%26aufirst%3DJ.%2B-H.%26aulast%3DNower%26aufirst%3DP.%26aulast%3DLemm%26aufirst%3DA.%2BJ.%26aulast%3DFridell%26aufirst%3DR.%2BA.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DRomine%26aufirst%3DJ.%2BL.%26aulast%3DBelema%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DV.%2BN.%26aulast%3DLaurent%26aufirst%3DD.%2BR.%26aulast%3DSerrano-Wu%26aufirst%3DM.%2BH.%26aulast%3DSnyder%26aufirst%3DL.%2BB.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DLangley%26aufirst%3DD.%2BR.%26aulast%3DGao%26aufirst%3DM.%26atitle%3DCharacterizations%2520of%2520HCV%2520NS5A%2520replication%2520complex%2520inhibitors%26jtitle%3DVirology%26date%3D2013%26volume%3D444%26spage%3D343%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2a','cit2b'],'ref3':['cit3a','cit3b'],'ref4':['cit4'],'ref5':['cit5a','cit5b'],'ref6':['cit6a','cit6b','cit6c'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11a','cit11b'],'ref12':['cit12'],'ref13':[],'ref14':['cit14a','cit14b'],'ref15':[],'ref16':[],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 17 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>  . </span><span class="cited-content_cbyCitation_article-title">2015 Philip S. Portoghese Medicinal Chemistry Lectureship. Curing Hepatitis C Virus Infection with Direct-Acting Antiviral Agents: The Arc of a Medicinal Chemistry Triumph. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (16)
                                     , 7311-7351. <a href="https://doi.org/10.1021/acs.jmedchem.6b00915" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00915</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00915%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D2015%252BPhilip%252BS.%252BPortoghese%252BMedicinal%252BChemistry%252BLectureship.%252BCuring%252BHepatitis%252BC%252BVirus%252BInfection%252Bwith%252BDirect-Acting%252BAntiviral%252BAgents%25253A%252BThe%252BArc%252Bof%252Ba%252BMedicinal%252BChemistry%252BTriumph%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D18062016%26date%3D08082016%26date%3D25082016%26volume%3D59%26issue%3D16%26spage%3D7311%26epage%3D7351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandre V.  Ivachtchenko</span>, <span class="hlFld-ContribAuthor ">Oleg D.  Mitkin</span>, <span class="hlFld-ContribAuthor ">Pavel M.  Yamanushkin</span>, <span class="hlFld-ContribAuthor ">Irina V.  Kuznetsova</span>, <span class="hlFld-ContribAuthor ">Elena A.  Bulanova</span>, <span class="hlFld-ContribAuthor ">Natalia A.  Shevkun</span>, <span class="hlFld-ContribAuthor ">Angela G.  Koryakova</span>, <span class="hlFld-ContribAuthor ">Ruben N.  Karapetian</span>, <span class="hlFld-ContribAuthor ">Vadim V.  Bichko</span>, <span class="hlFld-ContribAuthor ">Andrey S.  Trifelenkov</span>, <span class="hlFld-ContribAuthor ">Dmitry V.  Kravchenko</span>, <span class="hlFld-ContribAuthor ">Natalia V.  Vostokova</span>, <span class="hlFld-ContribAuthor ">Mark S.  Veselov</span>, <span class="hlFld-ContribAuthor ">Nina V.  Chufarova</span>, and <span class="hlFld-ContribAuthor ">Yan A.  Ivanenkov</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Highly Potent Hepatitis C Virus NS5A Inhibitor (AV4025). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (18)
                                     , 7716-7730. <a href="https://doi.org/10.1021/jm500951r" title="DOI URL">https://doi.org/10.1021/jm500951r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500951r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500951r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BHighly%252BPotent%252BHepatitis%252BC%252BVirus%252BNS5A%252BInhibitor%252B%252528AV4025%252529%26aulast%3DIvachtchenko%26aufirst%3DAlexandre%2BV.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D23062014%26date%3D09092014%26date%3D25092014%26date%3D22082014%26volume%3D57%26issue%3D18%26spage%3D7716%26epage%3D7730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Makonen  Belema</span> and <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Daclatasvir, a Pan-Genotypic Hepatitis C Virus NS5A Replication Complex Inhibitor with Potent Clinical Effect. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (12)
                                     , 5057-5071. <a href="https://doi.org/10.1021/jm500335h" title="DOI URL">https://doi.org/10.1021/jm500335h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500335h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500335h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BDaclatasvir%25252C%252Ba%252BPan-Genotypic%252BHepatitis%252BC%252BVirus%252BNS5A%252BReplication%252BComplex%252BInhibitor%252Bwith%252BPotent%252BClinical%252BEffect%26aulast%3DBelema%26aufirst%3DMakonen%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D03032014%26date%3D21042014%26date%3D26062014%26volume%3D57%26issue%3D12%26spage%3D5057%26epage%3D5071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Makonen  Belema</span>, <span class="hlFld-ContribAuthor ">Omar D.  Lopez</span>, <span class="hlFld-ContribAuthor ">John A.  Bender</span>, <span class="hlFld-ContribAuthor ">Jeffrey L.  Romine</span>, <span class="hlFld-ContribAuthor ">Denis R.  St. Laurent</span>, <span class="hlFld-ContribAuthor ">David R.  Langley</span>, <span class="hlFld-ContribAuthor ">Julie A.  Lemm</span>, <span class="hlFld-ContribAuthor ">Donald R.  O’Boyle, II</span>, <span class="hlFld-ContribAuthor ">Jin-Hua  Sun</span>, <span class="hlFld-ContribAuthor ">Chunfu  Wang</span>, <span class="hlFld-ContribAuthor ">Robert A.  Fridell</span>, and <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Development of Hepatitis C Virus NS5A Replication Complex Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (5)
                                     , 1643-1672. <a href="https://doi.org/10.1021/jm401793m" title="DOI URL">https://doi.org/10.1021/jm401793m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401793m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401793m%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BDevelopment%252Bof%252BHepatitis%252BC%252BVirus%252BNS5A%252BReplication%252BComplex%252BInhibitors%26aulast%3DBelema%26aufirst%3DMakonen%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D19112013%26date%3D03022014%26date%3D13032014%26volume%3D57%26issue%3D5%26spage%3D1643%26epage%3D1672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Makonen Belema, Van N. Nguyen, Carol Bachand, Dan H. Deon, Jason
T. Goodrich, Clint A. James, Rico Lavoie, Omar D. Lopez, Alain Martel, Jeffrey L. Romine, Edward H. Ruediger, Lawrence B. Snyder, Denis R. St. Laurent, Fukang Yang, Juliang Zhu, Henry
S. Wong, David R. Langley, Stephen P. Adams, Glenn H. Cantor, Anjaneya Chimalakonda, Aberra Fura, Benjamin M. Johnson, Jay O. Knipe, Dawn D. Parker, Kenneth
S. Santone, Robert A. Fridell, Julie A. Lemm, Donald R. O’Boyle, II, Richard J. Colonno, Min Gao, Nicholas
A. Meanwell, <span class="NLM_string-name hlFld-ContribAuthor">Lawrence G. Hamann</span>. </span><span class="cited-content_cbyCitation_article-title">Hepatitis C Virus NS5A Replication Complex Inhibitors: The Discovery of Daclatasvir. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (5)
                                     , 2013-2032. <a href="https://doi.org/10.1021/jm401836p" title="DOI URL">https://doi.org/10.1021/jm401836p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401836p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401836p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHepatitis%252BC%252BVirus%252BNS5A%252BReplication%252BComplex%252BInhibitors%25253A%252BThe%252BDiscovery%252Bof%252BDaclatasvir%26aulast%3DBelema%26aufirst%3DMakonen%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D27112013%26date%3D12022014%26volume%3D57%26issue%3D5%26spage%3D2013%26epage%3D2032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaoyi  Sun</span>, <span class="hlFld-ContribAuthor ">Qi  Jia</span>, <span class="hlFld-ContribAuthor ">Zaihui  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Applications of amide isosteres in medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (18)
                                     , 2535-2550. <a href="https://doi.org/10.1016/j.bmcl.2019.07.033" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.07.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.07.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.07.033%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DApplications%252Bof%252Bamide%252Bisosteres%252Bin%252Bmedicinal%252Bchemistry%26aulast%3DSun%26aufirst%3DShaoyi%26date%3D2019%26volume%3D29%26issue%3D18%26spage%3D2535%26epage%3D2550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Makonen  Belema</span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery and Development of Daclatasvir: An Inhibitor of the Hepatitis C Virus NS5A Replication Complex. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 27-55. <a href="https://doi.org/10.1007/7355_2018_47" title="DOI URL">https://doi.org/10.1007/7355_2018_47</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2018_47&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2018_47%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDiscovery%252Band%252BDevelopment%252Bof%252BDaclatasvir%25253A%252BAn%252BInhibitor%252Bof%252Bthe%252BHepatitis%252BC%252BVirus%252BNS5A%252BReplication%252BComplex%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2019%26date%3D2019%26spage%3D27%26epage%3D55%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHCV%25253A%252BThe%252BJourney%252Bfrom%252BDiscovery%252Bto%252Ba%252BCure%26aulast%3DSofia%26aufirst%3DMichael%2BJ.%26date%3D2019%26volume%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui-Zhen  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi-Long  Zhao</span>, <span class="hlFld-ContribAuthor ">Cheng-He  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advance in oxazole-based medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>144 </em>, 444-492. <a href="https://doi.org/10.1016/j.ejmech.2017.12.044" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.12.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.12.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.12.044%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvance%252Bin%252Boxazole-based%252Bmedicinal%252Bchemistry%26aulast%3DZhang%26aufirst%3DHui-Zhen%26date%3D2018%26volume%3D144%26spage%3D444%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Youngsu  You</span>, <span class="hlFld-ContribAuthor ">Hee Sun  Kim</span>, <span class="hlFld-ContribAuthor ">Jung Woo  Park</span>, <span class="hlFld-ContribAuthor ">Gyochang  Keum</span>, <span class="hlFld-ContribAuthor ">Sung Key  Jang</span>, <span class="hlFld-ContribAuthor ">B. Moon  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfur(
              vi
              ) fluoride exchange as a key reaction for synthesizing biaryl sulfate core derivatives as potent hepatitis C virus NS5A inhibitors and their structure–activity relationship studies. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (55)
                                     , 31803-31821. <a href="https://doi.org/10.1039/C8RA05471A" title="DOI URL">https://doi.org/10.1039/C8RA05471A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA05471A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA05471A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSulfur%252528%252Bvi%252B%252529%252Bfluoride%252Bexchange%252Bas%252Ba%252Bkey%252Breaction%252Bfor%252Bsynthesizing%252Bbiaryl%252Bsulfate%252Bcore%252Bderivatives%252Bas%252Bpotent%252Bhepatitis%252BC%252Bvirus%252BNS5A%252Binhibitors%252Band%252Btheir%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bstudies%26aulast%3DYou%26aufirst%3DYoungsu%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D55%26spage%3D31803%26epage%3D31821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guangdi  Li</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>. </span><span class="cited-content_cbyCitation_article-title">Current therapy for chronic hepatitis C: The role of direct-acting antivirals. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Research</span><span> <strong>2017,</strong> <em>142 </em>, 83-122. <a href="https://doi.org/10.1016/j.antiviral.2017.02.014" title="DOI URL">https://doi.org/10.1016/j.antiviral.2017.02.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.antiviral.2017.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.antiviral.2017.02.014%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Research%26atitle%3DCurrent%252Btherapy%252Bfor%252Bchronic%252Bhepatitis%252BC%25253A%252BThe%252Brole%252Bof%252Bdirect-acting%252Bantivirals%26aulast%3DLi%26aufirst%3DGuangdi%26date%3D2017%26volume%3D142%26spage%3D83%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N.A.  Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">Direct-Acting Antiviral Agents for the Treatment of Hepatitis C Virus Infection. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 553-627. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12406-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12406-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12406-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12406-0%26sid%3Dliteratum%253Aachs%26atitle%3DDirect-Acting%252BAntiviral%252BAgents%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatitis%252BC%252BVirus%252BInfection%26aulast%3DMeanwell%26aufirst%3DN.A.%26date%3D2017%26spage%3D553%26epage%3D627%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">W.  Li</span>, <span class="hlFld-ContribAuthor ">W.  Zhao</span>, <span class="hlFld-ContribAuthor ">X.  Liu</span>, <span class="hlFld-ContribAuthor ">X.  Huang</span>, <span class="hlFld-ContribAuthor ">O. D.  Lopez</span>, <span class="hlFld-ContribAuthor ">J. E.  Leet</span>, <span class="hlFld-ContribAuthor ">R. M.  Fancher</span>, <span class="hlFld-ContribAuthor ">V.  Nguyen</span>, <span class="hlFld-ContribAuthor ">J.  Goodrich</span>, <span class="hlFld-ContribAuthor ">J.  Easter</span>, <span class="hlFld-ContribAuthor ">Y.  Hong</span>, <span class="hlFld-ContribAuthor ">J.  Caceres-Cortes</span>, <span class="hlFld-ContribAuthor ">S. Y.  Chang</span>, <span class="hlFld-ContribAuthor ">L.  Ma</span>, <span class="hlFld-ContribAuthor ">M.  Belema</span>, <span class="hlFld-ContribAuthor ">L. G.  Hamann</span>, <span class="hlFld-ContribAuthor ">M.  Gao</span>, <span class="hlFld-ContribAuthor ">M.  Zhu</span>, <span class="hlFld-ContribAuthor ">Y.-Z.  Shu</span>, <span class="hlFld-ContribAuthor ">W. G.  Humphreys</span>, <span class="hlFld-ContribAuthor ">B. M.  Johnson</span>. </span><span class="cited-content_cbyCitation_article-title">Biotransformation of Daclatasvir In Vitro and in Nonclinical Species: Formation of the Main Metabolite by Pyrrolidine  -Oxidation and Rearrangement. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2016,</strong> <em>44 </em>
                                    (6)
                                     , 809-820. <a href="https://doi.org/10.1124/dmd.115.068866" title="DOI URL">https://doi.org/10.1124/dmd.115.068866</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.115.068866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.115.068866%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DBiotransformation%252Bof%252BDaclatasvir%252BIn%252BVitro%252Band%252Bin%252BNonclinical%252BSpecies%25253A%252BFormation%252Bof%252Bthe%252BMain%252BMetabolite%252Bby%252BPyrrolidine%252B%2525C2%2525A0-Oxidation%252Band%252BRearrangement%26aulast%3DLi%26aufirst%3DW.%26date%3D2016%26date%3D2016%26volume%3D44%26issue%3D6%26spage%3D809%26epage%3D820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas O.  Moore</span>, <span class="hlFld-ContribAuthor ">Michael  Paradowski</span>, <span class="hlFld-ContribAuthor ">Simon E.  Ward</span>. </span><span class="cited-content_cbyCitation_article-title">An atom-efficient and convergent approach to the preparation of NS5A inhibitors by C–H activation. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (12)
                                     , 3307-3313. <a href="https://doi.org/10.1039/C6OB00340K" title="DOI URL">https://doi.org/10.1039/C6OB00340K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6OB00340K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6OB00340K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DAn%252Batom-efficient%252Band%252Bconvergent%252Bapproach%252Bto%252Bthe%252Bpreparation%252Bof%252BNS5A%252Binhibitors%252Bby%252BC%2525E2%252580%252593H%252Bactivation%26aulast%3DMoore%26aufirst%3DThomas%2BO.%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D12%26spage%3D3307%26epage%3D3313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Makonen  Belema</span>, <span class="hlFld-ContribAuthor ">Shawn K.  Pack</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">Daclatasvir (Daklinza): The First-in-Class HCV NS5A Replication Complex Inhibitor. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 43-60. <a href="https://doi.org/10.1002/9781118819951.ch3" title="DOI URL">https://doi.org/10.1002/9781118819951.ch3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118819951.ch3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118819951.ch3%26sid%3Dliteratum%253Aachs%26atitle%3DDaclatasvir%252B%252528Daklinza%252529%25253A%252BThe%252BFirst-in-Class%252BHCV%252BNS5A%252BReplication%252BComplex%252BInhibitor%26aulast%3DBelema%26aufirst%3DMakonen%26date%3D2015%26date%3D2015%26spage%3D43%26epage%3D60%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DInnovative%252BDrug%252BSynthesis%26aulast%3DLi%26aufirst%3DJie%2BJack%26date%3D2015%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Il Hak  Bae</span>, <span class="hlFld-ContribAuthor ">Hee Sun  Kim</span>, <span class="hlFld-ContribAuthor ">Youngsu  You</span>, <span class="hlFld-ContribAuthor ">Chieyeon  Chough</span>, <span class="hlFld-ContribAuthor ">Weonu  Choe</span>, <span class="hlFld-ContribAuthor ">Min Kyung  Seon</span>, <span class="hlFld-ContribAuthor ">Seung Gi  Lee</span>, <span class="hlFld-ContribAuthor ">Gyochang  Keum</span>, <span class="hlFld-ContribAuthor ">Sung Key  Jang</span>, <span class="hlFld-ContribAuthor ">B.  Moon Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Novel benzidine and diaminofluorene prolinamide derivatives as potent hepatitis C virus NS5A inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>101 </em>, 163-178. <a href="https://doi.org/10.1016/j.ejmech.2015.06.033" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.06.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.06.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.06.033%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bbenzidine%252Band%252Bdiaminofluorene%252Bprolinamide%252Bderivatives%252Bas%252Bpotent%252Bhepatitis%252BC%252Bvirus%252BNS5A%252Binhibitors%26aulast%3DBae%26aufirst%3DIl%2BHak%26date%3D2015%26volume%3D101%26spage%3D163%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Florian  Wakenhut</span>, <span class="hlFld-ContribAuthor ">Thien Duc  Tran</span>, <span class="hlFld-ContribAuthor ">Chris  Pickford</span>, <span class="hlFld-ContribAuthor ">Stephen  Shaw</span>, <span class="hlFld-ContribAuthor ">Mike  Westby</span>, <span class="hlFld-ContribAuthor ">Caroline  Smith-Burchnell</span>, <span class="hlFld-ContribAuthor ">Lesa  Watson</span>, <span class="hlFld-ContribAuthor ">Michael  Paradowski</span>, <span class="hlFld-ContribAuthor ">Jared  Milbank</span>, <span class="hlFld-ContribAuthor ">David  Stonehouse</span>, <span class="hlFld-ContribAuthor ">Kathy  Cheung</span>, <span class="hlFld-ContribAuthor ">Robert  Wybrow</span>, <span class="hlFld-ContribAuthor ">Felice  Daverio</span>, <span class="hlFld-ContribAuthor ">Samuel  Crook</span>, <span class="hlFld-ContribAuthor ">Keith  Statham</span>, <span class="hlFld-ContribAuthor ">David  Leese</span>, <span class="hlFld-ContribAuthor ">Darren  Stead</span>, <span class="hlFld-ContribAuthor ">Fiona  Adam</span>, <span class="hlFld-ContribAuthor ">Duncan  Hay</span>, <span class="hlFld-ContribAuthor ">Lee R.  Roberts</span>, <span class="hlFld-ContribAuthor ">Jean-Yves  Chiva</span>, <span class="hlFld-ContribAuthor ">Carly  Nichols</span>, <span class="hlFld-ContribAuthor ">David C.  Blakemore</span>, <span class="hlFld-ContribAuthor ">Gilles H.  Goetz</span>, <span class="hlFld-ContribAuthor ">Ye  Che</span>, <span class="hlFld-ContribAuthor ">Iain  Gardner</span>, <span class="hlFld-ContribAuthor ">Satish  Dayal</span>, <span class="hlFld-ContribAuthor ">Andrew  Pike</span>, <span class="hlFld-ContribAuthor ">Rob  Webster</span>, <span class="hlFld-ContribAuthor ">David C.  Pryde</span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery of Potent Nonstructural Protein 5A (NS5A) Inhibitors with a Unique Resistance Profile-Part 2. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2014,</strong> <em>9 </em>
                                    (7)
                                     , 1387-1396. <a href="https://doi.org/10.1002/cmdc.201400046" title="DOI URL">https://doi.org/10.1002/cmdc.201400046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201400046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201400046%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DThe%252BDiscovery%252Bof%252BPotent%252BNonstructural%252BProtein%252B5A%252B%252528NS5A%252529%252BInhibitors%252Bwith%252Ba%252BUnique%252BResistance%252BProfile-Part%2525E2%252580%2525852%26aulast%3DWakenhut%26aufirst%3DFlorian%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D7%26spage%3D1387%26epage%3D1396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erik  De Clercq</span>. </span><span class="cited-content_cbyCitation_article-title">Current race in the development of DAAs (direct-acting antivirals) against HCV. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2014,</strong> <em>89 </em>
                                    (4)
                                     , 441-452. <a href="https://doi.org/10.1016/j.bcp.2014.04.005" title="DOI URL">https://doi.org/10.1016/j.bcp.2014.04.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2014.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2014.04.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DCurrent%252Brace%252Bin%252Bthe%252Bdevelopment%252Bof%252BDAAs%252B%252528direct-acting%252Bantivirals%252529%252Bagainst%252BHCV%26aulast%3DDe%2BClercq%26aufirst%3DErik%26date%3D2014%26volume%3D89%26issue%3D4%26spage%3D441%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/medium/jm-2013-016203_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4016203&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/medium/jm-2013-016203_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selected analogues of anilide series.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4016203&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/medium/jm-2013-016203_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Analogues with Benzimidazole and Benzoxazole Scaffolds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4016203&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline, HOBT, EDCI, CH<sub>2</sub>Cl<sub>2</sub>; (b.1) AcOH, 65 °C; (b.2) DIAD, Ph<sub>3</sub>P, THF; (c) Me<sub>3</sub>Sn≡SnMe<sub>3</sub>, Pd(Ph<sub>3</sub>P)<sub>4</sub>, DMF, 80 °C; (d.1) HCl/dioxane/MeOH; (d.2) 20% TFA/CH<sub>2</sub>Cl<sub>2</sub>; (e) RCO<sub>2</sub>H, HATU, DIEA, DMF.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/medium/jm-2013-016203_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Compound <b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4016203&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HNO<sub>3</sub>/H<sub>2</sub>SO<sub>4</sub>; (b) 1 atm H<sub>2</sub>, 20% Pd(OH)<sub>2</sub>/C, MeOH/EtOAc; (c) <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline, EEDQ, CH<sub>2</sub>Cl<sub>2</sub>; (d) HCl/dioxane/MeOH; (e) (<i>R</i>)-PhCH(NMe<sub>2</sub>)CO<sub>2</sub>H, HATU, DIEA, DMF.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/medium/jm-2013-016203_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation Oxazole-Linked <i>bis</i>-Benzimidazole Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4016203&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3 N HCl/H<sub>2</sub>O, 80 °C; (b) SnCl<sub>2</sub>·2H<sub>2</sub>O, MeOH, 70 °C; (c) <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline, HATU, DIEA, DMF; (d) AcOH, 60 °C; (e) NaN<sub>3</sub>, CH<sub>3</sub>CN, 60 °C; (f) SnCl<sub>2</sub>·2H<sub>2</sub>O, MeOH, 60 °C; (g) <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline, <i>i</i>-BuO<sub>2</sub>CCl, <i>N</i>-methylmorpholine, DIEA, THF; (h) NaOH, MeOH; (i) HATU, DIEA, DMF; (j) C<sub>2</sub>Cl<sub>6</sub>, Ph<sub>3</sub>P, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>; (k) HCl/MeOH/dioxane, 0 °C to rt; (l) (<i>R</i>)-PhCH(NMe<sub>2</sub>)CO<sub>2</sub>H, HATU, DIEA, DMF.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/medium/jm-2013-016203_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of Oxazole-Linked Benzimidazole-Anilide Hybrid Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4016203&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline, EDCI, CH<sub>2</sub>Cl<sub>2</sub>; (b) <b>23</b>, HATU, DIEA, DMF; (c) C<sub>2</sub>Cl<sub>6</sub>, Ph<sub>3</sub>P, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>; (d) HCl/MeOH/dioxane, 0 °C to rt; (e) (<i>R</i>)-PhCH(NMe<sub>2</sub>)CO<sub>2</sub>H, HATU, DIEA, DMF; (f) (2<i>S</i>)-1-[(2<i>R</i>)-2-(dimethylamino)-2-phenylacetyl]pyrrolidine-2-carboxylic acid, HATU, DIEA, DMF.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/medium/jm-2013-016203_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of Regioisomeric Oxazole-Linked Anilides <b>38a</b> and <b>38b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4016203&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HATU, DIEA, DMF; (b) C<sub>2</sub>Cl<sub>6</sub>, Ph<sub>3</sub>P, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>; (c) H<sub>2</sub> (20 psi), 10% Pd/C, MeOH; (d) <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline, HATU, DIEA, DMF; (e) HCl/MeOH/dioxane, 0 °C to rt; (f) (<i>R</i>)-PhCH(NMe<sub>2</sub>)CO<sub>2</sub>H, HATU, DIEA, DMF; (g) EDCI, HOAT, <i>N</i>-methylmorpholine, DMF; (h) Burgess reagent, THF, 100 °C; (i) H<sub>2</sub> (1 atm), 10% Pd/C, EtOH/THF; (j) 20% TFA/CH<sub>2</sub>Cl<sub>2</sub>; (k) <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline, EEDQ, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/medium/jm-2013-016203_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Bioisosteric design strategy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4016203&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/medium/jm-2013-016203_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Preparation of Biarylimidazole Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-5/jm4016203/production/images/large/jm-2013-016203_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4016203&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline, HATU, DIEA, DMF; (b) NH<sub>4</sub>OAc, xylenes, 140 °C; (c) bis(pinacolato)diboron, Pd(Ph<sub>3</sub>P)<sub>4</sub>, KOAc, 1,4-dioxane; (d) <b>46a</b>, Pd(Ph<sub>3</sub>P)<sub>4</sub>, NaHCO<sub>3</sub>, DME, 80 °C; (e) 25% TFA/CH<sub>2</sub>Cl<sub>2</sub>; (f) RCO<sub>2</sub>H, HATU, DIEA, DMF; (g) Pd(Ph<sub>3</sub>P)<sub>4</sub>, NaHCO<sub>3</sub>, DMF, 80 °C; (h) H<sub>2</sub> (60 psi), 10% Pd/C, K<sub>2</sub>CO<sub>3</sub>, MeOH.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52775" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52775" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 20 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Scheel, T. K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span> </span><span class="NLM_article-title">Understanding the hepatitis C virus life cycle paves the way for highly effective therapies</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">849</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm4016203&amp;key=10.1038%2Fnm.3248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm4016203&amp;key=23836234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm4016203&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKru7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=837-849&author=T.+K.+H.+Scheelauthor=C.+M.+Rice&title=Understanding+the+hepatitis+C+virus+life+cycle+paves+the+way+for+highly+effective+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the hepatitis C virus life cycle paves the way for highly effective therapies</span></div><div class="casAuthors">Scheel, Troels K. H.; Rice, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">837-849</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  More than two decades of intense research has provided a detailed understanding of hepatitis C virus (HCV), which chronically infects 2% of the world's population.  This effort has paved the way for the development of antiviral compds. to spare patients from life-threatening liver disease.  An exciting new era in HCV therapy dawned with the recent approval of two viral protease inhibitors, used in combination with pegylated interferon-α and ribavirin; however, this is just the beginning.  Multiple classes of antivirals with distinct targets promise highly efficient combinations, and interferon-free regimens with short treatment duration and fewer side effects are the future of HCV therapy.  Ongoing and future trials will det. the best antiviral combinations and whether the current seemingly rich pipeline is sufficient for successful treatment of all patients in the face of major challenges, such as HCV diversity, viral resistance, the influence of host genetics, advanced liver disease and other co-morbidities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpde8altGxkeLVg90H21EOLACvtfcHk0ljXKL2jJyzX6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKru7rI&md5=dabc9fbc7dc0bc56115d5ede0d8ae072</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1038%2Fnm.3248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3248%26sid%3Dliteratum%253Aachs%26aulast%3DScheel%26aufirst%3DT.%2BK.%2BH.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DUnderstanding%2520the%2520hepatitis%2520C%2520virus%2520life%2520cycle%2520paves%2520the%2520way%2520for%2520highly%2520effective%2520therapies%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D837%26epage%3D849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Manns, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Hahn, T.</span><span> </span><span class="NLM_article-title">Novel therapies for hepatitis C – one pill fits all?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=595-610&author=M.+P.+Mannsauthor=T.+von+Hahn&title=Novel+therapies+for+hepatitis+C+%E2%80%93+one+pill+fits+all%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManns%26aufirst%3DM.%2BP.%26aulast%3Dvon%2BHahn%26aufirst%3DT.%26atitle%3DNovel%2520therapies%2520for%2520hepatitis%2520C%2520%25E2%2580%2593%2520one%2520pill%2520fits%2520all%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D595%26epage%3D610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shah, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowdley, K. V.</span><span> </span><span class="NLM_article-title">Review of direct-acting antiviral agents for the treatment of chronic hepatitis C</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1107</span><span class="NLM_x">–</span> <span class="NLM_lpage">1121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm4016203&amp;key=10.1517%2F13543784.2013.806482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm4016203&amp;key=23735127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm4016203&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Ghur%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2013&pages=1107-1121&author=N.+Shahauthor=T.+Pierceauthor=K.+V.+Kowdley&title=Review+of+direct-acting+antiviral+agents+for+the+treatment+of+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Review of direct-acting antiviral agents for the treatment of chronic hepatitis C</span></div><div class="casAuthors">Shah, Nihar; Pierce, Tracey; Kowdley, Kris V.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1107-1121</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Rapid breakthroughs in the treatment of hepatitis C virus (HCV) infection have dramatically altered the treatment landscape for this chronic disease.  In 2011, the protease inhibitors (PIs) boceprevir and telaprevir in combination with peginterferon (peg-IFN) and ribavirin (RBV) were the first direct-acting antivirals (DAAs) approved in the United States for treatment of genotype (GT) 1 HCV.  Several DAAs currently in late-stage clin. trials, including NS3/NS4A serine PIs, NS5A inhibitors, NS5B polymerase inhibitors (both nucleoside and non-nucleoside) and cyclophilin inhibitors, both with and without peg-IFN and RBV, are promising for the treatment of HCV.  DAA regimens offer several advantages including that they specifically target HCV viral replication and thus appear to be less dependent on host characteristics, very high SVR rates accompanied by fewer side effects (SE) and lower pill burdens.  A review on the treatment of HCV is important and timely as the development on DAAs is progressing rapidly and the health-care providers need to be aware about this as these regimens are anticipated to become clin. available soon.  Areas covered: The literature was searched and reviewed using PubMed as well as data gathered from those presented at the international liver meetings, AASLD and EASL as well as CROI.  Expert opinion: With the potential of eliminating IFN and RBV, several DAAs under clin. development appear to be promising using novel approaches with good antiviral effects, shorter duration and lower SE profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXZExgJKmkr7Vg90H21EOLACvtfcHk0liGEOLTUXGrQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Ghur%252FO&md5=f761cff6a6710f4de9473db6509d20a9</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1517%2F13543784.2013.806482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2013.806482%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DN.%26aulast%3DPierce%26aufirst%3DT.%26aulast%3DKowdley%26aufirst%3DK.%2BV.%26atitle%3DReview%2520of%2520direct-acting%2520antiviral%2520agents%2520for%2520the%2520treatment%2520of%2520chronic%2520hepatitis%2520C%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2013%26volume%3D22%26spage%3D1107%26epage%3D1121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liang, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghany, M. G.</span><span> </span><span class="NLM_article-title">Current and future therapies for hepatitis C virus infection</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">1907</span><span class="NLM_x">–</span> <span class="NLM_lpage">1917</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm4016203&amp;key=10.1056%2FNEJMra1213651" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm4016203&amp;key=23675659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm4016203&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsl2gs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2013&pages=1907-1917&author=T.+J.+Liangauthor=M.+G.+Ghany&title=Current+and+future+therapies+for+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Current and future therapies for hepatitis C virus infection</span></div><div class="casAuthors">Liang, T. Jake; Ghany, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1907-1917</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  The recent approval of two direct-acting antiviral agents for hepatitis C viral (HCV) infection that specifically inhibit viral replication has dramatically increased the viral clearance rate.  It is anticipated that in the course of such a screening process, a large no. of persons will be found to be infected with HCV; this article reviews the current therapy for HCV infection and the landscape of drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4zjjmKeKrZrVg90H21EOLACvtfcHk0liGEOLTUXGrQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsl2gs78%253D&md5=6be058d0298a4441a180ac076d7293aa</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1056%2FNEJMra1213651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra1213651%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DT.%2BJ.%26aulast%3DGhany%26aufirst%3DM.%2BG.%26atitle%3DCurrent%2520and%2520future%2520therapies%2520for%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D368%26spage%3D1907%26epage%3D1917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettles, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belema, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridell, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano-Wu, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Boyle, D. R.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemm, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipe, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colonno, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasela, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">465</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm4016203&amp;key=10.1038%2Fnature08960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm4016203&amp;key=20410884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm4016203&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltVGhtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2010&pages=96-100&author=M.+Gaoauthor=R.+E.+Nettlesauthor=M.+Belemaauthor=L.+B.+Snyderauthor=V.+N.+Nguyenauthor=R.+A.+Fridellauthor=M.+H.+Serrano-Wuauthor=D.+R.+Langleyauthor=J.-H.+Sunauthor=D.+R.+O%E2%80%99Boyleauthor=J.+A.+Lemmauthor=C.+Wangauthor=J.+O.+Knipeauthor=C.+Chienauthor=R.+J.+Colonnoauthor=D.+M.+Graselaauthor=N.+A.+Meanwellauthor=L.+G.+Hamann&title=Chemical+genetics+strategy+identifies+an+HCV+NS5A+inhibitor+with+a+potent+clinical+effect"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect</span></div><div class="casAuthors">Gao, Min; Nettles, Richard E.; Belema, Makonen; Snyder, Lawrence B.; Nguyen, Van N.; Fridell, Robert A.; Serrano-Wu, Michael H.; Langley, David R.; Sun, Jin-Hua; O'Boyle, Donald R., II; Lemm, Julie A.; Wang, Chunfu; Knipe, Jay O.; Chien, Caly; Colonno, Richard J.; Grasela, Dennis M.; Meanwell, Nicholas A.; Hamann, Lawrence G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">7294</span>),
    <span class="NLM_cas:pages">96-100</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The worldwide prevalence of chronic hepatitis C virus (HCV) infection is estd. to be approaching 200 million people.  Current therapy relies upon a combination of pegylated interferon-α and ribavirin, a poorly tolerated regimen typically assocd. with less than 50% sustained virol. response rate in those infected with genotype 1 virus.  The development of direct-acting antiviral agents to treat HCV has focused predominantly on inhibitors of the viral enzymes NS3 protease and the RNA-dependent RNA polymerase NS5B.  Here we describe the profile of BMS-790052, a small mol. inhibitor of the HCV NS5A protein that exhibits picomolar half-max. effective concns. (EC50) towards replicons expressing a broad range of HCV genotypes and the JFH-1 genotype 2a infectious virus in cell culture.  In a phase I clin. trial in patients chronically infected with HCV, administration of a single 100-mg dose of BMS-790052 was assocd. with a 3.3 log10 redn. in mean viral load measured 24 h post-dose that was sustained for an addnl. 120 h in two patients infected with genotype 1b virus.  Genotypic anal. of samples taken at baseline, 24 and 144 h post-dose revealed that the major HCV variants obsd. had substitutions at amino-acid positions identified using the in vitro replicon system.  These results provide the first clin. validation of an inhibitor of HCV NS5A, a protein with no known enzymic function, as an approach to the suppression of virus replication that offers potential as part of a therapeutic regimen based on combinations of HCV inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAY7Lig0xT9LVg90H21EOLACvtfcHk0liGEOLTUXGrQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltVGhtbo%253D&md5=620427e987f2bccd153270cde2ef5027</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1038%2Fnature08960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08960%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DM.%26aulast%3DNettles%26aufirst%3DR.%2BE.%26aulast%3DBelema%26aufirst%3DM.%26aulast%3DSnyder%26aufirst%3DL.%2BB.%26aulast%3DNguyen%26aufirst%3DV.%2BN.%26aulast%3DFridell%26aufirst%3DR.%2BA.%26aulast%3DSerrano-Wu%26aufirst%3DM.%2BH.%26aulast%3DLangley%26aufirst%3DD.%2BR.%26aulast%3DSun%26aufirst%3DJ.-H.%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DD.%2BR.%26aulast%3DLemm%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DChien%26aufirst%3DC.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DChemical%2520genetics%2520strategy%2520identifies%2520an%2520HCV%2520NS5A%2520inhibitor%2520with%2520a%2520potent%2520clinical%2520effect%26jtitle%3DNature%26date%3D2010%26volume%3D465%26spage%3D96%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Belema, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Laurent, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Good, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nower, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valera, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Boyle, D. R.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridell, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemm, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipe, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, L. B.</span><span> </span><span class="NLM_article-title">HCV NS5A replication complex inhibitors. Part 5: Discovery of potent and pan-genotypic glycinamide cap derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4428</span><span class="NLM_x">–</span> <span class="NLM_lpage">4435</span><div class="note"><p class="first last">and references therein</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm4016203&amp;key=10.1016%2Fj.bmcl.2013.05.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm4016203&amp;key=23803586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm4016203&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVShtrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4428-4435&author=M.+Belemaauthor=V.+N.+Nguyenauthor=D.+R.+St.+Laurentauthor=O.+D.+Lopezauthor=Y.+Qiuauthor=A.+C.+Goodauthor=P.+T.+Nowerauthor=L.+Valeraauthor=D.+R.+O%E2%80%99Boyleauthor=J.-H.+Sunauthor=M.+Liuauthor=R.+A.+Fridellauthor=J.+A.+Lemmauthor=M.+Gaoauthor=J.+O.+Knipeauthor=N.+A.+Meanwellauthor=L.+B.+Snyder&title=HCV+NS5A+replication+complex+inhibitors.+Part+5%3A+Discovery+of+potent+and+pan-genotypic+glycinamide+cap+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">HCV NS5A replication complex inhibitors. Part 5: Discovery of potent and pan-genotypic glycinamide cap derivatives</span></div><div class="casAuthors">Belema, Makonen; Nguyen, Van N.; St. Laurent, Denis R.; Lopez, Omar D.; Qiu, Yuping; Good, Andrew C.; Nower, Peter T.; Valera, Lourdes; O'Boyle, Donald R.; Sun, Jin-Hua; Liu, Mengping; Fridell, Robert A.; Lemm, Julie A.; Gao, Min; Knipe, Jay O.; Meanwell, Nicholas A.; Snyder, Lawrence B.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4428-4435</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The isoquinolinamide series of HCV NS5A inhibitors exemplified by compds. (I) and (II) provided the first dual genotype-1a/1b (GT-1a/1b) inhibitor class that demonstrated a significant improvement in potency toward GT-1a replicons compared to that of the initial program lead, stilbene (III).  Structure-activity relationship (SAR) studies that uncovered an alternate phenylglycine-based cap series that exhibit further improvements in virol. profile, along with some insights into the pharmacophoric elements assocd. with the GT-1a potency, are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxZgPIvpbytrVg90H21EOLACvtfcHk0lgCgiRfjsWtBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVShtrbO&md5=156e18764c9727e50bfd911f72d875d7</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.040%26sid%3Dliteratum%253Aachs%26aulast%3DBelema%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DV.%2BN.%26aulast%3DSt.%2BLaurent%26aufirst%3DD.%2BR.%26aulast%3DLopez%26aufirst%3DO.%2BD.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DGood%26aufirst%3DA.%2BC.%26aulast%3DNower%26aufirst%3DP.%2BT.%26aulast%3DValera%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DD.%2BR.%26aulast%3DSun%26aufirst%3DJ.-H.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DFridell%26aufirst%3DR.%2BA.%26aulast%3DLemm%26aufirst%3DJ.%2BA.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DSnyder%26aufirst%3DL.%2BB.%26atitle%3DHCV%2520NS5A%2520replication%2520complex%2520inhibitors.%2520Part%25205%253A%2520Discovery%2520of%2520potent%2520and%2520pan-genotypic%2520glycinamide%2520cap%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4428%26epage%3D4435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Kugler-Steigmeier, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friederich, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graf, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutz, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlatter, C.</span><span> </span><span class="NLM_article-title">Genotoxicity of aniline derivatives in various short-term tests</span> <span class="citation_source-journal">Mutat. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">211</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm4016203&amp;key=10.1016%2F0027-5107%2889%2990011-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm4016203&amp;key=2494442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm4016203&amp;key=1%3ACAS%3A528%3ADyaL1MXitVOmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=211&publication_year=1989&pages=279-289&author=M.+E.+Kugler-Steigmeierauthor=U.+Friederichauthor=U.+Grafauthor=W.+K.+Lutzauthor=P.+Maierauthor=C.+Schlatter&title=Genotoxicity+of+aniline+derivatives+in+various+short-term+tests"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Genotoxicity of aniline derivatives in various short-term tests</span></div><div class="casAuthors">Kugler-Steigmeier, M. E.; Friederich, U.; Graf, U.; Lutz, W. K.; Maier, P.; Schlatter, C.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Fundamental and Molecular Mechanisms of Mutagenesis</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">211</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">279-89</span>CODEN:
                <span class="NLM_cas:coden">MUREAV</span>;
        ISSN:<span class="NLM_cas:issn">0027-5107</span>.
    </div><div class="casAbstract">Various substituted aniline derivs. were tested for genotoxicity in several short-term tests to examine the hypothesis that a substitution at both ortho positions (2,6-disubstitution) could prevent genotoxicity due to steric hindrance of an enzymic activation to electrophilic intermediates.  In the Salmonella/microsome assay, 2,6-dialkylsubstituted anilines and 2,4,6-trimethylaniline (2,4,6-TMA) were weakly mutagenic in strain TA100 when 20% S9 mix was used, although effects were small compared to those of 2,4-dimethylaniline and 2,4,5-trimethylaniline (2,4,5-TMA).  In Drosophila melanogaster, however, 2,4,6-TMA and 2,4,6-trichloroaniline were mutagenic in the wing spot test at 2-3 times lower doses than 2,4,5-TMA.  In the 6-thioguanine resistance test in cultured fibroblasts, 2,4,6-TMA was again mutagenic at lower doses than 2,4,5-TMA.  Two methylene-bis-aniline derivs. were also tested with the above methods: 4,4'-methylene-bis-[(2-chloroaniline)] (MOCA) was moderately genotoxic in all 3 tests systems whereas 4,4'-methylene-bis-[(2-ethyl-6-methylaniline)] (MMEA) showed no genotoxicity at all.  DNA binding studies in rats, however, revealed that MOCA and MMEA produced DNA adducts in the liver at levels typically found for moderately strong genotoxic carcinogens.  Thus, the predictive value of the in vitro test systems and particularly the Salmonella/microsome assay is inadequate to detect genotoxicity in arom. amines.  Genotoxicity seems to be a general property of aniline derivs. and does not seem to be greatly influenced by substitution at both ortho positions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7X8K383lt8bVg90H21EOLACvtfcHk0lgCgiRfjsWtBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXitVOmtbg%253D&md5=f362df1cf93da42f697b7ca4d19ff59f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2F0027-5107%2889%2990011-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0027-5107%252889%252990011-0%26sid%3Dliteratum%253Aachs%26aulast%3DKugler-Steigmeier%26aufirst%3DM.%2BE.%26aulast%3DFriederich%26aufirst%3DU.%26aulast%3DGraf%26aufirst%3DU.%26aulast%3DLutz%26aufirst%3DW.%2BK.%26aulast%3DMaier%26aufirst%3DP.%26aulast%3DSchlatter%26aufirst%3DC.%26atitle%3DGenotoxicity%2520of%2520aniline%2520derivatives%2520in%2520various%2520short-term%2520tests%26jtitle%3DMutat.%2520Res.%26date%3D1989%26volume%3D211%26spage%3D279%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="note"><p class="first last">For a glimpse into the type of studies required to assess and/or understand the risk-factors associated with the genotoxic liabilities of embedded anilines, see:</p></div><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Behnia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelius, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipkova, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnghar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washburn, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brigance, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stetsko, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henwood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wojciechowski, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, W. G.</span><span> </span><span class="NLM_article-title">Estimation of the extent of in vivo formation of a mutagenic aromatic amine from a potent thyromimetic compound: correlation of in vitro and in vivo findings</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">912</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx200087q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=905-912&author=K.+Behniaauthor=G.+Corneliusauthor=J.+Wangauthor=P.+Shipkovaauthor=S.+Johngharauthor=W.+Washburnauthor=R.+Briganceauthor=P.+Stetskoauthor=A.+Henwoodauthor=J.+P.+Wojciechowskiauthor=P.+Maratheauthor=A.+D.+Rodriguesauthor=W.+G.+Humphreys&title=Estimation+of+the+extent+of+in+vivo+formation+of+a+mutagenic+aromatic+amine+from+a+potent+thyromimetic+compound%3A+correlation+of+in+vitro+and+in+vivo+findings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1021%2Ftx200087q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200087q%26sid%3Dliteratum%253Aachs%26aulast%3DBehnia%26aufirst%3DK.%26aulast%3DCornelius%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DShipkova%26aufirst%3DP.%26aulast%3DJohnghar%26aufirst%3DS.%26aulast%3DWashburn%26aufirst%3DW.%26aulast%3DBrigance%26aufirst%3DR.%26aulast%3DStetsko%26aufirst%3DP.%26aulast%3DHenwood%26aufirst%3DA.%26aulast%3DWojciechowski%26aufirst%3DJ.%2BP.%26aulast%3DMarathe%26aufirst%3DP.%26aulast%3DRodrigues%26aufirst%3DA.%2BD.%26aulast%3DHumphreys%26aufirst%3DW.%2BG.%26atitle%3DEstimation%2520of%2520the%2520extent%2520of%2520in%2520vivo%2520formation%2520of%2520a%2520mutagenic%2520aromatic%2520amine%2520from%2520a%2520potent%2520thyromimetic%2520compound%253A%2520correlation%2520of%2520in%2520vitro%2520and%2520in%2520vivo%2520findings%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26spage%3D905%26epage%3D912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bylund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindgren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olofsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czene, S.</span><span> </span><span class="NLM_article-title">Metabolic profiling of TRPV1 antagonists of the benzothiazole amide series: Implications for in vitro genotoxicity assessment</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2013&pages=201-210&author=J.+Bylundauthor=C.+Peterssonauthor=A.+Lindgrenauthor=S.+Olofssonauthor=S.+Czene&title=Metabolic+profiling+of+TRPV1+antagonists+of+the+benzothiazole+amide+series%3A+Implications+for+in+vitro+genotoxicity+assessment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBylund%26aufirst%3DJ.%26aulast%3DPetersson%26aufirst%3DC.%26aulast%3DLindgren%26aufirst%3DA.%26aulast%3DOlofsson%26aufirst%3DS.%26aulast%3DCzene%26aufirst%3DS.%26atitle%3DMetabolic%2520profiling%2520of%2520TRPV1%2520antagonists%2520of%2520the%2520benzothiazole%2520amide%2520series%253A%2520Implications%2520for%2520in%2520vitro%2520genotoxicity%2520assessment%26jtitle%3DXenobiotica%26date%3D2013%26volume%3D43%26spage%3D201%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="note"><p class="first last">It is noteworthy that not all anilines are promutagenic. For a theoretical treatment and examples on how anilines’ genotoxic liability could be mitigated by incorporating appropriate substituents, see:</p></div><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shamovsky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borjesson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norden, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasselgren, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donovan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjo, P.</span><span> </span><span class="NLM_article-title">Explanation for main features of structure-genotoxicity relationships of aromatic amines by theoretical studies of their activation pathways in CYP1A2</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">16168</span><span class="NLM_x">–</span> <span class="NLM_lpage">16185</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja206427u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=16168-16185&author=I.+Shamovskyauthor=L.+Ripaauthor=L.+Borjessonauthor=C.+Meeauthor=B.+Nordenauthor=P.+Hansenauthor=C.+Hasselgrenauthor=M.+O%E2%80%99Donovanauthor=P.+Sjo&title=Explanation+for+main+features+of+structure-genotoxicity+relationships+of+aromatic+amines+by+theoretical+studies+of+their+activation+pathways+in+CYP1A2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1021%2Fja206427u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja206427u%26sid%3Dliteratum%253Aachs%26aulast%3DShamovsky%26aufirst%3DI.%26aulast%3DRipa%26aufirst%3DL.%26aulast%3DBorjesson%26aufirst%3DL.%26aulast%3DMee%26aufirst%3DC.%26aulast%3DNorden%26aufirst%3DB.%26aulast%3DHansen%26aufirst%3DP.%26aulast%3DHasselgren%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Donovan%26aufirst%3DM.%26aulast%3DSjo%26aufirst%3DP.%26atitle%3DExplanation%2520for%2520main%2520features%2520of%2520structure-genotoxicity%2520relationships%2520of%2520aromatic%2520amines%2520by%2520theoretical%2520studies%2520of%2520their%2520activation%2520pathways%2520in%2520CYP1A2%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D16168%26epage%3D16185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Birch, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groombridge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mee, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schramm, C.</span><span> </span><span class="NLM_article-title">Rationally designing safer anilines: The challenging case of 4-aminobiphenyls</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3923</span><span class="NLM_x">–</span> <span class="NLM_lpage">3933</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3001295" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3923-3933&author=A.+M.+Birchauthor=S.+Groombridgeauthor=R.+Lawauthor=A.+G.+Leachauthor=C.+D.+Meeauthor=C.+Schramm&title=Rationally+designing+safer+anilines%3A+The+challenging+case+of+4-aminobiphenyls"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1021%2Fjm3001295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3001295%26sid%3Dliteratum%253Aachs%26aulast%3DBirch%26aufirst%3DA.%2BM.%26aulast%3DGroombridge%26aufirst%3DS.%26aulast%3DLaw%26aufirst%3DR.%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DMee%26aufirst%3DC.%2BD.%26aulast%3DSchramm%26aufirst%3DC.%26atitle%3DRationally%2520designing%2520safer%2520anilines%253A%2520The%2520challenging%2520case%2520of%25204-aminobiphenyls%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3923%26epage%3D3933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hamann, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manfredi, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krystek, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augeri, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betebenner, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhns, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupisella, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darienzo, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Custer, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biller, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostrowski, J.</span><span> </span><span class="NLM_article-title">Tandem optimization of target activity and elimination of mutagenic potential in a potent series of <i>N</i>-aryl bicyclic hydantoin-based selective androgen receptor modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1860</span><span class="NLM_x">–</span> <span class="NLM_lpage">1864</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Fjm4016203&amp;key=10.1016%2Fj.bmcl.2007.01.076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm4016203&amp;key=17292608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm4016203&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis1OgtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1860-1864&author=L.+G.+Hamannauthor=M.+C.+Manfrediauthor=C.+Sunauthor=S.+R.+Krystekauthor=Y.+Huangauthor=Y.+Biauthor=D.+J.+Augeriauthor=T.+Wangauthor=Y.+Zouauthor=D.+A.+Betebennerauthor=A.+Furaauthor=R.+Seethalaauthor=R.+Gollaauthor=J.+E.+Kuhnsauthor=J.+A.+Lupisellaauthor=C.+J.+Darienzoauthor=L.+L.+Custerauthor=J.+L.+Priceauthor=J.+M.+Johnsonauthor=S.+A.+Billerauthor=R.+Zahlerauthor=J.+Ostrowski&title=Tandem+optimization+of+target+activity+and+elimination+of+mutagenic+potential+in+a+potent+series+of+N-aryl+bicyclic+hydantoin-based+selective+androgen+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Tandem optimization of target activity and elimination of mutagenic potential in a potent series of N-aryl bicyclic hydantoin-based selective androgen receptor modulators</span></div><div class="casAuthors">Hamann, Lawrence G.; Manfredi, Mark C.; Sun, Chongqing; Krystek, Stanley R.; Huang, Yanting; Bi, Yingzhi; Augeri, David J.; Wang, Tammy; Zou, Yan; Betebenner, David A.; Fura, Aberra; Seethala, Ramakrishna; Golla, Rajasree; Kuhns, Joyce E.; Lupisella, John A.; Darienzo, Celia J.; Custer, Laura L.; Price, Jennifer L.; Johnson, James M.; Biller, Scott A.; Zahler, Robert; Ostrowski, Jacek</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1860-1864</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Pharmacokinetic studies in cynomolgus monkeys with a novel prototype selective androgen receptor modulator revealed trace amts. of an aniline fragment released through hydrolytic metab.  This aniline fragment was detd. to be mutagenic in an Ames assay.  Subsequent concurrent optimization for target activity and avoidance of mutagenicity led to the identification of a pharmacol. superior clin. candidate without mutagenic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvKnarhfgrgbVg90H21EOLACvtfcHk0li0uVjFuyOM3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis1OgtL4%253D&md5=5511a61de3af0ecc58d761a3bcb4bf12</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.01.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.01.076%26sid%3Dliteratum%253Aachs%26aulast%3DHamann%26aufirst%3DL.%2BG.%26aulast%3DManfredi%26aufirst%3DM.%2BC.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DKrystek%26aufirst%3DS.%2BR.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DBi%26aufirst%3DY.%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DBetebenner%26aufirst%3DD.%2BA.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DGolla%26aufirst%3DR.%26aulast%3DKuhns%26aufirst%3DJ.%2BE.%26aulast%3DLupisella%26aufirst%3DJ.%2BA.%26aulast%3DDarienzo%26aufirst%3DC.%2BJ.%26aulast%3DCuster%26aufirst%3DL.%2BL.%26aulast%3DPrice%26aufirst%3DJ.%2BL.%26aulast%3DJohnson%26aufirst%3DJ.%2BM.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DZahler%26aufirst%3DR.%26aulast%3DOstrowski%26aufirst%3DJ.%26atitle%3DTandem%2520optimization%2520of%2520target%2520activity%2520and%2520elimination%2520of%2520mutagenic%2520potential%2520in%2520a%2520potent%2520series%2520of%2520N-aryl%2520bicyclic%2520hydantoin-based%2520selective%2520androgen%2520receptor%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1860%26epage%3D1864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Barmeld, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">Small molecule conformational preferences derived from crystal structure data. A medicinal chemistry focused analysis</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci7002494" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=1-24&author=K.+A.+Barmeldauthor=B.+Kuhnauthor=D.+C.+Reuterauthor=M.+Stahl&title=Small+molecule+conformational+preferences+derived+from+crystal+structure+data.+A+medicinal+chemistry+focused+analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fci7002494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci7002494%26sid%3Dliteratum%253Aachs%26aulast%3DBarmeld%26aufirst%3DK.%2BA.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DReuter%26aufirst%3DD.%2BC.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DSmall%2520molecule%2520conformational%2520preferences%2520derived%2520from%2520crystal%2520structure%2520data.%2520A%2520medicinal%2520chemistry%2520focused%2520analysis%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2008%26volume%3D48%26spage%3D1%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Lin, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanza, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castonguay, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamenecka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Riper, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egger, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mumford, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCoss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagmann, W. K.</span><span> </span><span class="NLM_article-title">Bioisosteric replacement of anilide with benzoxazole: Potent and orally bioavailable antagonists of VLA-4</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2331</span><span class="NLM_x">–</span> <span class="NLM_lpage">2334</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=2331-2334&author=L.+S.+Linauthor=T.+J.+Lanzaauthor=L.+A.+Castonguayauthor=T.+Kameneckaauthor=E.+McCauleyauthor=G.+Van+Riperauthor=L.+A.+Eggerauthor=R.+A.+Mumfordauthor=X.+Tongauthor=M.+MacCossauthor=J.+A.+Schmidtauthor=W.+K.+Hagmann&title=Bioisosteric+replacement+of+anilide+with+benzoxazole%3A+Potent+and+orally+bioavailable+antagonists+of+VLA-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DL.%2BS.%26aulast%3DLanza%26aufirst%3DT.%2BJ.%26aulast%3DCastonguay%26aufirst%3DL.%2BA.%26aulast%3DKamenecka%26aufirst%3DT.%26aulast%3DMcCauley%26aufirst%3DE.%26aulast%3DVan%2BRiper%26aufirst%3DG.%26aulast%3DEgger%26aufirst%3DL.%2BA.%26aulast%3DMumford%26aufirst%3DR.%2BA.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DJ.%2BA.%26aulast%3DHagmann%26aufirst%3DW.%2BK.%26atitle%3DBioisosteric%2520replacement%2520of%2520anilide%2520with%2520benzoxazole%253A%2520Potent%2520and%2520orally%2520bioavailable%2520antagonists%2520of%2520VLA-4%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D2331%26epage%3D2334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Belema, M.; Good, A. C.; Goodrich, J. T.; Kakarla, R.; Li, G.; Lopez, O. D.; Nguyen, V. N.; Kapur, J.; Qiu, Y.; Romine, J. L.; St. Laurent, D. R.; Serrano-Wu, M. H.; Snyder, L. B.; Yang, F.</span><span> </span><span class="NLM_article-title">Bi-1<i>H</i>-benzimidazoles as hepatitis C virus inhibitors</span>. PCT Int. Patent WO2010-017401,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=M.+Belema&author=A.+C.+Good&author=J.+T.+Goodrich&author=R.+Kakarla&author=G.+Li&author=O.+D.+Lopez&author=V.+N.+Nguyen&author=J.+Kapur&author=Y.+Qiu&author=J.+L.+Romine&author=D.+R.+St.+Laurent&author=M.+H.+Serrano-Wu&author=L.+B.+Snyder&author=F.+Yang&title=Bi-1H-benzimidazoles+as+hepatitis+C+virus+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBelema%26aufirst%3DM.%26atitle%3DBi-1H-benzimidazoles%2520as%2520hepatitis%2520C%2520virus%2520inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Nobel, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lommerse, J. P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span> </span><span class="NLM_article-title">Hydrogen bonding properties of oxygen and nitrogen acceptors in aromatic heterocycles</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2060</span><span class="NLM_x">–</span> <span class="NLM_lpage">2074</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1997&pages=2060-2074&author=I.+Nobelauthor=S.+L.+Priceauthor=J.+P.+M.+Lommerseauthor=R.+Taylor&title=Hydrogen+bonding+properties+of+oxygen+and+nitrogen+acceptors+in+aromatic+heterocycles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNobel%26aufirst%3DI.%26aulast%3DPrice%26aufirst%3DS.%2BL.%26aulast%3DLommerse%26aufirst%3DJ.%2BP.%2BM.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DHydrogen%2520bonding%2520properties%2520of%2520oxygen%2520and%2520nitrogen%2520acceptors%2520in%2520aromatic%2520heterocycles%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1997%26volume%3D18%26spage%3D2060%26epage%3D2074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">For details on the biological assays, see:</p></div><span class="NLM_contrib-group">Laurent, D. R.; Serrano-Wu, M. H.; Belema, M.; Ding, M.; Fang, H.; Gao, M.; Goodrich, J. T.; Krause, R. G.; Lemm, J. A.; Liu, M.; Lopez, O.; Nguyen, V. N.; Nower, P. T.; O’Boyle, D. R.; Pearce, B. C.; Romine, J. L.; Valera, L.; Sun, J.-H.; Wang, Y.-K.; Yang, F.; Yang, X.; Meanwell, N. A.; Snyder, L. B.</span><span> </span><span class="NLM_article-title">HCV NS5A replication complex inhibitors. Part 4. Optimization for genotype 1a replicon inhibitory activity</span>.  <span class="citation_source-journal">J. Med. Chem.</span> [Online early access]. DOI: <span class="refDoi"> DOI: 10.1021/jm301796k</span> . Published Online: April 10,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/jm301796k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=D.+R.+Laurent&author=M.+H.+Serrano-Wu&author=M.+Belema&author=M.+Ding&author=H.+Fang&author=M.+Gao&author=J.+T.+Goodrich&author=R.+G.+Krause&author=J.+A.+Lemm&author=M.+Liu&author=O.+Lopez&author=V.+N.+Nguyen&author=P.+T.+Nower&author=D.+R.+O%E2%80%99Boyle&author=B.+C.+Pearce&author=J.+L.+Romine&author=L.+Valera&author=J.-H.+Sun&author=Y.-K.+Wang&author=F.+Yang&author=X.+Yang&author=N.+A.+Meanwell&author=L.+B.+Snyder&title=HCV+NS5A+replication+complex+inhibitors.+Part+4.+Optimization+for+genotype+1a+replicon+inhibitory+activity&doi=10.1021%2Fjm301796k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1021%2Fjm301796k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301796k%26sid%3Dliteratum%253Aachs%26aulast%3DLaurent%26aufirst%3DD.%2BR.%26atitle%3DHCV%2520NS5A%2520replication%2520complex%2520inhibitors.%2520Part%25204.%2520Optimization%2520for%2520genotype%25201a%2520replicon%2520inhibitory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26doi%3D10.1021%2Fjm301796k%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">No difference in replicon activity was observed when select compounds were tested as either free base or TFA salt.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=No+difference+in+replicon+activity+was+observed+when+select+compounds+were+tested+as+either+free+base+or+TFA+salt."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><div class="note"><p class="first last">For a report on the susceptibility of 2-methylbenzoxazole containing analogue to hydrolytic opening of the ring under assay sample-handling conditions, see:</p></div><span class="NLM_contrib-group">McElhinny, C. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewin, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascarella, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Runyon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brieaddy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, F. I.</span><span> </span><span class="NLM_article-title">Hydrolytic instability of the important orexin 1 receptor antagonist SB-334867: Possible confounding effects on in vivo and in vitro studies</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">6661</span><span class="NLM_x">–</span> <span class="NLM_lpage">6664</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6661-6664&author=C.+J.+McElhinnyauthor=A.+H.+Lewinauthor=S.+W.+Mascarellaauthor=S.+Runyonauthor=L.+Brieaddyauthor=F.+I.+Carroll&title=Hydrolytic+instability+of+the+important+orexin+1+receptor+antagonist+SB-334867%3A+Possible+confounding+effects+on+in+vivo+and+in+vitro+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcElhinny%26aufirst%3DC.%2BJ.%26aulast%3DLewin%26aufirst%3DA.%2BH.%26aulast%3DMascarella%26aufirst%3DS.%2BW.%26aulast%3DRunyon%26aufirst%3DS.%26aulast%3DBrieaddy%26aufirst%3DL.%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26atitle%3DHydrolytic%2520instability%2520of%2520the%2520important%2520orexin%25201%2520receptor%2520antagonist%2520SB-334867%253A%2520Possible%2520confounding%2520effects%2520on%2520in%2520vivo%2520and%2520in%2520vitro%2520studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D6661%26epage%3D6664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="note"><p class="first last">Incubation of <b>15a</b> and <b>16a</b> in replicon medium (5 μM, 37 °C, 48 h) followed by EtOAc extraction and LC/MS analyses revealed that the main peak for each corresponded with the respective parental compounds. It should be noted, however, that no attempt was made to ascertain their concentration or to determine if the putative hydrolysis products would have been extracted from the assay medium under the noted conditions.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lopez, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Laurent, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belema, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano-Wu, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodrich, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripka, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nower, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valera, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Boyle, D. R.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridell, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemm, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Good, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, L. B.</span><span> </span><span class="NLM_article-title">HCV NS5A replication complex inhibitors. Part 3: Discovery of potent analogs with distinct core topologies</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=779-784&author=O.+D.+Lopezauthor=V.+N.+Nguyenauthor=D.+R.+St.+Laurentauthor=M.+Belemaauthor=M.+H.+Serrano-Wuauthor=J.+T.+Goodrichauthor=F.+Yangauthor=Y.+Qiuauthor=A.+S.+Ripkaauthor=P.+T.+Nowerauthor=L.+Valeraauthor=M.+Liuauthor=D.+R.+O%E2%80%99Boyleauthor=J.-H.+Sunauthor=R.+A.+Fridellauthor=J.+A.+Lemmauthor=M.+Gaoauthor=A.+C.+Goodauthor=N.+A.+Meanwellauthor=L.+B.+Snyder&title=HCV+NS5A+replication+complex+inhibitors.+Part+3%3A+Discovery+of+potent+analogs+with+distinct+core+topologies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLopez%26aufirst%3DO.%2BD.%26aulast%3DNguyen%26aufirst%3DV.%2BN.%26aulast%3DSt.%2BLaurent%26aufirst%3DD.%2BR.%26aulast%3DBelema%26aufirst%3DM.%26aulast%3DSerrano-Wu%26aufirst%3DM.%2BH.%26aulast%3DGoodrich%26aufirst%3DJ.%2BT.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DRipka%26aufirst%3DA.%2BS.%26aulast%3DNower%26aufirst%3DP.%2BT.%26aulast%3DValera%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DD.%2BR.%26aulast%3DSun%26aufirst%3DJ.-H.%26aulast%3DFridell%26aufirst%3DR.%2BA.%26aulast%3DLemm%26aufirst%3DJ.%2BA.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DGood%26aufirst%3DA.%2BC.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DSnyder%26aufirst%3DL.%2BB.%26atitle%3DHCV%2520NS5A%2520replication%2520complex%2520inhibitors.%2520Part%25203%253A%2520Discovery%2520of%2520potent%2520analogs%2520with%2520distinct%2520core%2520topologies%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D779%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">It is noteworthy that a side product that is believed to be a regioisomer of <b>18</b>, and which would have ultimately yielded <b>38b</b>, is formed during the dinitration of 2,5-diphenyloxazole and was carried through the subsequent transformations until the penultimate step, where it was removed through recrystallization.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=It+is+noteworthy+that+a+side+product+that+is+believed+to+be+a+regioisomer+of+18%2C+and+which+would+have+ultimately+yielded+38b%2C+is+formed+during+the+dinitration+of+2%2C5-diphenyloxazole+and+was+carried+through+the+subsequent+transformations+until+the+penultimate+step%2C+where+it+was+removed+through+recrystallization."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="note"><p class="first last">There is an error in the replicon activity of the phenylacetyl cap analogue of <b>21</b> (i.e., (2<i>S</i>)-1-(2-phenylacetyl)-<i>N</i>-[4-(5-{4-[(2<i>S</i>)-1-(2-phenylacetyl)pyrrolidine-2-amido]phenyl}-1,3-oxazol-2-yl)phenyl]pyrrolidine-2-carboxamide) reported previously in ref <a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">14a</a> because of a sample contamination issue. The revised EC<sub>50</sub> value of this analogue toward GT-1b replicon is 429 nM.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="note"><p class="first last">Preparation of compound <b>31b</b> from 3-aminobenzoic acid according to the procedure described for its regioisomer, <b>31a</b>, resulted in a final product containing a significant amount of an unidentified impurity, which could not be removed readily. The alternate route provided a sample of <b>31b</b> in 90% HPLC purity.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><div class="note"><p class="first last">For an example of the use of imidazoles as amide isosteres, see:</p></div><span class="NLM_contrib-group">Breslin, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miskowski, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukla, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leister, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Winter, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somers, M. V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peeters, D. C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roevens, P. W. M.</span><span> </span><span class="NLM_article-title">Design, synthesis, and tripeptidyl peptidase II inhibitory activity of a novel series of (<i>S</i>)-2,3-dihydro-2-(4-alkyl-1<i>H</i>-imidazol-2-yl)-1<i>H</i>-indoles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5303</span><span class="NLM_x">–</span> <span class="NLM_lpage">5310</span><div class="note"><p class="first last">and ref <a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">10</a> cited therein</p></div></span><div class="citationLinks">[<a href="/doi/10.1021/jm0202831" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5303-5310&author=H.+J.+Breslinauthor=T.+A.+Miskowskiauthor=M.+J.+Kuklaauthor=W.+H.+Leisterauthor=H.+L.+De+Winterauthor=D.+A.+Gauthierauthor=M.+V.+F.+Somersauthor=D.+C.+G.+Peetersauthor=P.+W.+M.+Roevens&title=Design%2C+synthesis%2C+and+tripeptidyl+peptidase+II+inhibitory+activity+of+a+novel+series+of+%28S%29-2%2C3-dihydro-2-%284-alkyl-1H-imidazol-2-yl%29-1H-indoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm0202831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0202831%26sid%3Dliteratum%253Aachs%26aulast%3DBreslin%26aufirst%3DH.%2BJ.%26aulast%3DMiskowski%26aufirst%3DT.%2BA.%26aulast%3DKukla%26aufirst%3DM.%2BJ.%26aulast%3DLeister%26aufirst%3DW.%2BH.%26aulast%3DDe%2BWinter%26aufirst%3DH.%2BL.%26aulast%3DGauthier%26aufirst%3DD.%2BA.%26aulast%3DSomers%26aufirst%3DM.%2BV.%2BF.%26aulast%3DPeeters%26aufirst%3DD.%2BC.%2BG.%26aulast%3DRoevens%26aufirst%3DP.%2BW.%2BM.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520tripeptidyl%2520peptidase%2520II%2520inhibitory%2520activity%2520of%2520a%2520novel%2520series%2520of%2520%2528S%2529-2%252C3-dihydro-2-%25284-alkyl-1H-imidazol-2-yl%2529-1H-indoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5303%26epage%3D5310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Bachand, C.; Belema, M.; Deon, D. H.; Good, A. C.; Goodrich, J. T.; James, C. A.; Lavoie, R.; Lopez, O. D.; Martel, A.; Meanwell, N. A.; Nguyen, V. N.; Romine, J. L.; Ruediger, E. H.; Snyder, L. B.; St. Laurent, D. R.; Yang, F.; Langley, D. R.; Wang, G.; Hamann, L. G.</span><span> </span><span class="NLM_article-title">Hepatitis C virus inhibitors</span>. PCT Int. Patent WO2008-021927,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=C.+Bachand&author=M.+Belema&author=D.+H.+Deon&author=A.+C.+Good&author=J.+T.+Goodrich&author=C.+A.+James&author=R.+Lavoie&author=O.+D.+Lopez&author=A.+Martel&author=N.+A.+Meanwell&author=V.+N.+Nguyen&author=J.+L.+Romine&author=E.+H.+Ruediger&author=L.+B.+Snyder&author=D.+R.+St.+Laurent&author=F.+Yang&author=D.+R.+Langley&author=G.+Wang&author=L.+G.+Hamann&title=Hepatitis+C+virus+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBachand%26aufirst%3DC.%26atitle%3DHepatitis%2520C%2520virus%2520inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Walters, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murcko, M. A.</span><span> </span><span class="NLM_article-title">What do medicinal chemists actually make? A 50-year retrospective</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6405</span><span class="NLM_x">–</span> <span class="NLM_lpage">6416</span><div class="note"><p class="first last">and references cited therein</p></div></span><div class="citationLinks">[<a href="/doi/10.1021/jm200504p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm4016203&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFWjsr7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6405-6416&author=W.+P.+Waltersauthor=J.+Greenauthor=J.+R.+Weissauthor=M.+A.+Murcko&title=What+do+medicinal+chemists+actually+make%3F+A+50-year+retrospective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">What Do Medicinal Chemists Actually Make? A 50-Year Retrospective</span></div><div class="casAuthors">Walters, W. Patrick; Green, Jeremy; Weiss, Jonathan R.; Murcko, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6405-6416</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Despite the dramatically increasing costs of pharmaceutical R&D productivity, as measured by the no. of new drugs approved each year, has languished during the past decade.  Many different explanations have been proposed to account for this decline, such as increasing regulatory scrutiny, the inherent inefficiency of very large organizations, the pursuit of highly speculative targets identified from genomics, and more objective decision-making about advancing marginal compds. into latest age clin. trials.  Another factor often cited to help explain low pharmaceutical productivity is that, paradoxically, many compds. synthesized by medicinal chemists are not "druglike", at least as measured by various criteria.  The authors discuss the past, present and perspectives in the development of medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg5xuF4wHqKrVg90H21EOLACvtfcHk0lgrQlIRGbkx2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFWjsr7O&md5=33109f9d55967be0d34f377f433621e4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm200504p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200504p%26sid%3Dliteratum%253Aachs%26aulast%3DWalters%26aufirst%3DW.%2BP.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DWeiss%26aufirst%3DJ.%2BR.%26aulast%3DMurcko%26aufirst%3DM.%2BA.%26atitle%3DWhat%2520do%2520medicinal%2520chemists%2520actually%2520make%253F%2520A%252050-year%2520retrospective%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6405%26epage%3D6416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><div class="note"><p class="first last">Although dimerically configured core/cap pharmacophore moieties appeared to be needed for potent GT-1a activity, it is noteworthy that a tool compound lacking the GT-1a potency-enhancing cap elements discussed in the text and exhibiting GT-1a EC<sub>50</sub> >10 μM binds to GT-1a protein:</p></div><span class="NLM_contrib-group">O’Boyle, D. R.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J. -H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nower, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemm, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridell, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romine, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belema, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurent, D. R.,  St.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano-Wu, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, M.</span><span> </span><span class="NLM_article-title">Characterizations of HCV NS5A replication complex inhibitors</span> <span class="citation_source-journal">Virology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">444</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=444&publication_year=2013&pages=343-354&author=D.+R.+O%E2%80%99Boyleauthor=J.+-H.+Sunauthor=P.+Nowerauthor=A.+J.+Lemmauthor=R.+A.+Fridellauthor=C.+Wangauthor=J.+L.+Romineauthor=M.+Belemaauthor=V.+N.+Nguyenauthor=D.+R.+Laurentauthor=M.+H.+Serrano-Wuauthor=L.+B.+Snyderauthor=N.+A.+Meanwellauthor=D.+R.+Langleyauthor=M.+Gao&title=Characterizations+of+HCV+NS5A+replication+complex+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DD.%2BR.%26aulast%3DSun%26aufirst%3DJ.%2B-H.%26aulast%3DNower%26aufirst%3DP.%26aulast%3DLemm%26aufirst%3DA.%2BJ.%26aulast%3DFridell%26aufirst%3DR.%2BA.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DRomine%26aufirst%3DJ.%2BL.%26aulast%3DBelema%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DV.%2BN.%26aulast%3DLaurent%26aufirst%3DD.%2BR.%26aulast%3DSerrano-Wu%26aufirst%3DM.%2BH.%26aulast%3DSnyder%26aufirst%3DL.%2BB.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DLangley%26aufirst%3DD.%2BR.%26aulast%3DGao%26aufirst%3DM.%26atitle%3DCharacterizations%2520of%2520HCV%2520NS5A%2520replication%2520complex%2520inhibitors%26jtitle%3DVirology%26date%3D2013%26volume%3D444%26spage%3D343%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm4016203&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-5%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm4016203%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm4016203" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                931KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799277a0b933d54","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
